<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>EBV on VitaminDWiki</title><link>/tags/ebv.html</link><description>Recent content in EBV on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sun, 04 May 2025 00:00:00 +0000</lastBuildDate><atom:link href="/tags/ebv/index.xml" rel="self" type="application/rss+xml"/><item><title>Many viruses deactivate the Vitamin D Receptor - measles might also</title><link>/posts/many-viruses-deactivate-the-vitamin-d-receptor-measles-might-also.html</link><pubDate>Sun, 04 May 2025 00:00:00 +0000</pubDate><guid>/posts/many-viruses-deactivate-the-vitamin-d-receptor-measles-might-also.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#measles-virus-and-its-potential-impact-on-vitamin-d-receptor-activation-perplexity-ai-may-2025">Measles Virus and Its Potential Impact on Vitamin D Receptor Activation Perplexity AI May 2025&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#8-related-items-in-vitamindwiki">8 related items in VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="measles-virus-and-its-potential-impact-on-vitamin-d-receptor-activation-perplexity-ai-may-2025">Measles Virus and Its Potential Impact on Vitamin D Receptor Activation Perplexity AI May 2025&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.perplexity.ai/search/might-the-measles-virus-reduce-gqoIT6M_SiK3VBlhd_Tq2Q">Perplexity AI - Deep Research&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Current research suggests that measles virus may potentially interfere with vitamin D receptor (VDR) activation, though direct evidence is limited. This report examines the relationship between measles virus and the vitamin D signaling pathway, exploring both direct and circumstantial evidence for how this virus might influence VDR function and the broader implications for immune response.&lt;/p></description></item><item><title>Epstein-Barr Virus increases Multiple Sclerosis risk by 1.8 X</title><link>/posts/epstein-barr-virus-increases-multiple-sclerosis-risk-by-18-x.html</link><pubDate>Wed, 05 Mar 2025 00:00:00 +0000</pubDate><guid>/posts/epstein-barr-virus-increases-multiple-sclerosis-risk-by-18-x.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#impact-of-lifestyle-factors-post-infectious-mononucleosis-on-multiple-sclerosis-risk">Impact of lifestyle factors post-infectious mononucleosis on multiple sclerosis risk&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="impact-of-lifestyle-factors-post-infectious-mononucleosis-on-multiple-sclerosis-risk">Impact of lifestyle factors post-infectious mononucleosis on multiple sclerosis risk&lt;/h4>
&lt;p>Eur J Epidemiol. 2025 Mar 4. &lt;a href="https://doi.org/10.1007/s10654-025-01212-1">doi: 10.1007/s10654-025-01212-1&lt;/a>&lt;/p>
&lt;p>Eva Johansson 1, Tomas Olsson 1 2, Lars Alfredsson 3 4, Anna Karin Hedström 5&lt;/p>
&lt;p>Background: Accumulating evidence suggest that Epstein-Barr virus (EBV) is crucial in the development of multiple sclerosis (MS), with inadequate infection control possibly contributing to disease onset. Past infectious mononucleosis (IM) has been found to interact with smoking, obesity, and sun exposure. We aimed to investigate potential interactions between a history of IM and the following risk factors for MS: passive smoking, alcohol consumption, fish consumption, vitamin D status, adolescent sleep duration and sleep quality.&lt;/p></description></item><item><title>2 year study of COVID by US Congress - published</title><link>/posts/2-year-study-of-covid-by-us-congress-published.html</link><pubDate>Mon, 02 Dec 2024 00:00:00 +0000</pubDate><guid>/posts/2-year-study-of-covid-by-us-congress-published.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#press-release-final-report-covid-select-concludes-2-year-investigation-issues-500-page-final-report">PRESS RELEASE: FINAL REPORT: COVID Select Concludes 2-Year Investigation, Issues 500+ Page Final Report&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#findings-discussed-by-stand-for-freedomhttpsstandforhealthfreedomcomhouse-cleaning-dec-7-2024">Findings discussed by &lt;a href="https://standforhealthfreedom.com/house-cleaning/">Stand for Freedom&lt;/a> Dec 7, 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#findings-did-not-include-a-call-for-a-special-prosecutor">Findings DID NOT include a call for a special prosecutor&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamindwiki-virus-category-with--of-studies-as-of-oct-2024">VitaminDWiki Virus category (with # of studies) as of Oct 2024&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="press-release-final-report-covid-select-concludes-2-year-investigation-issues-500-page-final-report">PRESS RELEASE: FINAL REPORT: COVID Select Concludes 2-Year Investigation, Issues 500+ Page Final Report&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.malone.news/p/press-release-final-report-covid?utm_source=post-email-title&amp;amp;publication_id=583200&amp;amp;post_id=152467782&amp;amp;utm_campaign=email-post-title&amp;amp;isFreemail=false&amp;amp;r=ofo3r&amp;amp;triedRedirect=true&amp;amp;utm_medium=email">Robert Malone Substack&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Interesting comments&lt;/p>
&lt;p>&lt;strong>&lt;a href="https://drive.google.com/file/d/1blH7EBk8w6aMGqAv5xKufjBhMs0pQdpt/view?usp=sharing">Copy of report in Google Drive&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Conclusions include&lt;/strong>&lt;/p></description></item><item><title>COVIDIndex - over 1,000 publications</title><link>/posts/covidindex-over-1000-publications.html</link><pubDate>Thu, 24 Oct 2024 00:00:00 +0000</pubDate><guid>/posts/covidindex-over-1000-publications.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#covidindex">COVIDIndex&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamindwiki-virus-category-and-subtopics-oct-2024">VitaminDWiki Virus category and subtopics (Oct 2024)&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="covidindex">COVIDIndex&lt;/h4>
&lt;p>&lt;a href="https://covidindex.science/index-entries">https://covidindex.science/index-entries&lt;/a>&lt;/p>
&lt;hr>
&lt;h5 id="can-search-for-words-in-title-author-description-or-topic">Can search for words in title, author, description, or topic&lt;/h5>
&lt;hr>
&lt;h5 id="101-topicshttpscovidindexsciencetopics-as-of-oct-2024">101 &lt;a href="https://covidindex.science/topics">topics&lt;/a> as of Oct 2024:&lt;/h5>
&lt;p>adverse events,    adverse-event reporting systems,    aging risk factor,    all cause mortality,    antibody dependent enhancement (ADE),    at risk populations,    autoimmunity,    bioethics,    breakthrough cases,    bromhexine,    budesonide,    cancer,    cannabidiol (CBD),    censorship,    clinical cases,    clinical trial endpoints,    clinical trials,    COVID-19,    credentialed opposition,    crime,    deaths,    disabilities,    education,    emergency use authorization (EUA),    environment,    excess mortality,    fact checking,    FDA approvals,    financial incentives influence,    fluvoxamine,    gene therapy,    government agency definitions,    graphene oxide,    health statistics,    health statistics misleading practices,    healthcare,    heart disorders,    hospitalizations,    human rights,    hunger,    hydroxychloroquine,    immunodeficiency and immunopathological disorders,    infection fatality rate (IFR),    informed consent,    international law,    ivermectin,    lipid nanoparticles,    lockdowns,    long COVID,    Mandates,    manufacturers,    manufacturers liability legal immunity,    manufacturers US government contracts,    manufacturers violations and fines,    masks,    medical freedom,    medical treatment protocols,    medical treatments,    mental health,    monoclonal antibodies,    mRNA,    natural immunity,    neurological disorders,    nutraceuticals,    obesity risk factor,    parental rights,    pathogen isolation,    pathogen origin,    pharmaceuticals,    polymerase chain reaction (PCR) testing issues,    poverty,    povidone iodine,    pre-existing conditions risk factor,    prior conditions relapse,    professional medical codes,    quercetin,    remdesivir,    reproductive system issues,    respiratory illness,    reverse transcription,    risk calculators,    risk factors,    SARS-CoV-2 spike protein,    shingles (herpes zoster) and chickenpox (herpes varicella),    US law,    vaccine (or viral) immune escape (VIE),    vaccine biodistribution,    vaccine composition,    vaccine dynamics,    vaccine ingredients,    vaccine injury testimonials,    vaccine passports,    vaccine quality control,    vaccine systemic and virological concerns,    vaccines,    vascular system issues,    ventilators,    vitamin C,    vitamin D,    Wifi/EMR,    zinc&lt;/p></description></item><item><title>How Vitamin D helps the body fight viral infections such as COVID-19</title><link>/posts/how-vitamin-d-helps-the-body-fight-viral-infections-such-as-covid-19.html</link><pubDate>Thu, 26 Sep 2024 00:00:00 +0000</pubDate><guid>/posts/how-vitamin-d-helps-the-body-fight-viral-infections-such-as-covid-19.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#role-of-vitamin-d-in-covid-19-and-other-viral-infections">Role of vitamin D in COVID-19 and other viral infections&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#some-covid-and-vitamin-d-studies">Some COVID and Vitamin D studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#some-other-virus-and-vitamin-d-studies">Some other Virus and Vitamin D studies&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="role-of-vitamin-d-in-covid-19-and-other-viral-infections">Role of vitamin D in COVID-19 and other viral infections&lt;/h4>
&lt;p>World J Virol. Sep 25, 2024; 13(3):  &lt;a href="https://doi.org/10.5501/wjv.v13.i3.95349">doi: 10.5501/wjv.v13.i3.95349&lt;/a>&lt;/p>
&lt;p>Muhammet Mesut Nezir Engin,&lt;/p>
&lt;p>Öner Özdemir &lt;a href="mailto:onerozdemir@sakarya.edu.tr">onerozdemir@sakarya.edu.tr&lt;/a>&lt;/p>
&lt;p>&lt;strong>Table of Contents&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/webp/viral-infection-toc.webp" alt="image" width="600">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/webp/viral-infections-table.webp" alt="image" width="800">
&lt;p>Vitamin D is a steroid hormone that is naturally produced in the body or obtained through dietary sources, primarily under the influence of UVB radiation. This essential nutrient has a vital role in numerous physiological processes, encompassing immune function, cell growth, differentiation, insulin regulation, and cardiovascular well-being, along with its pivotal role in sustaining the delicate equilibrium of calcium and phosphate concentrations in the body.&lt;/p></description></item><item><title>Multiple Sclerosis is treated by Vitamin D – 10 reasons</title><link>/posts/multiple-sclerosis-is-treated-by-vitamin-d-10-reasons.html</link><pubDate>Mon, 23 Sep 2024 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-is-treated-by-vitamin-d-10-reasons.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#will-there-be-enough-evidence-to-offer-vitamin-d-supplementation-to-patients-with-multiple-sclerosis-in2024">Will there be Enough Evidence to offer Vitamin D Supplementation to Patients with Multiple Sclerosis in 2024?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#asked-perplexity-ai-why-does-the-attached-study-believe-that-vitamin-d-can-treatms">Asked Perplexity AI: Why does the attached study believe that Vitamin D can treat MS?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#note-vitamin-d-has-been-treated-by-the-coimbra-protocol-since-about-2010">Note: Vitamin D has been treated by the Coimbra protocol since about 2010&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="will-there-be-enough-evidence-to-offer-vitamin-d-supplementation-to-patients-with-multiple-sclerosis-in2024">Will there be Enough Evidence to offer Vitamin D Supplementation to Patients with Multiple Sclerosis in 2024?&lt;/h4>
&lt;p>Journal of Neurology Research Reviews &amp;amp; Reports doi.org/10.47363/JNRRR/2024(6)204&lt;/p></description></item><item><title>COVID US booster shot to cost 200 dollars (if uninsured)</title><link>/posts/covid-us-booster-shot-to-cost-200-dollars-if-uninsured.html</link><pubDate>Tue, 03 Sep 2024 00:00:00 +0000</pubDate><guid>/posts/covid-us-booster-shot-to-cost-200-dollars-if-uninsured.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#coronavirus-vaccines-once-free-are-now-pricey-for-uninsured-people">Coronavirus vaccines, once free, are now pricey for uninsured people&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#many-alternatives-to-boosters---such-as-20-of-vitamin-d-to-prevent-most-viral-infections-for-4-years">Many alternatives to boosters - such as $20 of vitamin D to prevent most viral infections for 4 years&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#virus-entries-in-vitamindwiki-as-of-aug-2024">VIRUS entries in VitaminDWiki as of Aug 2024&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="coronavirus-vaccines-once-free-are-now-pricey-for-uninsured-people">Coronavirus vaccines, once free, are now pricey for uninsured people&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.washingtonpost.com/health/2024/09/03/covid-vaccine-bridge-access-program-expires-cdc/?utm_campaign=wp_the7&amp;amp;utm_medium=email&amp;amp;utm_source=newsletter&amp;amp;wpisrc=nl_the7&amp;amp;carta-url=https%3A%2F%2Fs2.washingtonpost.com%2Fcar-ln-tr%2F3ee8ca9%2F66d6e9ee97ff550effc39143%2F596bdb5f9bbc0f403f990f33%2F57%2F95%2F66d6e9ee97ff550effc39143">Washington Post - free&lt;/a>&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&amp;ldquo;The program’s elimination marks the latest tear in a safety net that once ensured people could protect themselves against the coronavirus regardless of their financial situation. Health experts worry that the paltry 22 percent rate of adults staying up-to-date on vaccines will erode further. And they fear that the roughly 25 million people without health insurance in the nation will be especially vulnerable to covid because they tend to be in poorer health and avoid medical care when sick.&amp;rdquo;&lt;/p></description></item><item><title>Pfizer COVID vaccinations resulted in altering immune systems (increased IgG4 )</title><link>/posts/pfizer-covid-vaccinations-resulted-in-altering-immune-systems-increased-igg4.html</link><pubDate>Tue, 20 Aug 2024 00:00:00 +0000</pubDate><guid>/posts/pfizer-covid-vaccinations-resulted-in-altering-immune-systems-increased-igg4.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#it-appears-vaccinations--increased-igg4--decreases-immune-system--turbo-cancers-etc">It appears Vaccinations ==&amp;gt; increased IgG4 ==&amp;gt; decreases immune system ==&amp;gt; turbo cancers etc.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#kids-who-received-mrna-covid-vaccines-had-altered-immune-systems-a-year-later--aug-2024">Kids Who Received mRNA COVID Vaccines Had Altered Immune Systems a Year Later – Aug 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#delayed-induction-of-noninflammatory-sars-cov-2-spike-specific-igg4-antibodies-detected-1-year-after-bnt162b2-vaccination-in-children--july-2024">Delayed Induction of Noninflammatory SARS-CoV-2 Spike-Specific IgG4 Antibodies Detected 1 Year After BNT162b2 Vaccination in Children – July 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#igg4-antibodies-induced-by-repeated-vaccination-may-generate-immune-tolerance-to-the-sars-cov-2-spike-protein--may-2023">IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein – May 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-does-a-large-increase-in-igg4-mean-about-the-long-term-immune-system-response--asked-perplexity-ai-aug-2024">What does a large increase in IgG4 mean about the long-term immune system response – Asked Perplexity AI Aug 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-are-the-potential-consequences-of-elevated-igg4-levels-on-overall-health---asked-perplexity-ai-aug-2024">What are the potential consequences of elevated IgG4 levels on overall health - asked Perplexity AI Aug 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#can-vitamin-d-supplementation-affect-igg4-levels---i-asked-perplexity-ai-aug-2024-yes">Can vitamin D supplementation affect IgG4 levels - I asked Perplexity AI Aug 2024 (YES!)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#do-high-levels-of-igg4-speed-up-cancer-growth---asked-perplexity-ai-aug-2024">Do high levels of IgG4 speed up cancer growth? - Asked Perplexity AI Aug 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#10-related-items-in-vitamindwiki">10 related items in VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="it-appears-vaccinations--increased-igg4--decreases-immune-system--turbo-cancers-etc">It appears Vaccinations ==&amp;gt; increased IgG4 ==&amp;gt; decreases immune system ==&amp;gt; turbo cancers etc.&lt;/h4>
&lt;hr>
&lt;h4 id="kids-who-received-mrna-covid-vaccines-had-altered-immune-systems-a-year-later--aug-2024">Kids Who Received mRNA COVID Vaccines Had Altered Immune Systems a Year Later – Aug 2024&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://childrenshealthdefense.org/defender/kids-pfizer-mrna-covid-vaccines-altered-immune-systems-year-later/?utm_source=luminate&amp;amp;utm_medium=email&amp;amp;utm_campaign=defender&amp;amp;utm_id=20240819%20">ChildrensHealth Defense&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Dr. Hollis Vitamin D interview and transcript (works great, but no profit)</title><link>/posts/dr-hollis-vitamin-d-interview-and-transcript-works-great-but-no-profit.html</link><pubDate>Tue, 16 Jul 2024 00:00:00 +0000</pubDate><guid>/posts/dr-hollis-vitamin-d-interview-and-transcript-works-great-but-no-profit.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#your-body-is-begging-for-vitamin-d-july-2024">Your Body Is BEGGING For Vitamin D!! July 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#start-of-transcript">Start of Transcript&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="your-body-is-begging-for-vitamin-d-july-2024">Your Body Is BEGGING For Vitamin D!! July 2024&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.youtube.com/watch?v=QAQ7r6jLEww">Eric Berg YouTube 53 minutes&lt;/a>&lt;/strong>&lt;/p>
&lt;h4 id="start-of-transcript">Start of Transcript&lt;/h4>
&lt;p>0:00:00.0 EB: Today we&amp;rsquo;re gonna be talking to Professor Bruce Hollis, the pioneer in Vitamin D research. You&amp;rsquo;re gonna find this extremely fascinating. Let&amp;rsquo;s dive right in. So, Dr. Hollis, I watched one of your videos and I literally had to put it on pause because you said something that blew me away. I&amp;rsquo;ve never heard this before in my life, and I had to spend the next eight hours trying to validate what you said, which is absolutely a hundred percent true. And this little piece of information will explain a lot of, I think, the confusions that people observe when they see negative research on vitamin D and a lot of other things. So that piece of information was related to, there&amp;rsquo;s actually two different systems in the body that deal with vitamin D. There&amp;rsquo;s, I guess one with bone and skeleton, and then there&amp;rsquo;s another system for everything else. Can you kind of, just as simple as possible, kind of explain those two systems?&lt;/p></description></item><item><title>Vitamin D and Health 154 dollar book (abstracts only)</title><link>/posts/vitamin-d-and-health-154-dollar-book-abstracts-only.html</link><pubDate>Thu, 23 May 2024 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-health-154-dollar-book-abstracts-only.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#chapter-one---vitamin-d-and-immune-system">Chapter One - Vitamin D and immune system&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#chapter-two---vitamin-d-and-bone-health-what-vitamin-d-can-and-cannot-do">Chapter Two - Vitamin D and bone health: What vitamin D can and cannot do&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#chapter-three---vitamin-d-and-cardiovascular-diseases">Chapter Three - Vitamin D and cardiovascular diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#chapter-four---vitamin-d-and-cancer">Chapter Four - Vitamin D and cancer&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#chapter-five---diabetes-and-vitamin-d-the-effect-of-insulin-sensitivity-and-gut-microbial-health">Chapter Five - Diabetes and vitamin D: The effect of insulin sensitivity and gut microbial health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#chapter-six---vitamin-d-alzheimers-disease-and-related-dementia">Chapter Six - Vitamin D, Alzheimer’s disease and related dementia&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#chapter-seven---vitamin-d-and-obesity">Chapter Seven - Vitamin D and obesity&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#chapter-eight---vitamin-d-and-celiac-disease">Chapter Eight - Vitamin D and celiac disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#chapter-nine---vitamin-d-and-viral-infections-infectious-diseases-autoimmune-diseases-and-cancers">Chapter Nine - Vitamin D and viral infections: Infectious diseases, autoimmune diseases, and cancers&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;p>–-&lt;/p></description></item><item><title>Vitamin D response varies from resistance that increases through life to hypersensitivity</title><link>/posts/vitamin-d-response-varies-from-resistance-that-increases-through-life-to-hypersensitivity.html</link><pubDate>Thu, 09 May 2024 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-response-varies-from-resistance-that-increases-through-life-to-hypersensitivity.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#significance-of-vitamin-d-responsiveness-on-the-etiology-of-vitamin-d-related-diseases">Significance of vitamin D responsiveness on the etiology of vitamin D-related diseases&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="significance-of-vitamin-d-responsiveness-on-the-etiology-of-vitamin-d-related-diseases">Significance of vitamin D responsiveness on the etiology of vitamin D-related diseases&lt;/h4>
&lt;p>Steroids &lt;a href="https://doi.org/10.1016/j.steroids.2024.109437">https://doi.org/10.1016/j.steroids.2024.109437&lt;/a> PDF behind paywall&lt;/p>
&lt;p>Ulla M. Järvelin a b 1, Juho M. Järvelin c 2&lt;/p>
&lt;p>&lt;strong>Highlights&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Response to Vitamin D (VD) is a continuum, varying from VD resistance to VD hypersensitivity.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Low response to VD leads to autoimmunity. VD more than recommended is needed.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Strong response to VD leads to organ calcification. The sun and extra VD cause harm.&lt;/p></description></item><item><title>Vitamin D: Viral infections, Infectious diseases, EBV and MS, Virus and Cancers – Grant</title><link>/posts/vitamin-d-viral-infections-infectious-diseases-ebv-and-ms-virus-and-cancers-grant.html</link><pubDate>Sun, 03 Mar 2024 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-viral-infections-infectious-diseases-ebv-and-ms-virus-and-cancers-grant.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-viral-infectionsinfectious-diseases-autoimmune-diseases-and-cancers">Vitamin D and viral infections:Infectious diseases, autoimmune diseases, and cancers&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#infectious-diseases">Infectious diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#autoimmune-diseases">Autoimmune diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#viruses-and-cancer">Viruses and cancer&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusion">Conclusion&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="vitamin-d-and-viral-infectionsinfectious-diseases-autoimmune-diseases-and-cancers">Vitamin D and viral infections:Infectious diseases, autoimmune diseases, and cancers&lt;/h3>
&lt;p>&lt;strong>Advances in Food and Nutrition Research ISSN 1043-4526, &lt;a href="https://doi.org/10.1016/bs.afnr.2023.12.007">https://doi.org/10.1016/bs.afnr.2023.12.007&lt;/a>&lt;/strong>&lt;/p>
&lt;p>William B. Grant: Sunlight, Nutrition and Health Research Center, San Francisco, USA &lt;a href="mailto:wbgrant@infionline.net">wbgrant@infionline.net&lt;/a>&lt;/p>
&lt;p>&lt;strong>Abstract&lt;/strong>&lt;/p>
&lt;p>Viruses can cause many human diseases. Three types of human diseases caused by viruses are discussed in this chapter: infectious diseases, autoimmune diseases, and cancers. The infectious diseases included in this chapter include three respiratory tract diseases: influenza, COVID-19, and respiratory syncytial virus. In addition, the mos­quito-borne dengue virus diseases are discussed. Vitamin D can reduce risk, severity, and mortality of the respiratory tract diseases and possibly for dengue virus. Many autoimmune diseases are initiated by the body&amp;rsquo;s reaction to a viral infection. The protective role of vitamin D in Epstein-Barr virus-related diseases such as multiple sclerosis is discussed. There are a few cancers linked to viral infections. Such cancers include cervical cancer, head and neck cancers, Hodgkin&amp;rsquo;s and non-Hodgkin&amp;rsquo;s lym­phoma, and liver cancer. Vitamin D plays an important role in reducing risk of cancer incidence and mortality, although not as strongly for viral-linked cancers as for other types of cancer.&lt;/p></description></item><item><title>Professor Raoult is calling for a moratorium on COVID-19 vaccines</title><link>/posts/professor-raoult-is-calling-for-a-moratorium-on-covid-19-vaccines.html</link><pubDate>Sun, 04 Feb 2024 00:00:00 +0000</pubDate><guid>/posts/professor-raoult-is-calling-for-a-moratorium-on-covid-19-vaccines.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#we-are-the-good-guys--mainly-professor-didier-raoult-">&amp;ldquo;We are the Good Guys&amp;rdquo; ( mainly, Professor Didier Raoult )&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="we-are-the-good-guys--mainly-professor-didier-raoult-">&amp;ldquo;We are the Good Guys&amp;rdquo; ( mainly, Professor Didier Raoult )&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://petermcculloughmd.substack.com/p/we-are-the-good-guys?utm_campaign=email-post&amp;amp;r=ofo3r&amp;amp;utm_source=substack&amp;amp;utm_medium=email">McCullough substack&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&amp;ldquo;A tireless researcher, he has published 2,300 papers and is the most cited microbiologist in Europe. He and his team have discovered 468 species of bacteria—about 1/5 of all those named and described. The bacteria genus Raoultella was named in his honor. He is probably best known as the discoverer of the so-called giant virus, so large it had previously been mistaken for an intracellular bacterium. He has won 13 major awards and is a Commander of the National Order of Merit.&amp;rdquo;&lt;/p></description></item><item><title>People with Multiple Sclerosis have blunted responses to Vitamin D supplementation</title><link>/posts/people-with-multiple-sclerosis-have-blunted-responses-to-vitamin-d-supplementation.html</link><pubDate>Wed, 17 Jan 2024 00:00:00 +0000</pubDate><guid>/posts/people-with-multiple-sclerosis-have-blunted-responses-to-vitamin-d-supplementation.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#transcriptomics-identifies-blunted-immunomodulatory-effects-of-vitamin-d-in-people-with-multiple-sclerosis">Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#9-related-items-in-vitamindwiki">9 related items in VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#several-health-problems-have-a-blunted-response-to-vitamin-d-supplementation">Several Health problems have a blunted response to Vitamin D supplementation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#strange-that-studies-have-not-tried-activating-the-vdr-in-people-with-ms">Strange that studies have not tried activating the VDR in people with MS&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="transcriptomics-identifies-blunted-immunomodulatory-effects-of-vitamin-d-in-people-with-multiple-sclerosis">Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosis&lt;/h4>
&lt;p>Scientific Reports Vol 14, Article number: 1436 (2024) &lt;a href="https://doi.org/10.1038/s41598-024-51779-0">https://doi.org/10.1038/s41598-024-51779-0&lt;/a>&lt;/p>
&lt;p>Wei Z. Yeh, Rodney Lea, Jim Stankovich, Sandeep Sampangi, Louise Laverick, Anneke Van der Walt, Vilija Jokubaitis, Melissa Gresle &amp;amp; Helmut Butzkueven&lt;/p></description></item><item><title>Blood–brain barrier dysfunction in multiple sclerosis (improved by vitamin D, etc.)</title><link>/posts/bloodbrain-barrier-dysfunction-in-multiple-sclerosis-improved-by-vitamin-d-etc.html</link><pubDate>Sat, 16 Dec 2023 00:00:00 +0000</pubDate><guid>/posts/bloodbrain-barrier-dysfunction-in-multiple-sclerosis-improved-by-vitamin-d-etc.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#bloodbrain-barrier-dysfunction-in-multiple-sclerosis-causes-consequences-and-potential-effects-of-therapies">Blood–brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#31600-hits-for-blood-brain-barrier-vitamin-d-in-google-scholar---april-2025">31,600 hits for &amp;ldquo;blood brain barrier&amp;rdquo; &amp;ldquo;vitamin d&amp;rdquo; in Google Scholar - April 2025&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-brain-in-vitamindwiki">See Brain in VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-in-vitamindwiki">See also in VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="bloodbrain-barrier-dysfunction-in-multiple-sclerosis-causes-consequences-and-potential-effects-of-therapies">Blood–brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies&lt;/h4>
&lt;p>Lancet January, 2024DOI:https://doi.org/10.1016/S1474-4422(23)00377-0 PDF behind paywall&lt;/p>
&lt;p>Bettina Zierfuss, PhD, Catherine Larochelle, MD PhD, Prof Alexandre Prat, MD PhD&lt;/p>
&lt;p>Summary&lt;/p>
&lt;p>Established by brain endothelial cells, the &lt;strong>blood–brain barrier&lt;/strong> (BBB) regulates the trafficking of molecules, restricts immune cell entry into the CNS, and has an active role in neurovascular coupling (the regulation of cerebral blood flow to support neuronal activity). In the early stages of multiple sclerosis, around the time of symptom onset, inflammatory BBB damage is accompanied by pathogenic immune cell infiltration into the CNS. In the later stages of multiple sclerosis, dysregulation of neurovascular coupling is associated with grey matter atrophy.&lt;/p></description></item><item><title>COVID infections or vaccinations may increase Multiple Sclerosis (if low D) - several studies</title><link>/posts/covid-infections-or-vaccinations-may-increase-multiple-sclerosis-if-low-d-several-studies.html</link><pubDate>Thu, 23 Nov 2023 00:00:00 +0000</pubDate><guid>/posts/covid-infections-or-vaccinations-may-increase-multiple-sclerosis-if-low-d-several-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-potential-role-of-sars-cov-2-infection-and-vaccines-in-multiple-sclerosis-onset-and-reactivation-a-case-series-and-literature-review---july-2023">The Potential Role of SARS-CoV-2 Infection and Vaccines in Multiple Sclerosis Onset and Reactivation: A Case Series and Literature Review - July 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#covid-19-and-multiple-sclerosis-a-complex-relationship-possibly-aggravated-by-low-vitamin-d-levels---feb-2023">COVID-19 and Multiple Sclerosis: A Complex Relationship Possibly Aggravated by Low Vitamin D Levels - Feb 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#multiple-sclerosis-is-associated-with-worse-covid-19-outcomes-compared-to-the-general-population-a-population-based-study---nov-2023">Multiple sclerosis is associated with worse COVID-19 outcomes compared to the general population: A population-based study - Nov 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#new-onset-multiple-sclerosis-post-covid-19-vaccination-and-correlation-with-possible-predictors-in-a-case-control-study---march-2023">New Onset Multiple Sclerosis Post-COVID-19 Vaccination and Correlation With Possible Predictors in a Case-Control Study - March 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vaccination-and-multiple-sclerosis---dr-campbell-youtube-may-2023">Vaccination and multiple sclerosis - Dr. Campbell, YouTube May 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-potential-role-of-sars-cov-2-infection-and-vaccines-in-multiple-sclerosis-onset-and-reactivation-a-case-series-and-literature-review---july-2023">The Potential Role of SARS-CoV-2 Infection and Vaccines in Multiple Sclerosis Onset and Reactivation: A Case Series and Literature Review - July 2023&lt;/h4>
&lt;p>Viruses . 2023 Jul 18;15(7):1569. &lt;a href="https://doi.org/10.3390/v15071569.">doi: 10.3390/v15071569.&lt;/a>&lt;/p></description></item><item><title>Vitamin D and COVID-19 - nice charts, more studies are needed</title><link>/posts/vitamin-d-and-covid-19-nice-charts-more-studies-are-needed.html</link><pubDate>Mon, 30 Oct 2023 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-covid-19-nice-charts-more-studies-are-needed.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-covid-19-an-update-on-evidence-and-potential-therapeutic-implications">Vitamin D and COVID-19: An Update on Evidence and Potential Therapeutic Implications&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d---virus-sections-as-of-oct-2023">Vitamin D - Virus sections as of Oct 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-and-covid-19-an-update-on-evidence-and-potential-therapeutic-implications">Vitamin D and COVID-19: An Update on Evidence and Potential Therapeutic Implications&lt;/h4>
&lt;p>Review Cureus. 2023 Sep 28;15(9):e46121. &lt;a href="https://doi.org/10.7759/cureus.46121">doi: 10.7759/cureus.46121&lt;/a>&lt;/p>
&lt;p>Aakanksha V Tiwari 1, Suwarna Dangore-Khasbage 2&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/png/update-1.png" alt="image" width="700">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/png/update-2.png" alt="image" width="700">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/png/update-3.png" alt="image" width="500">
&lt;p>The COVID-19 pandemic created havoc in the whole world since 2019. It is an explosively spreading infectious disease in which the infectious agent enters the body through sneezing coughing touching etc. The primary site of infection is the respiratory system, and the various common symptoms are dry cough, fever, dyspnea, sore throat, nasal congestion, and loss of taste sensation. A majority of the patients experience diarrhea, vomiting, severe headache, and muscle pain. Many research have been undertaken to study the therapeutic implications of different elements in coronavirus infection. One such element of interest is vitamin D. There is evidence in the literature regarding the usefulness of vitamin D in severe acute respiratory distress syndrome (ARDS) and several respiratory diseases. As the site of infection in coronavirus infection is primarily the respiratory system, reviewing in detail the correlation of this vitamin with SARS-CoV-2 infection, is an area of keen interest. Thus, the aim of this article is to explore and describe in detail the relation between the two, with reference to levels of this vitamin in diagnosed subjects and a need for its supplementation in the management of coronavirus infection and also in the prevention of post-COVID-19 complications.&lt;/p></description></item><item><title>COVID and Vitamin D book by Anderson and Grimes</title><link>/posts/covid-and-vitamin-d-book-by-anderson-and-grimes.html</link><pubDate>Fri, 22 Sep 2023 00:00:00 +0000</pubDate><guid>/posts/covid-and-vitamin-d-book-by-anderson-and-grimes.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d3-and-the-great-biology-reset">VITAMIN D3 AND THE GREAT BIOLOGY RESET&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#interview-of-author-dr-anderson-by-dr-campbell-nov-2023-and-feb-2024">Interview of author Dr. Anderson by Dr. Campbell Nov 2023 and Feb 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#here-is-the-book-i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdfanderson-grimes-vitamin-d3-and-the-great-biology-reset-compresspdfpdfpdfa-and-i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentsepubzipanderson-grimes-kindle-formatepubkindlea">Here is the book &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/anderson-grimes-vitamin-d3-and-the-great-biology-reset-compresspdf.pdf">PDF&lt;/a> and &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/epub+zip/anderson-grimes-kindle-format.epub">Kindle&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#table-of-contents">Table of Contents&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-authors-other-books-publications-interviews-and-videos">The author&amp;rsquo;s other books, publications, interviews, and videos&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#virus-sections-in-vitamindwiki-sept-2023">Virus Sections in VitaminDWiki (Sept 2023)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#a-previous-book-influence-of-vitamin-d-on-covid-19-guidebook---benskin-sept-2021postsinfluence-of-vitamin-d-on-covid-19-guidebook-benskin">A previous book: &lt;a href="/posts/influence-of-vitamin-d-on-covid-19-guidebook-benskin">Influence of Vitamin D on COVID-19 (Guidebook) - Benskin Sept 2021&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#a-previous-book-vitamin-d-deficiency-and-covid-19-book-by-drs-anderson-and-grimes---july-2020postsvitamin-d-deficiency-and-covid-19-book-by-drs-anderson-and-grimes">A previous book: &lt;a href="/posts/vitamin-d-deficiency-and-covid-19-book-by-drs-anderson-and-grimes">Vitamin D Deficiency and Covid-19: Book by Drs Anderson and Grimes - July 2020&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d3-and-the-great-biology-reset">VITAMIN D3 AND THE GREAT BIOLOGY RESET&lt;/h4>
&lt;p>&lt;strong>A journey from global D-deficiency and Lab-leaked viruses,to Nuclear Vaccines from the Gates of Hell&lt;/strong>&lt;/p></description></item><item><title>Epstein-Barr Virus may be a prerequisite for Multiple Sclerosis</title><link>/posts/epstein-barr-virus-may-be-a-prerequisite-for-multiple-sclerosis.html</link><pubDate>Thu, 10 Aug 2023 00:00:00 +0000</pubDate><guid>/posts/epstein-barr-virus-may-be-a-prerequisite-for-multiple-sclerosis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#risk-factors-for-multiple-sclerosis-in-the-context-of-epstein-barr-virus-infection">Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="risk-factors-for-multiple-sclerosis-in-the-context-of-epstein-barr-virus-infection">Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection&lt;/h4>
&lt;p>Front Immunol. 2023 Jul 24;14:1212676. &lt;a href="https://doi.org/10.3389/fimmu.2023.1212676">doi: 10.3389/fimmu.2023.1212676&lt;/a>&lt;/p>
&lt;p>Anna Karin Hedström 1&lt;/p>
&lt;p>&lt;strong>Table of contents&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/ebv-toc.jpg" alt="image" width="350">
&lt;p>&lt;strong>Combined Risk Factors for MS&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/ms-risk-factors.jpg" alt="image" width="350">
&lt;p>Compelling evidence indicates that Epstein Barr virus (EBV) infection is a prerequisite for multiple sclerosis (MS). The disease may arise from a complex interplay between latent EBV infection, genetic predisposition, and various environmental and lifestyle factors that negatively affect immune control of the infection. Evidence of gene-environment interactions and epigenetic modifications triggered by environmental factors in genetically susceptible individuals supports this view. This review gives a short introduction to EBV and host immunity and discusses evidence indicating EBV as a prerequisite for MS. The role of genetic and environmental risk factors, and their interactions, in MS pathogenesis is reviewed and put in the context of EBV infection. Finally, possible preventive measures are discussed based on the findings presented.&lt;/p></description></item><item><title>End of Alzheimer's videos, transcripts and many studies</title><link>/posts/end-of-alzheimers-videos-transcripts-and-many-studies.html</link><pubDate>Sun, 02 Jul 2023 00:00:00 +0000</pubDate><guid>/posts/end-of-alzheimers-videos-transcripts-and-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#recode-protocol-1740year-and-you-can-now-live-in-yourhome">RECODE Protocol $1740/year, and you can now live in your home&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#12-point-summary-of-end-of-alzheimers-by-bredsen---oct-2024">12 point summary of End Of Alzheimers&amp;rsquo; by Bredsen - Oct 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bredesen-protocol-success-stories-and-case-studies---video-july-2024">Bredesen Protocol Success Stories and Case Studies - video July 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#alzheimers-before-symptoms-can-now-be-detected-many-ways-to-prevent-having-symptoms---may-2024">Alzheimer&amp;rsquo;s before symptoms can now be detected, many ways to prevent having symptoms - May 2024&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#updates-on-the-prevention-and-treatment-of-alzheimersdisease---june-2023">Updates on the Prevention and Treatment of Alzheimer’s Disease - June 2023&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#rct-trial-of-protocol-in-6states">RCT Trial of protocol in 6 states&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#proteins">Proteins&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#other-treatments-just-slow-alzdecline">Other treatments just slow Alz decline&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#innate-immune-system-bone-marrow-endothelial-cells-and-brainmicroglia">Innate Immune system: bone marrow, endothelial cells, and brain microglia&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#treatment-supports-energy-and-reducesinflammation">Treatment supports energy and reduces inflammation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#80-of-sleep-apnea-goesundiagnosed">80% of sleep apnea goes undiagnosed&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#omega-6">Omega-6&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#omega-3-ratio-andindex">Omega-3 ratio and index&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#sleep">Sleep&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#tests-for-alz---can-beexpensive">Tests for Alz - can be expensive&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#tick-borne-infections">Tick-borne infections&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#processed-foods">Processed foods.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bredesen-co-authored-paper-with-rick-johnson-and-daveperlmutter">Bredesen co-authored paper with Rick Johnson and Dave Perlmutter&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#avoid-fructose---turns-down-theatp">Avoid fructose - turns down the ATP&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#randle-cycle">Randle Cycle&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#methylene-blue">Methylene blue&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#opening-up-pacific-neuroscience-institute-soon-for-a-variety-of-healthproblems">Opening up &amp;ldquo;Pacific Neuroscience Institute&amp;rdquo; soon for a variety of health problems&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#moca-30--no-alz-0--alz-protocol-has-great-success-if-18-works-for0">MoCA 30 = no Alz, 0 = Alz, protocol has great success if &amp;gt;18. works for 0&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#transcript-pdf">Transcript PDF&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#previous-mercola-interview-oct2021">Previous Mercola Interview Oct 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#is-alzheimers-reversible---interview-by-lufkin-nov-2023">Is Alzheimer&amp;rsquo;s Reversible? - interview by lufkin Nov 2023&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#alzheimers-is-now-optional-heres-why-and-how---dale-bredesen---video-sept2023">Alzheimer’s Is Now Optional: Here’s Why And How - Dale Bredesen - video Sept 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#vitamindwiki">VitaminDWiki&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#alzheimers-cognition--overviewtagsalzheimers-cognition-overviewhtml">&lt;a href="/tags/alzheimers-cognition-overview.html">Alzheimers-Cognition - Overview&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#overview-parkinsons-and-vitamindpostsoverview-parkinsons-and-vitamin-d">&lt;a href="/posts/overview-parkinsons-and-vitamin-d">Overview Parkinsons and Vitamin D&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#comparing-high-dose-vitamin-dtherapiespostscomparing-high-dose-vitamin-d-therapies">&lt;a href="/posts/comparing-high-dose-vitamin-d-therapies">Comparing High-dose vitamin D therapies&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-end-of-alzheimers-and-dementia-if-adjust-vitamin-d-b-12-iron-omega-3-etcpoststhe-end-of-alzheimers-and-dementia-if-adjust-vitamin-d-b-12-iron-omega-3-etc">&lt;a href="/posts/the-end-of-alzheimers-and-dementia-if-adjust-vitamin-d-b-12-iron-omega-3-etc">The End of Alzheimer&amp;rsquo;s and Dementia if adjust Vitamin D, B-12, Iron, Omega-3, etc.&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rationale-for-a-multi-factorial-approach-for-the-reversal-of-cognitive-decline-in-alzheimers-disease-and-mci-a-review---jan2023">Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review - Jan 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#reverse-alzheimers-30-summit---webinars-june2023">Reverse Alzheimer’s 3.0 Summit - webinars June 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#observed-improvement-in-cognition-during-a-personalized-lifestyle-intervention-in-people-with-cognitive-decline---jun2023">Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline - Jun 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#a-few-of-his-manybooks">A few of his many books&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#the-ageless-brain-how-to-sharpen-and-protect-your-mind-for-a-lifetime---march-2025--perplexity-ai-summaryhttpswwwperplexityaisearchsplease-summarize-the-ageless-enxiragltzaokc4onlzsq">The Ageless Brain: How to Sharpen and Protect Your Mind for a Lifetime - March 2025 -&lt;a href="https://www.perplexity.ai/search/splease-summarize-the-ageless-ENxIRAGLTz.aokc4oNlzSQ">Perplexity AI summary&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>

 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-end-of-alzheimers-program-the-first-protocol-to-enhance-cognition-and-reverse-decline-at-any-age---aug-202010">The End of Alzheimer&amp;rsquo;s Program: The First Protocol to Enhance Cognition and Reverse Decline at Any Age - Aug 2020 $10&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-end-of-alzheimers-a-comprehensive-guide-to-effective-prevention-strategiesfree">THE END OF ALZHEIMER&amp;rsquo;S: A Comprehensive Guide To Effective Prevention Strategies. FREE&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#workbook-for-the-end-of-alzheimers-program-by-dale-bredesen---sept-202313">Workbook For The End Of Alzheimer&amp;rsquo;s Program By Dale Bredesen - Sept 2023, $13&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-how-not-to-age-book-diet-exercise-supplements-dr-greger---dec-2023postshow-not-to-age-book-diet-exercise-supplements-dr-greger">See also &lt;a href="/posts/how-not-to-age-book-diet-exercise-supplements-dr-greger">How Not To Age book (diet, exercise, supplements) Dr. Greger - Dec 2023&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="recode-protocol-1740year-and-you-can-now-live-in-yourhome">RECODE Protocol $1740/year, and you can now live in your home&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.apollohealthco.com/solution/recode/">Recode: The Only Clinically Proven Program to Reverse Cognitive Decline in Early-Stage Alzheimer’s Disease.&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Physiological Basis for Using Vitamin D to Improve Health - Sunil</title><link>/posts/physiological-basis-for-using-vitamin-d-to-improve-health-sunil.html</link><pubDate>Sun, 28 May 2023 00:00:00 +0000</pubDate><guid>/posts/physiological-basis-for-using-vitamin-d-to-improve-health-sunil.html</guid><description>&lt;p>Biomedicines 2023, 11, 1542. &lt;a href="https://doi.org/10.3390/">https://doi.org/10.3390/&lt;/a> biomedicines11061542&lt;/p>
&lt;p>Sunil J. Wimalawansa&lt;/p>
&lt;p>Medicine, Endocrinology &amp;amp; Nutrition, Cardio Metabolic Institute, (former) Rutgers University, North Brunswick, NJ 08901, USA; &lt;a href="mailto:suniljw@hotmail.com">suniljw@hotmail.com&lt;/a>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h5 id="several-of-the-charts-and-tables">Several of the charts and tables&lt;/h5>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pb-fig-1.jpg" alt="image" width="600">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pb-table-1.jpg" alt="image" width="650">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pb-ng-and-rr-fig-3.jpg" alt="image" width="600">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pb-dose-response-f4.jpg" alt="image" width="700">
&lt;hr>
&lt;h5 id="abstract">Abstract&lt;/h5>
&lt;p>Vitamin D is essential for life—its sufficiency improves metabolism, hormonal release, immune functions, and maintaining health. Vitamin D deficiency increases the vulnerability and severity of type 2 diabetes, metabolic syndrome, cancer, obesity, and infections. The active enzyme that generates vitamin D &lt;span>[calcitriol: 1,25(OH)2D]&lt;/span>, CYP27B1 (1a-hydoxylase), and its receptors (VDRs) are distributed ubiquitously in cells. Once calcitriol binds with VDRs, the complexes are translocated to the nucleus and interact with responsive elements, up- or down-regulating the expression of over 1200 genes and modulating metabolic and physiological functions. Administration of vitamin D3 or correct metabolites at proper doses and frequency for longer periods would achieve the intended benefits. While various tissues have different thresholds for 25(OH)D concentrations, levels above 50 ng/mL are necessary to mitigate conditions such as infections/sepsis, cancer, and reduce premature deaths. Cholecalciferol (D3) (not its metabolites) should be used to correct vitamin D deficiency and raise serum 25(OH)D to the target concentration. In contrast, calcifediol &lt;span>[25(OH)D]&lt;/span> raises serum 25(OH)D concentrations rapidly and is the agent of choice in emergencies such as infections, for those who are in ICUs, and for insufficient hepatic 25-hydroxylase (CYP2R1) activity. In contrast, calcitriol is necessary to maintain serum-ionized calcium concentration in persons with advanced renal failure and hypoparathyroidism. Calcitriol is, however, ineffective in most other conditions, including infections, and as vitamin D replacement therapy. Considering the high costs and higher incidence of adverse effects due to narrow therapeutic margins (ED50), 1a-vitamin D analogs, such as 1a-(OH)D and 1,25(OH)2D, should not be used for other conditions. Calcifediol analogs cost 20 times more than D3—thus, they are not indicated as a routine vitamin D supplement for hypovitaminosis D, osteoporosis, or renal failure. Healthcare workers should resist accepting inappropriate promotions, such as calcifediol for chronic renal failure and calcitriol for osteoporosis or infections—there is no physiological rationale for doing so. Maintaining the population&amp;rsquo;s vitamin D sufficiency (above 40 ng/mL) with vitamin D3 supplements and/or daily sun exposure is the most cost-effective way to reduce chronic diseases and sepsis, overcome viral epidemics and pandemics, and reduce healthcare costs. Furthermore, vitamin D sufficiency improves overall health (hence reducing absenteeism), reduces the severity of chronic diseases such as metabolic and cardiovascular diseases and cancer, decreases all-cause mortality, and minimizes infection-related complications such as sepsis and COVID-19-related hospitalizations and deaths. Properly using vitamin D is the most cost-effective way to reduce chronic illnesses and healthcare costs: thus, it should be a part of routine clinical care.&lt;/p></description></item><item><title>COVID appears to be treated by many antioxidants (Vitamins D, C, E, K, and Quercetin, Curcumin, etc)</title><link>/posts/covid-appears-to-be-treated-by-many-antioxidants-vitamins-d-c-e-k-and-quercetin-curcumin-etc.html</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>/posts/covid-appears-to-be-treated-by-many-antioxidants-vitamins-d-c-e-k-and-quercetin-curcumin-etc.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#an-emerging-natural-antioxidant-therapy-for-covid-19-infection-patients-current-and-future-directions">An emerging natural antioxidant therapy for COVID-19 infection patients: Current and future directions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#antioxidants-and-long-covid---nov-2022-preprint">Antioxidants and Long Covid - Nov 2022 preprint&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="an-emerging-natural-antioxidant-therapy-for-covid-19-infection-patients-current-and-future-directions">An emerging natural antioxidant therapy for COVID-19 infection patients: Current and future directions&lt;/h4>
&lt;p>FoodFrontiers. 2023;1-28. DOI: 10.1002/fft2.207&lt;/p>
&lt;p>Amit Kumar Shrivastava1 I Prafulla Kumar Sahu2 I Teresa Cecchi3 I Laxmi Shrestha1 I Sanjay Kumar Shah4 I Anamika Gupta5 I Anjan Palikhey1© Bishal Joshi6 I Pramodkumar P. Gupta7 I Jitendra Upadhyaya8	I&lt;/p></description></item><item><title>Mechanisms of Autoimmunity – video and transcript – Beltran</title><link>/posts/mechanisms-of-autoimmunity-video-and-transcript-beltran.html</link><pubDate>Sun, 01 Jan 2023 00:00:00 +0000</pubDate><guid>/posts/mechanisms-of-autoimmunity-video-and-transcript-beltran.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#dr-beltran">Dr. Beltran&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#change-the-diet--less-leaky-gut-improve-vdr">Change the diet ==&amp;gt; less leaky gut, improve VDR&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="dr-beltran">Dr. Beltran&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/dr.-eduardo-beltran.jpg" alt="image" width="200">
&lt;p>**&lt;a href="https://www.youtube.com/watch?v=h5jkIYa-3Cg&amp;amp;t=11s&amp;amp;ab_channel=Dr.EduardoBeltran">35 minute YouRube Video&lt;/a>))&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#dr-beltran">Dr. Beltran&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#change-the-diet--less-leaky-gut-improve-vdr">Change the diet ==&amp;gt; less leaky gut, improve VDR&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/meachanisms-1.jpg" alt="image" width="500">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/png/beltran-2png.png" alt="image" width="900">
&lt;p>0:00:06.5** Beltran: &lt;strong>Hello everybody, this is Dr. Beltran speaking here. I&amp;rsquo;m a physician. I specialize within the field of internal medicine and dermatology.&lt;/strong> I&amp;rsquo;m originally from South America, Brazil. That&amp;rsquo;s where I work as a physician. I&amp;rsquo;m also a research scientist in the United States and also a vitamin D expert. **The subject for today is going to be on the Mechanisms of Autoimmunity. I will be explaining on how autoimmunity takes place and what are the different contributing factors that can lead to autoimmunity. I&amp;rsquo;m also the author of The LGS Protocol, which is the Leaky Gut Syndrome Protocol. It&amp;rsquo;s a protocol that I utilize to be able to treat patients who do have autoimmune diseases.&lt;/p></description></item><item><title>The vitamins and minerals that help the immune system respond to respiratory viruses</title><link>/posts/the-vitamins-and-minerals-that-help-the-immune-system-respond-to-respiratory-viruses.html</link><pubDate>Tue, 06 Dec 2022 00:00:00 +0000</pubDate><guid>/posts/the-vitamins-and-minerals-that-help-the-immune-system-respond-to-respiratory-viruses.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#how-micronutrients-fuel-immune-system-at-the-molecular-level-an-approach-to-the-immune-response-against-respiratory-viruses">How Micronutrients Fuel Immune System at the Molecular Level: An Approach to the Immune Response Against Respiratory Viruses&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#general-overview-of-micronutrients">General overview of micronutrients&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#functions-in-airway-epithelial-barrier">Functions in airway epithelial barrier&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#roles-in-the-antiviral-response-mediated-by-interferons-ifn-i">Roles in the antiviral response mediated by interferons (IFN)-I&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#functions-in-nk-cell-differentiation-and-activation">Functions in NK cell differentiation and activation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#functions-in-the-inflammatory-response">Functions in the inflammatory response&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#roles-in-the-adaptive-cellular-response">Roles in the adaptive cellular response&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#functions-in-the-adaptive-humoral-response">Functions in the adaptive humoral response&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#concluding-remarks">Concluding remarks&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="how-micronutrients-fuel-immune-system-at-the-molecular-level-an-approach-to-the-immune-response-against-respiratory-viruses">How Micronutrients Fuel Immune System at the Molecular Level: An Approach to the Immune Response Against Respiratory Viruses&lt;/h4>
&lt;p>Cell Physiol Biochem 2022;56(S1):53-88 DOI: 10.335944000000591&lt;/p></description></item><item><title>23 COVID mitigation strategies: at least 6 of which increase Vitamin D in cells</title><link>/posts/23-covid-mitigation-strategies-at-least-6-of-which-increase-vitamin-d-in-cells.html</link><pubDate>Fri, 02 Dec 2022 00:00:00 +0000</pubDate><guid>/posts/23-covid-mitigation-strategies-at-least-6-of-which-increase-vitamin-d-in-cells.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#sars-cov-2-recent-past-and-present-an-unusual-review">SARS-CoV-2: Recent Past and Present: An Unusual Review&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#some-vitamin-d-and-covid-items-in-vitamindwiki">Some Vitamin D and COVID items in VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#note-zinc-quercetin-ozone-hyperbaric-oxygen-glutathione-etc-all-increase-vitamin-d-in-cells">Note: Zinc, Quercetin, Ozone, Hyperbaric Oxygen, Glutathione etc, all increase Vitamin D in cells&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#ivermectin">Ivermectin&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#curcumin">Curcumin&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="sars-cov-2-recent-past-and-present-an-unusual-review">SARS-CoV-2: Recent Past and Present: An Unusual Review&lt;/h4>
&lt;p>African Journal of Pharmaceutical Sciences Vol 2, Issue 2, Sept 2022 &lt;a href="https://doi.org/10.51483/AFJPS.2.2.2022.1-33">doi: 10.51483/AFJPS.2.2.2022.1-33&lt;/a>&lt;/p>
&lt;p>Joseph Kajima Mulengi1 Dept of Chemistry. Faculty of Sciences, University of Tlemcen, Algeria. E-mail: &lt;a href="mailto:healthychem@gmail.com">healthychem@gmail.com&lt;/a>&lt;/p>
&lt;p>&lt;strong>PDF Table of Contents&lt;/strong>&lt;/p></description></item><item><title>Herpes virus and vitamin D - many studies</title><link>/posts/herpes-virus-and-vitamin-d-many-studies.html</link><pubDate>Mon, 14 Nov 2022 00:00:00 +0000</pubDate><guid>/posts/herpes-virus-and-vitamin-d-many-studies.html</guid><description>&lt;p>Vitamin D is not as good as a vaccine at preventing Shingles,&lt;br>
but Vitamin D also fights 100+ other health problems, including many viruses&lt;br>
Vitamin D improves the vaccine effectivness&lt;br>
Topical Vitamin D appears to treat shingles&lt;br>
The virus protects itself by reducing Vitamin D Receptor by 8X&lt;/p>
&lt;hr>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#27-x-more-likely-to-have-low-vitamin-d-if-have-herpes-simplex-virus-2---nov-2022">2.7 X more likely to have low Vitamin D if have Herpes Simplex Virus-2 - Nov 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#herpesvirus-and-vitamin-d-in-immunosuppressed-patients---inconclusive-meta-analysis-jan-2021">Herpesvirus and Vitamin D in immunosuppressed patients - inconclusive meta-analysis Jan 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#2-doses-of-zoster-vaccine-provides-protection-against-shingles-for-more-than-4-years---april-2024">2 doses of Zoster Vaccine provides protection against Shingles for more than 4 years - April 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#chinese-in-s-california-with-2-doses-of-zoster-vaccine-had-similar-benefits-for-4-years-a-subset-of-kaiser-study----march-2024">Chinese in S. California with 2 doses of Zoster Vaccine had similar benefits for 4 years (a subset of Kaiser study?) - March 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cold-sores-herpes-labialis-occur-more-often-in-winter-is-associated-with-low-levels-of-vitamin-d---2019">Cold Sores (herpes labialis) occur more often in winter is associated with low levels of vitamin D - 2019&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="27-x-more-likely-to-have-low-vitamin-d-if-have-herpes-simplex-virus-2---nov-2022">2.7 X more likely to have low Vitamin D if have Herpes Simplex Virus-2 - Nov 2022&lt;/h4>
&lt;p>&lt;strong>The association between serum 25-hydroxyvitamin D and the prevalence of herpes simplex virus&lt;/strong>&lt;/p></description></item><item><title>Fatigue and other long-haul problems appear to be associated with low Magnesium - Chambers</title><link>/posts/fatigue-and-other-long-haul-problems-appear-to-be-associated-with-low-magnesium-chambers.html</link><pubDate>Sun, 30 Oct 2022 00:00:00 +0000</pubDate><guid>/posts/fatigue-and-other-long-haul-problems-appear-to-be-associated-with-low-magnesium-chambers.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#antioxidants-and-long-covid">Antioxidants and Long Covid&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-in-vifatmindwiki">See also in VifatminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="antioxidants-and-long-covid">Antioxidants and Long Covid&lt;/h4>
&lt;p>Open Access Library Journal &amp;gt; Vol.9 No.10, October 2022 DOI: 10.4236/oalib.1109414&lt;/p>
&lt;p>Patrick Chambers&lt;/p>
&lt;p>Department of Pathology, Torrance Memorial Medical Center, Torrance, California, USA.&lt;/p>
&lt;p>Long Covid has many symptoms that overlap with&lt;/p>
&lt;ul>
&lt;li>
&lt;p>ME (myalgic encephalo-myelitis)/&lt;/p>
&lt;/li>
&lt;li>
&lt;p>CFS (chronic fatigue syndrome),&lt;/p>
&lt;/li>
&lt;li>
&lt;p>FM (fibromyalgia),&lt;/p>
&lt;/li>
&lt;li>
&lt;p>EBV (Epstein-Barr virus),&lt;/p>
&lt;/li>
&lt;li>
&lt;p>CMV (cytomegalovirus),&lt;/p>
&lt;/li>
&lt;li>
&lt;p>CIRS (chronic inflammatory response syndrome),&lt;/p>
&lt;/li>
&lt;li>
&lt;p>MCAS (mast cell activation syndrome),&lt;/p>
&lt;/li>
&lt;li>
&lt;p>POTS (postural orthostatic tachycardia syndrome), and&lt;/p></description></item><item><title>Anti-oxidants and Long-Covid (Mg, Glutamate, Butyrate, etc)</title><link>/posts/anti-oxidants-and-long-covid-mg-glutamate-butyrate-etc.html</link><pubDate>Sun, 02 Oct 2022 00:00:00 +0000</pubDate><guid>/posts/anti-oxidants-and-long-covid-mg-glutamate-butyrate-etc.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#anti-oxidants-and-long-covid--sept-2022">Anti-oxidants and Long Covid – Sept 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-long-covid-is-now-the-biggest-covid-concern---many-studiespostslong-covid-is-now-the-biggest-covid-concern-many-studies">See also &lt;a href="/posts/long-covid-is-now-the-biggest-covid-concern-many-studies">Long-COVID is now the biggest COVID concern - many studies&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="anti-oxidants-and-long-covid--sept-2022">Anti-oxidants and Long Covid – Sept 2022&lt;/h4>
&lt;p>Patrick Chambers, MD preprint&lt;/p>
&lt;p>Department of Pathology, Torrance Memorial Medical Center, Torrance, California Email: &lt;a href="mailto:pwc@gte.net">pwc@gte.net&lt;/a>&lt;/p>
&lt;p>Open Access Library Journal, 9: &lt;em>&lt;em>&lt;strong>. &lt;a href="https://dx.doi.org/10.4236/">https://dx.doi.org/10.4236/&lt;/a>&lt;/strong>&lt;/em>.2022.&lt;/em>****&lt;/p>
&lt;p>Long Covid has many symptoms that overlap with&lt;/p>
&lt;ul>
&lt;li>
&lt;p>ME (myalgic encephalomyelitis)/CFS (chronic fatigue syndrome),&lt;/p>
&lt;/li>
&lt;li>
&lt;p>FM (fibromyalgia),&lt;/p>
&lt;/li>
&lt;li>
&lt;p>EBV (Epstein-Barr virus),&lt;/p>
&lt;/li>
&lt;li>
&lt;p>CMV (cytomegalovirus),&lt;/p>
&lt;/li>
&lt;li>
&lt;p>CIRS (chronic inflammatory response syndrome),&lt;/p></description></item><item><title>You are probably unaware that health needs a Ca-Mg ratio of 2</title><link>/posts/you-are-probably-unaware-that-health-needs-a-ca-mg-ratio-of-2.html</link><pubDate>Mon, 26 Sep 2022 00:00:00 +0000</pubDate><guid>/posts/you-are-probably-unaware-that-health-needs-a-ca-mg-ratio-of-2.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#camg-d-the-shield-that-interdicts-the-crown-viruses-and-vaccines">Ca:Mg D, the Shield that Interdicts the Crown Viruses and Vaccines&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="camg-d-the-shield-that-interdicts-the-crown-viruses-and-vaccines">Ca:Mg D, the Shield that Interdicts the Crown Viruses and Vaccines&lt;/h4>
&lt;p>Preprint DOI: 10.4236/oalib.1109249, PP. 1-24&lt;/p>
&lt;p>Patrick Chambers&lt;/p>
&lt;p>The calcium to magnesium ratio plus adequate vitamin D greatly determine success or not in the immune battle against pathogens and cancer, not to mention cardiovascular disease. Ionized calcium and magnesium in normal, healthy individuals can be calculated and a ratio determined from serum levels. Using widely accepted laboratory reference range values and NHANES data, the recommended daily allowances from the Institute of Medicine of the National Academy of Sciences for calcium, magnesium, and D3 (cholecalciferol) are objectively refuted mathematically and physiologically. Midrange values for both cations, despite RDA sufficiency, are shown to be unattainable without secondary hyperparathyroidism (high parathormone (PTH), low D) or hypoparathyroidism (low PTH, high iCa:iMg) at the officially designated level of 25(OH)D sufficiency (30 ng/mL). Calcium and magnesium utilize the same calcium sensing receptor (CaSR) not only on cell membranes but also on organelle membranes. Intramitochondrial hydroxylation of chole-calciferol can become compromised. An imbalanced intake of calcium and magnesium can impact the efficacy of vitamin D supplementation. Several pertinent articles underscoring these conclusions are analyzed in detail. The impact of an imbalanced Ca:Mg ratio on Covid-19, Long Covid and vaccination is also discussed.&lt;/p></description></item><item><title>Many viral infections can be fought by Vitamin D (Astronaut’s in this case)</title><link>/posts/many-viral-infections-can-be-fought-by-vitamin-d-astronauts-in-this-case.html</link><pubDate>Tue, 30 Aug 2022 00:00:00 +0000</pubDate><guid>/posts/many-viral-infections-can-be-fought-by-vitamin-d-astronauts-in-this-case.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#reducing-virus-infection-risk-in-space-environments-through-nutrient-supplementation">Reducing Virus Infection Risk in Space Environments through Nutrient Supplementation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#clipped-from-pdf">Clipped from PDF&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#gene-analysis-found-that-egcg-has-the-potential-to-help-vitamin-d-with-700-rct-has-proven-to-help">Gene analysis found that EGCG has the potential to help, vitamin D, with &amp;gt;700 RCT has proven to help&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-related-in-vitamindwiki">See related in VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="reducing-virus-infection-risk-in-space-environments-through-nutrient-supplementation">Reducing Virus Infection Risk in Space Environments through Nutrient Supplementation&lt;/h4>
&lt;p>August 2022 Genes 13(9):1536; DOI: 10.3390/genes13091536&lt;/p>
&lt;p>Hui LiYa-Wen XueYuan QuanHong-Yu Zhang&lt;/p>
&lt;p>Space exploration has brought many challenges to human physiology. In order to evaluate and reduce possible pathological reactions triggered by space environments, we conducted bioinformatics analyses on the methylation data of the Mars 520 mission and human transcriptome data in the experiment simulating gravity changes. The results suggest that gene expression levels and DNA methylation levels were changed under the conditions of isolation and gravity changes, and multiple viral infection-related pathways were found in the enrichment analysis results of changed genes including Epstein Barr virus (EBV) infection, Hepatitis B virus (HBV) infection, Herpes simplex virus (HSV) infection and Kaposi’s sarcoma-associated herpesvirus (KHSV) infection. In this study, we found that &lt;strong>Epigallocatechin-3-gallate (EGCG) and vitamin D&lt;/strong> are helpful in reducing viral infection risk. In addition, the causal associations between nutrients and viral infections were calculated using Two sample Mendelian Randomization (2SMR) method, the results indicated that vitamin D can reduce EBV infection and HBV infection risk. In summary, our study suggests that space environments increase the risk of human viral infection, which may be reduced by supplementing EGCG and vitamin D. These results can be used to formulate medical plans for astronauts, which have practical application value for future space exploration.&lt;/p></description></item><item><title>Long-COVID is now the biggest COVID concern - many studies</title><link>/posts/long-covid-is-now-the-biggest-covid-concern-many-studies.html</link><pubDate>Sun, 17 Jul 2022 00:00:00 +0000</pubDate><guid>/posts/long-covid-is-now-the-biggest-covid-concern-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#long-covid-is-the-3rd-leading-neurological-disorder-in-the-us---march-2025">Long-COVID is the 3rd leading neurological disorder in the US - March 2025&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#of-people-getting-covid-36-got-long-covid-429-studies---jan-2025">Of people getting COVID, 36% got Long-COVID (429 studies) - Jan 2025&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#might-long-covid-symptoms-be-reduced-by-corticosteroids--asked-perplexity-ai-aug-2024">Might long-covid symptoms be reduced by corticosteroids? Asked Perplexity AI Aug 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#64-of-brazilians-had-long-covid-symptoms-1-year-after-hospital-discharge-wonder-why--july-2024">64% of Brazilians had Long-COVID symptoms 1 year after hospital discharge (wonder why) – July 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#some-early-long-covid-symptoms-persist-for-at-least-3-years-in-us-veterans--may-2024">Some early Long-COVID symptoms persist for at least 3 years in US veterans – May 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-associated-with-low-vitamin-d--oct-2023">Long COVID associated with Low Vitamin D – Oct 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-22x-more-likely-if-had-2-covid-vaccinations---dec-2022">Long-COVID 2.2X more-likely if had 2 COVID vaccinations - Dec 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-100-gone-in-29-of-long-covid-patients-after-histamin-treatment-mast-cells---march-2024">Long-COVID 100% gone in 29% of long-COVID patients after histamin treatment (mast cells) - March 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-is-a-national-emergency-26-trillion--jama-2022">Long-COVID is a national emergency: $2.6 trillion JAMA 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-fatigue-has-debilitating-impact-span-stylecolor00fcan-be-worse-than-some-cancersspan----jan-2024">Long-COVID Fatigue has Debilitating Impact, &lt;span style="color:#00F;">Can be Worse than some Cancers&lt;/span> - Jan 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf06creatinespan-significantly-reduced-long-covid-in-a-small-6-month-trial---sept-2023">&lt;span style="color:#F06;">Creatine&lt;/span> significantly reduced Long-COVID in a small 6 month trial - Sept 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-world-wide--65-million---jan-2023">Long-COVID world-wide = 65 million - Jan 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#some-long-covid-problems-still-around-after-2-years-especially-if-hospitalized---aug-2023">Some Long-COVID problems still around after 2 years, especially if hospitalized - Aug 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-symptom-chart--sept2022">Long-COVID symptom chart- Sept 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-could-be-a-mass-disabling-event---may-2023">Long-COVID could be a mass disabling event - May 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#gut-bacteria-significantly-reduced-long-covid---rct-may-2023">Gut bacteria significantly reduced Long-COVID - RCT May 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#inflammation-and-immunity-troubles-top-long-covid-suspect-list-many-citations---feb-42023">Inflammation and immunity troubles top long-COVID suspect list (many citations) - Feb 4, 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-symptom-clusters---fatigue-cognitive-and-respiratory---dr-been-video-jan2023">Long COVID Symptom Clusters - Fatigue, Cognitive and Respiratory - Dr. Been Video Jan 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#2nd-covid-infection-increases-the-risk-of-long-covid--2022">2nd COVID infection increases the risk of Long-COVID - 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#metformin-might-reduce-the-chance-of-long-covid-after-covid-by-40---jan2023">Metformin might reduce the chance of Long-COVID after COVID by 40% - Jan 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-treatment-trials-include-nac-guanfacine-and-lithium---jan2023">Long-COVID treatment trials include NAC, Guanfacine, and Lithium - Jan 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-medical-costs-average-9000-in-the-first-6-months-far-more-in-lost-wages--dec2022">Long-COVID medical costs average $9,000 in the first 6 months (far more in lost wages) – Dec 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#post-viral-symptoms---some-might-be-just-in-the-brain---dec-92022">Post-viral symptoms - some might be just in the brain - Dec 9, 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#2nd-covid-infection-increased-by-3x-chance-of-going-to-the-hospital-in-next-6-months-us-veterans---nov2022">2nd COVID infection increased by 3X chance of going to the hospital in next 6 months (US veterans) - Nov 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#im-a-physician-battling-long-covid-i-can-assure-you-its-real---oct-282022">I’m a physician battling long COVID. I can assure you it’s real - Oct 28, 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#increased-use-of-medical-services-after-test-positive-for-covid-in-ontario---oct2022">Increased use of medical services after test positive for COVID (in Ontario) - Oct 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-fought-in-some-individuals-by-lumbrokinase-heparin-or-natto-serra--2022">Long-COVID fought in some individuals by Lumbrokinase, Heparin, or Natto Serra - 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-may-set-you-back-a-decade-in-exercise-gains---oct-132022">Long COVID may set you back a decade in exercise gains - Oct 13, 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#47-of-covid-patients-had-not-fully-recovered-6-months-later---oct2022-outcomes-among-confirmed-cases-and-a-matched-comparison-group-in-the-long-covid-in-scotland-study-nature-communications-volume-13-article-number-5663-2022-httpsdoiorg101038s41467-022-33415-5">47% of Covid Patients had NOT Fully Recovered 6 months later - Oct 2022** Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study **Nature Communications volume 13, Article number: 5663 (2022) &lt;a href="https://doi.org/10.1038/s41467-022-33415-5">https://doi.org/10.1038/s41467-022-33415-5&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#type-1-diabetes-29-x-more-likely-within-30-days-of-covid-infection---oct2022-sars-cov-2--the-incidence-of-diabetes-1-in-childrenhttpswwwtrialsitenewscomasars-cov-2-the-incidence-of-diabetes-1-in-children-ba8a0160-trial-site-news-cohort-of-1849411-individuals-aged-younger-than-35-years-without-diabetes-who-were-followed-from-march-1-2020-to-nov-22-2021">Type 1 Diabetes 2.9 x more likely within 30 days of COVID infection - Oct 2022** &lt;a href="https://www.trialsitenews.com/a/sars-cov-2-the-incidence-of-diabetes-1-in-children-ba8a0160">SARS-CoV-2 &amp;amp; the Incidence of Diabetes 1 in Children&lt;/a> Trial Site News **&amp;ldquo;cohort of 1,849,411 individuals aged younger than 35 years without diabetes, who were followed from March 1, 2020, to Nov. 22, 2021.&amp;rdquo;&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#strokes-heart-attacks-sudden-deaths-does-america-understand-the-long-term-risks-of-catching-covid---oct2022-fortune-magazinehttpsfortunecom20221006strokes-heart-attacks-sudden-death-america-long-term-risks-catching-covid-carolyn-barberutm_sourcesubstackutm_mediumemail--a-httpswwwisrael21corgnew-study-links-covid-19-to-strokes-in-younger-patients--large-international-study--involving-136-research-institutions-in-32-countries-has-documented-an-increased-incidence-of-ischemic-strokes-in-young-patients-compared-to-pre-pandemic-levels-more-than-a-third-were-under-the-age-of-55-and-many-lacked-typical-risk-factors-such-as-smoking-diabetes-and-high-blood-pressure">Strokes, heart attacks, sudden deaths: Does America understand the long-term risks of catching COVID? - Oct 2022** &lt;a href="https://fortune.com/2022/10/06/strokes-heart-attacks-sudden-death-america-long-term-risks-catching-covid-carolyn-barber/?utm_source=substack&amp;amp;utm_medium=email">fortune Magazine&lt;/a> *** &amp;ldquo;A [https://www.israel21c.org/new-study-links-covid-19-to-strokes-in-younger-patients/|** large international study **] involving 136 research institutions in 32 countries has documented an increased incidence of ischemic strokes in young patients compared to pre-pandemic levels. More than a third were under the age of 55, and many lacked typical risk factors such as smoking, diabetes, and high blood pressure.&amp;rdquo;&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#a-wide-spectrum-of-types-severity-and-duration-of-long-covid-problems---oct2022-the-atlantichttpswwwtheatlanticcomideasarchive202210long-post-covid-symptoms-mild-cases670469utm_sourcefeed-long-covid-problems-include-organ-damage--profound-physical-debilitation--poor-mental-health--acute-respiratory-distress-syndrome--failing-hearts--collapsed-lungs--failed-kidneys--brain-hemorrhages--limbs-cut-off-from-blood-flow--heart-disease--stroke--blood-clot--diabetes--asthma--and-kidney-failure--shortness-of-breath--chest-pain--protracted-cough--lingering-loss-of-sense-of-smell--severe-fatigue--internal-tremors---gastrointestinal-problems--palpitations--dizziness--tiny-clots-to-block-tiny-blood-vessels-all-over-the-body--psychosocial-strain-and-suffering--severe-depression--crushing-fatigue--withering-brain-fog--reversible-cardiovascular-deconditioning-can-lead-to-a-racing-heart-rate-or-faintness-when-standing">A wide spectrum of types, severity, and duration of Long-COVID problems - Oct 2022** &lt;a href="https://www.theatlantic.com/ideas/archive/2022/10/long-post-covid-symptoms-mild-cases/670469/?utm_source=feed">The Atlantic&lt;/a> Long-COVID problems include **organ damage,   profound physical debilitation,   poor mental health,   acute respiratory distress syndrome,   failing hearts,   collapsed lungs,   failed kidneys,   brain hemorrhages,   limbs cut off from blood flow,   heart disease,   stroke,   blood clot,   diabetes,   asthma,   and kidney failure,   shortness of breath,   chest pain,   protracted cough,   lingering loss of sense of smell,   severe fatigue,   “internal tremors,   ” gastrointestinal problems,   palpitations,   dizziness,   tiny clots to block tiny blood vessels all over the body,   Psychosocial strain and suffering,   severe depression,   crushing fatigue,   withering brain fog,   reversible cardiovascular deconditioning (can lead to a racing heart rate or faintness when standing)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-consensus-of-3-long-covid-studies---sars-cov-2-in-tissue-epstein-virus-makes-it-worse---oct2022-new-ideas-emerge-concerning-how-to-treat-long-covidhttpswwwtrialsitenewscomanew-ideas-emerge-concerning-how-to-treat-long-covid-86ed9863-trial-site-news--consensus-has-emerged-on-three-points-1-in-long-covid-reservoirs-of-replicating-sars-cov-2-virus-remain-in-tissue-beyond-when-it-detected-in-blood-or-mucus">The consensus of 3 long-COVID studies - SARS-CoV-2 in tissue, Epstein virus makes it worse - Oct 2022** &lt;a href="https://www.trialsitenews.com/a/new-ideas-emerge-concerning-how-to-treat-long-covid-86ed9863">New Ideas Emerge Concerning How to Treat Long COVID&lt;/a> Trial Site News **** Consensus has emerged on three points: **1. In Long COVID, reservoirs of replicating SARS-CoV-2 virus remain in tissue beyond when it detected in blood or mucus.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-is-us-16-million-of-which-4-million-are-unable-to-work---oct2022-desperate-long-covid-patients-turn-to-unproven-alternative-therapieshttpswwwmdedgecomrheumatologyarticle258177long-coviddesperate-long-covid-patients-turn-unproven-alternativeecdwnl_eve_221002_mdedge-md-edge-probiotics-and-omega-3-were-mentioned-as-helpful">Long-COVID is US: 16 million, of which 4 million are unable to work - Oct 2022** &lt;a href="https://www.mdedge.com/rheumatology/article/258177/long-covid/desperate-long-covid-patients-turn-unproven-alternative?ecd=WNL_eve_221002_mdedge">Desperate long COVID patients turn to unproven alternative therapies&lt;/a> MD Edge] **Probiotics and Omega-3 were mentioned as helpful&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#42-increased-chance-of-neuro-problems-with-long-covid---dr-campbell-video-sept-262022-youtubehttpswwwyoutubecomwatchvyf4pebyeypuab_channeldrjohncampbell-long-term-neurologic-outcomes-of-covid-19-us-veterans---nature-medicine-sept-22-2022-hs-i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdflong-term-neurologic-outcomes-of-covid-19-compresspdfpdfpdfa----">42% increased chance of neuro problems with Long-COVID - Dr. Campbell Video Sept 26, 2022** &lt;a href="https://www.youtube.com/watch?v=yF4PebYeYpU&amp;amp;ab_channel=Dr.JohnCampbell">YouTube&lt;/a> &lt;strong>Long-term neurologic outcomes of COVID-19 (US Veterans) - Nature Medicine Sept 22, 2022 hs~&lt;/strong> &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/long-term-neurologic-outcomes-of-covid-19-compresspdf.pdf">PDF&lt;/a> **&amp;mdash;&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-has-forced-a-reckoning-for-one-of-medicines-most-neglected-diseases-cfs---sept2022-the-atlantichttpswwwtheatlanticcomhealtharchive202209mecfs-chronic-fatigue-syndrome-doctors-long-covid671518utm_sourcefeed--mecfs-involves-a-panoply-of-debilitating-symptoms-that-affect-many-organ-systems-and-that-get-worse-with-exertion-the-institute-of-medicine-estimates-that-it-affects-836000-to-25-million-people-in-the-us-alone-but-is-so-misunderstood-and-stigmatized-that-about-90-percent-of-people-who-have-it-have-never-been-diagnosed-">Long COVID Has Forced a Reckoning for One of Medicine’s Most Neglected Diseases (CFS) - Sept 2022** &lt;a href="https://www.theatlantic.com/health/archive/2022/09/mecfs-chronic-fatigue-syndrome-doctors-long-covid/671518/?utm_source=feed">The Atlantic&lt;/a> *** &amp;ldquo;ME/CFS involves a panoply of debilitating symptoms that affect many organ systems and that get worse with exertion. The Institute of Medicine estimates that it affects 836,000 to 2.5 million people in the U.S. alone, but is so misunderstood and stigmatized that about 90 percent of people who have it have never been diagnosed. &amp;quot;&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#2-x-higher-rate-of-long-covid-in-the-us-online-survey-than-in-the-uk---sept2022-us-mass-disabling-event---dr-campbell-videohttpswwwyoutubecomwatchv-ip9dlf0klgab_channeldrjohncampbell-us-data-comes-from-a-long-online-survey-which-takes-20-minutes-to-complete">2 X higher rate of Long-COVID in the US (online survey) than in the UK - Sept 2022** &lt;a href="https://www.youtube.com/watch?v=-ip9Dlf0KLg&amp;amp;ab_channel=Dr.JohnCampbell">US, Mass disabling event - Dr. Campbell video&lt;/a> **US data comes from a long online survey (which takes 20 minutes to complete)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#one-of-long-covids-worst-symptoms-is-also-its-most-misunderstood-brain-fog---sept-122022-the-atlantichttpswwwtheatlanticcomhealtharchive202209long-covid-brain-fog-symptom-executive-function671393utm_sourcefeed--its-also-among-the-most-misunderstood-it-wasnt-even-included-in-the-list-of-possible-covid-symptoms-when-the-coronavirus-pandemic-first-began-but-20-to-30-percent-of-patients-report-brain-fog-three-months-after-their-initial-infection-as-do-65-to-85-percent-of-the-long-haulers-who-stay-sick-for-much-longer-">One of Long COVID’s Worst Symptoms Is Also Its Most Misunderstood (brain fog) - Sept 12, 2022** &lt;a href="https://www.theatlantic.com/health/archive/2022/09/long-covid-brain-fog-symptom-executive-function/671393/?utm_source=feed">The Atlantic&lt;/a> *** &amp;ldquo;It’s also among the most misunderstood. It wasn’t even included in the list of possible COVID symptoms when the coronavirus pandemic first began. But 20 to 30 percent of patients report brain fog three months after their initial infection, as do 65 to 85 percent of the long-haulers who stay sick for much longer. &amp;quot;&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#a-person-having-long-covid-for-400-days-was-operated-on---had-virus-in-his-appendix-and-skin---sept2022-dr-been-youtube-videohttpswwwyoutubecomwatchvkcn8daaoduq-nasal-and-throat-tests-were-negative-virus-set-up-camp-elsewhere-in-the-body">A person having long-COVID for 400 days was operated on - had virus in his appendix and skin - Sept 2022** &lt;a href="https://www.youtube.com/watch?v=Kcn8DaaOdUQ">Dr. Been YouTube Video&lt;/a> **Nasal and throat tests were negative, Virus set up camp elsewhere in the body&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-is-a-35-trillion-dollar-problem-that-we-know-very-little-about---sept2022-no-mans-land-long-covid-knocks-young-workers-out-of-the-job-markethttpsabcnewsgocomhealthmans-land-long-covid-knocks-young-workers-jobstoryid89064127-abc-news-sept-5-calculations-factor-in-lost-earnings-medical-care-and-lower-quality-of-life">Long-COVID is a $3.5 trillion dollar problem that we know very little about - Sept 2022** &lt;a href="https://abcnews.go.com/Health/mans-land-long-covid-knocks-young-workers-job/story?id=89064127">&amp;lsquo;No man&amp;rsquo;s land&amp;rsquo;: Long COVID knocks young workers out of the job market&lt;/a> ABC News Sept 5 **&amp;ldquo;calculations factor in lost earnings, medical care and lower quality of life.&amp;rdquo;&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#us-va-handbook-of-long-covid-33-pages---aug2022">US VA handbook of Long-COVID 33 pages - Aug 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#for-some-patients-long-covid-symptoms-mask-something-else---aug2022-the-condition-may-be-common-but-issues-like-fever-shortness-of-breath-and-fatigue-can-also-be-signs-of-other-illnesseshttpswwwwiredcomstoryfor-some-patients-long-covid-symptoms-mask-something-else-wired-magazine---long-covid-can-be-easily-confused-with-countless-other-conditions-including-cardiovascular-diseases-such-as-hypertension-and-diabetes-autoimmune-diseases-like-lupus-and-multiple-sclerosis-and-cancer">For Some Patients, Long Covid Symptoms Mask Something Else - Aug 2022** &lt;a href="https://www.wired.com/story/for-some-patients-long-covid-symptoms-mask-something-else/">The condition may be common, but issues like fever, shortness of breath, and fatigue can also be signs of other illnesses.&lt;/a> Wired Magazine] *** &amp;ldquo;&amp;hellip; long Covid can be easily confused with countless other conditions, including cardiovascular diseases such as hypertension and diabetes, autoimmune diseases like lupus and multiple sclerosis, and cancer.&amp;rdquo;&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#15-other-long-haul-diseases-ebv-polio-mono-1918-influenza-zika-dengue---aug2022">15 other long-haul diseases: EBV, Polio, mono, 1918 influenza, Zika, Dengue - Aug 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-incidence-was-i-in-10-now-1-in-20-if-an-asymptomatic-infection---june2022">LONG-COVID incidence: was I in 10, now 1 in 20 if an asymptomatic infection - June 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-can-last-for-many-months---preventing-some-people-from-working---june2022">LONG-COVID can last for many months - preventing some people from working - June 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#covid-protects-itself-by-changing-the-activation-of--100-genes---april2021">COVID protects itself by changing the activation of &amp;gt; 100 genes - April 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-vitamin-d-receptor-activators-should-treatlong-covid">Vitamin D and Vitamin D receptor activators should treat Long-COVID&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covids-grip-will-likely-tighten-as-infections-continue---aug2022">Long COVID’s grip will likely tighten as infections continue - Aug 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-has-similar-symptoms-as-chronic-fatiguesyndrome">LONG-COVID has similar symptoms as Chronic Fatigue Syndrome&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#many-chronic-fatigue-symptoms-are-treated-by-d-ribose">Many Chronic Fatigue symptoms are treated by D-Ribose&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid--emergent-pandemic--dec2021">Long-COVID – Emergent Pandemic – Dec 2021&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="long-covid-is-the-3rd-leading-neurological-disorder-in-the-us---march-2025">Long-COVID is the 3rd leading neurological disorder in the US - March 2025&lt;/h4>
&lt;p>&lt;strong>&amp;ldquo;Long COVID — which, according to the American Academy of Neurology, is the third-leading neurological disorder in the U.S., behind tension-type headaches and migraines&amp;rdquo;&lt;/strong>&lt;/p></description></item><item><title>Magnesium is important to health</title><link>/posts/magnesium-is-important-to-health.html</link><pubDate>Wed, 01 Jun 2022 00:00:00 +0000</pubDate><guid>/posts/magnesium-is-important-to-health.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#magnesium-biochemistry-nutrition-detection-and-social-impact-of-diseases-linked-to-its-deficiency">Magnesium: Biochemistry, Nutrition, Detection, and Social Impact of Diseases Linked to Its Deficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#sections-clipped-from-pdf">Sections clipped from PDF&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="magnesium-biochemistry-nutrition-detection-and-social-impact-of-diseases-linked-to-its-deficiency">Magnesium: Biochemistry, Nutrition, Detection, and Social Impact of Diseases Linked to Its Deficiency&lt;/h4>
&lt;p>Nutrients 2021, 13(4), 1136; &lt;a href="https://doi.org/10.3390/nu13041136">https://doi.org/10.3390/nu13041136&lt;/a>&lt;/p>
&lt;p>Diana Fiorentini , Concettina Cappadone +, Giovanna Farruggia Correspondence: &lt;a href="mailto:giovanna.farruggia@unibo.it">giovanna.farruggia@unibo.it&lt;/a> and Cecilia Prata 0&lt;/p>
&lt;p>Department of Pharmacy and Biotechnology, Alma Mater Studiorum—University of Bologna,&lt;/p>
&lt;p>40126 Bologna, Italy; &lt;a href="mailto:diana.fiorentini@unibo.it">diana.fiorentini@unibo.it&lt;/a> (D.F.); &lt;a href="mailto:concettina.cappadone@unibo.it">concettina.cappadone@unibo.it&lt;/a> (C.C.); &lt;a href="mailto:cecilia.prata@unibo.it">cecilia.prata@unibo.it&lt;/a> (C.P.)&lt;/p>
&lt;h5 id="pdf-table-of-contents">PDF Table of Contents&lt;/h5>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/toc-mg.jpg" alt="image" width="500">
&lt;h5 id="mg-recommended-intake">Mg Recommended intake&lt;/h5>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/mg-requirements.jpg" alt="image" width="600">
&lt;h5 id="mg-deficiency-and-toxiocity">Mg Deficiency and Toxiocity&lt;/h5>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/mg-def-tox.jpg" alt="image" width="500">
&lt;p>Magnesium plays an important role in many physiological functions. Habitually low intakes of magnesium and in general the deficiency of this micronutrient induce changes in biochemical pathways that can increase the risk of illness and, in particular, chronic degenerative diseases. The assessment of magnesium status is consequently of great importance, however, its evaluation is difficult. The measurement of serum magnesium concentration is the most commonly used and readily available method for assessing magnesium status, even if serum levels have no reliable correlation with total body magnesium levels or concentrations in specific tissues. Therefore, this review offers an overview of recent insights into magnesium from multiple perspectives. Starting from a biochemical point of view, it aims at highlighting the risk due to insufficient uptake (frequently due to the low content of magnesium in the modern western diet), at suggesting strategies to reach the recommended dietary reference values, and at focusing on the importance of detecting physiological or pathological levels of magnesium in various body districts, in order to counteract the social impact of diseases linked to magnesium deficiency.&lt;/p></description></item><item><title>Long-Haul COVID after 3 months – only 5 percent had even 30 ng of Vitamin D</title><link>/posts/long-haul-covid-after-3-months-only-5-percent-had-even-30-ng-of-vitamin-d.html</link><pubDate>Wed, 04 May 2022 00:00:00 +0000</pubDate><guid>/posts/long-haul-covid-after-3-months-only-5-percent-had-even-30-ng-of-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#prevalence-of-vitamin-d-deficiency-among-patients-attending-post-covid-19-follow-up-clinic-a-cross-sectional-study">Prevalence of vitamin D deficiency among patients attending Post COVID-19 follow-up clinic: a cross-sectional study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#opinion-long-haul-needs-both-high-dose-vitamin-d-and-re-activation-of-the-vitamin-d-receptor">Opinion: Long-Haul needs both high dose vitamin D and re-activation of the Vitamin D Receptor&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#females-in-egypt-were-more-likely-to-get-long-haul">Females in Egypt were more likely to get Long-Haul&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-a-role-also-in-long-covid-19---april-2022">Vitamin D: A Role Also in Long COVID-19? - April 2022&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="prevalence-of-vitamin-d-deficiency-among-patients-attending-post-covid-19-follow-up-clinic-a-cross-sectional-study">Prevalence of vitamin D deficiency among patients attending Post COVID-19 follow-up clinic: a cross-sectional study&lt;/h4>
&lt;p>Eur Rev Med Pharmacol Sci . 2022 Apr;26(8):3038-3045. &lt;a href="https://doi.org/10.26355/eurrev_202204_28635.">doi: 10.26355/eurrev_202204_28635.&lt;/a>&lt;/p></description></item><item><title>Hepatitis normally rare in children: huge increase after lockdown (Adenovirus, low Vitamin D)</title><link>/posts/hepatitis-normally-rare-in-children-huge-increase-after-lockdown-adenovirus-low-vitamin-d.html</link><pubDate>Fri, 22 Apr 2022 00:00:00 +0000</pubDate><guid>/posts/hepatitis-normally-rare-in-children-huge-increase-after-lockdown-adenovirus-low-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-cause-of-a-new-type-of-hepatitis-in-children-is-found---1000-cases-july-27-2022">The cause of a new type of hepatitis in children is found - (1,000 cases) July 27, 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#studies-probe-adenovirus-link-to-childhood-hepatitis-cases-920-so-far---nyt-july-13-2022">Studies Probe Adenovirus Link to Childhood Hepatitis Cases (920 so far) - NYT July 13, 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#533-cases---may-18-2022">533 cases - May 18, 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#348-cases-spread-across-20-countries--may-13-2022">348 cases spread across 20 countries- May 13, 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-race-to-crack-the-surging-child-hepatitis-outbreak---april-22-2022">The race to crack the surging child hepatitis outbreak - April 22, 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#hepatitis-eight-children-given-liver-transplants-as-108-mystery-cases-detected-in-uk---april-21">Hepatitis: Eight children given liver transplants as 108 mystery cases detected in UK - April 21&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-cause-of-a-new-type-of-hepatitis-in-children-is-found---1000-cases-july-27-2022">The cause of a new type of hepatitis in children is found - (1,000 cases) July 27, 2022&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.economist.com/science-and-technology/2022/07/27/the-cause-of-a-new-type-of-hepatitis-in-children-is-found?utm_content=ed-picks-article-link-3&amp;amp;etear=science_nl_3&amp;amp;utm_campaign=r.science-newsletter&amp;amp;utm_medium=email.internal-newsletter.np&amp;amp;utm_source=salesforce-marketing-cloud&amp;amp;utm_term=7/27/2022&amp;amp;utm_id=1255320">The Economist&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Vitamin D, Zinc, Magnesium etc. are needed to fight COVID</title><link>/posts/vitamin-d-zinc-magnesium-etc-are-needed-to-fight-covid.html</link><pubDate>Sat, 09 Apr 2022 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-zinc-magnesium-etc-are-needed-to-fight-covid.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#deciphering-the-immunoboosting-potential-of-macro-and-micronutrients-in-covid-support-therapy">Deciphering the immunoboosting potential of macro and micronutrients in COVID support therapy&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="deciphering-the-immunoboosting-potential-of-macro-and-micronutrients-in-covid-support-therapy">Deciphering the immunoboosting potential of macro and micronutrients in COVID support therapy&lt;/h4>
&lt;p>Environmental Science and Pollution Research (2022) DOI: 10.1007/s11356-022-20075-7&lt;/p>
&lt;p>Gaber El-Saber Batiha, Ali I. Al-Gareeb, Safaa Qusti, Eida M. Alshammari, Deepak Kaushik, Ravinder Verma &amp;amp; Hayder M. Al-kuraishy&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/immunoboosting.jpg" alt="image" width="1000">
&lt;p>&lt;strong>Virus barriers&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/barriers.jpg" alt="image" width="500">
&lt;p>The immune system protects human health from the effects of pathogenic organisms; however, its activity is affected when individuals become infected. These activities require a series of molecules, substrates, and energy sources that are derived from diets. The consumed nutrients from diets help to enhance the immunity of infected individuals as it relates to COVID-19 patients. This study aims to review and highlight requirement and role of macro- and micronutrients of COVID-19 patients in enhancing their immune systems. Series of studies were found to have demonstrated the enhancing potentials of macronutrients (carbohydrates, proteins, and fats) and micronutrients (vitamins, copper, zinc, iron, calcium, magnesium, and selenium) in supporting the immune system’s fight against respiratory infections. Each of these nutrients performs a vital role as an antiviral defense in COVID-19 patients. Appropriate consumption or intake of dietary sources that yield these nutrients will help provide the daily requirement to support the immune system in its fight against pathogenic viruses such as COVID-19.&lt;/p></description></item><item><title>Long Covid, Short Magnesium - Chambers</title><link>/posts/long-covid-short-magnesium-chambers.html</link><pubDate>Tue, 05 Apr 2022 00:00:00 +0000</pubDate><guid>/posts/long-covid-short-magnesium-chambers.html</guid><description>&lt;p>&lt;strong>Preprint and published in April 2022&lt;br>
the following is extracted from the preprint&lt;br>
&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/long-covid-short-magnesium-compresspdf.pdf">Click Here for the published PDF&lt;/a> Scientific Research Publishing&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#abstract">Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">REFERENCES&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="abstract">Abstract&lt;/h4>
&lt;p>April 2022 DOI: 10.13140/RG.2.2.31726.08009&lt;/p>
&lt;p>Patrick W Chambers&lt;/p>
&lt;p>Long Covid, now also reported in children, has become increasingly alarming. Perhaps a third of those who develop MIS-C go on to experience Long Covid. Etiology is elusive. The role of vitamin D in bone and immune health has been recognized but magnesium deficiency has escaped attention. A physiologic and biochemical argument for its culpability in Long Covid as well Chronic Fatigue Syndrome, Fibromyalgia, Epstein Barr Virus, and Cytomegalovirus is presented.&lt;/p></description></item><item><title>Dietary Recommendations for COVID Long-Haul</title><link>/posts/dietary-recommendations-for-covid-long-haul.html</link><pubDate>Sun, 20 Mar 2022 00:00:00 +0000</pubDate><guid>/posts/dietary-recommendations-for-covid-long-haul.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#dietary-recommendations-for-post-covid-19-syndrome--march-2022">Dietary Recommendations for Post-COVID-19 Syndrome – March 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#some-of-these-authors-have-another-publication-due-out-in-march-2022-on-vitamin-d-and-long-haul-that-mentions-eprsin-barr-virus-and-the-downregulation-of-vdr-by-covid">Some of these authors have another publication due out in March 2022 on Vitamin D and Long-Haul that mentions Eprsin Barr Virus and the downregulation of VDR by COVID&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#google-scholar-has-1760-results-for-a-long-haul-ebv-search-march-2022">Google Scholar has 1,760 results for a Long-Haul EBV search March 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#costly-supplement-cocktail-for-long-haul---2021">Costly supplement cocktail for Long-Haul - 2021&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="dietary-recommendations-for-post-covid-19-syndrome--march-2022">Dietary Recommendations for Post-COVID-19 Syndrome – March 2022&lt;/h4>
&lt;p>Nutrients 2022, 14(6), 1305; &lt;a href="https://doi.org/10.3390/nu14061305">https://doi.org/10.3390/nu14061305&lt;/a>&lt;/p>
&lt;p>by Luigi Barrea 1,2,†ORCID,William B. Grant 3,†ORCID,Evelyn Frias-Toral 4,†,Claudia Vetrani 5,*ORCID,Ludovica Verde 5ORCID,Giulia de Alteriis 5,Annamaria Docimo 5ORCID,Silvia Savastano 2,5,Annamaria Colao 2,5,6 andGiovanna Muscogiuri 2,5,6&lt;/p></description></item><item><title>Mild Long-Haul 4.2 X more likely if type O blood - preprint</title><link>/posts/mild-long-haul-42-x-more-likely-if-type-o-blood-preprint.html</link><pubDate>Sun, 20 Mar 2022 00:00:00 +0000</pubDate><guid>/posts/mild-long-haul-42-x-more-likely-if-type-o-blood-preprint.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#blood-group-o-and-post-covid-19-syndrome---preprint">Blood group O and post-COVID-19 syndrome - preprint&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#type-o-is-very-common-in-many-people">Type O is very common in many people&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#no-a-or-b--antigens-in-type-o-blood">No A or B Antigens in type O blood&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="blood-group-o-and-post-covid-19-syndrome---preprint">Blood group O and post-COVID-19 syndrome - preprint&lt;/h4>
&lt;p>&amp;ldquo;The prevalence of PCS was&lt;/p>
&lt;ul>
&lt;li>
&lt;p>43.2% (19/44) in the blood group O and&lt;/p>
&lt;/li>
&lt;li>
&lt;p>23.7% in non-O subjects (14/60) (p=0.036).&lt;/p>
&lt;/li>
&lt;/ul>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/type-o-long-haul.jpg" alt="image" width="700">
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/blood-types-vary.jpg">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;hr>
&lt;h4 id="type-o-is-very-common-in-many-people">Type O is very common in many people&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/blood-types-vary.jpg" alt="image" width="500">
&lt;hr>
&lt;h4 id="no-a-or-b--antigens-in-type-o-blood">No A or B Antigens in type O blood&lt;/h4>
&lt;p>Type A: blood containing A antigens&lt;/p></description></item><item><title>Hypothesis: Smoking reduces Vitamin D, which activates EBV, which causes lung cancer</title><link>/posts/hypothesis-smoking-reduces-vitamin-d-which-activates-ebv-which-causes-lung-cancer.html</link><pubDate>Fri, 04 Mar 2022 00:00:00 +0000</pubDate><guid>/posts/hypothesis-smoking-reduces-vitamin-d-which-activates-ebv-which-causes-lung-cancer.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#epsteinbarr-virus-infection-in-lung-cancer-insights-and-perspectives">Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="epsteinbarr-virus-infection-in-lung-cancer-insights-and-perspectives">Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives&lt;/h4>
&lt;p>Pathogens 2022, 11(2), 132; &lt;a href="https://doi.org/10.3390/pathogens11020132">https://doi.org/10.3390/pathogens11020132&lt;/a>&lt;/p>
&lt;p>by Julio C. Osorio 1ORCID,Rancés Blanco 2,Alejandro H. Corvalán 3ORCID,Juan P. Muñoz 4,Gloria M. Calaf 4,5ORCID andFrancisco Aguayo 6,*&lt;/p>
&lt;p>1 Population Registry of Cali, Department of Pathology, Universidad del Valle, Cali 760042, Colombia&lt;/p>
&lt;p>2 Laboratorio de Oncovirología, Programa de Virología, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago 8380000, Chile&lt;/p></description></item><item><title>Osteoporosis, periodontal and other diseases share a risk factor – low vitamin D</title><link>/posts/osteoporosis-periodontal-and-other-diseases-share-a-risk-factor-low-vitamin-d.html</link><pubDate>Fri, 04 Mar 2022 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-periodontal-and-other-diseases-share-a-risk-factor-low-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#osteoporosis-and-periodontal-diseases---an-update-on-their-association-and-mechanistic-links">Osteoporosis and periodontal diseases - An update on their association and mechanistic links&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#viruses-such-as-covid-and-ebv-deactivate-the-vitamin-d-receptor---which-reduces-the-vitamin-d-getting-to-cells">Viruses such as COVID and EBV deactivate the Vitamin D Receptor - which reduces the Vitamin D getting to cells&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="osteoporosis-and-periodontal-diseases---an-update-on-their-association-and-mechanistic-links">Osteoporosis and periodontal diseases - An update on their association and mechanistic links&lt;/h4>
&lt;p>Review Periodontol 2000. 2022 Mar 4. &lt;a href="https://doi.org/10.1111/prd.12422">doi: 10.1111/prd.12422&lt;/a> behind paywall&lt;/p>
&lt;p>Bo Yu 1, Cun-Yu Wang 2 3&lt;/p>
&lt;p>Periodontitis and osteoporosis are prevalent inflammation-associated skeletal disorders that pose significant public health challenges to our aging population. Both periodontitis and osteoporosis are bone disorders closely associated with inflammation and aging. There has been consistent intrigue on whether a systemic skeletal disease such as osteoporosis will amplify the alveolar bone loss in periodontitis. A survey of the literature published in the &lt;strong>past 25 years&lt;/strong> indicates that systemic low bone mineral density (BMD) is associated with alveolar bone loss, while recent evidence also suggests a correlation between clinical attachment loss and other parameters of periodontitis. Inflammation and its influence on bone remodeling play critical roles in the pathogenesis of both osteoporosis and periodontitis and could serve as the central mechanistic link between these disorders. Enhanced cytokine production and elevated inflammatory response exacerbate osteoclastic bone resorption while inhibiting osteoblastic bone formation, resulting in a net bone loss. With aging, accumulation of oxidative stress and cellular senescence drive the progression of osteoporosis and exacerbation of periodontitis.&lt;/p></description></item><item><title>Multiple Sclerosis Risk factors include virus such as Human Herpesvirus 6A – many studies</title><link>/posts/multiple-sclerosis-risk-factors-include-virus-such-as-human-herpesvirus-6a-many-studies.html</link><pubDate>Mon, 28 Feb 2022 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-factors-include-virus-such-as-human-herpesvirus-6a-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#human-herpesvirus-6a-is-a-risk-factor-for-multiple-sclerosis---2022">Human Herpesvirus 6A Is a Risk Factor for Multiple Sclerosis - 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-role-of-herpesvirus-6a-and-6b-in-multiple-sclerosis-and-epilepsy---2020">The role of herpesvirus 6A and 6B in multiple sclerosis and epilepsy - 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#herpesviruses-are-extremely-prevelant">Herpesviruses are extremely prevelant&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#human-herpesvirus-6--multiple-sclerosis-27000-publications-as-of-feb-2022">Human herpesvirus 6 &amp;ldquo;multiple sclerosis&amp;rdquo; 27,000 publications as of Feb 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#hhv-6-foundation">hhv-6 Foundation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#evidence-linking-hhv-6-with-multiple-sclerosis-2014---cited-by-111-studies-as-of-feb-2022">Evidence linking HHV-6 with multiple sclerosis (2014) - cited by 111 studies as of Feb 2022&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="human-herpesvirus-6a-is-a-risk-factor-for-multiple-sclerosis---2022">Human Herpesvirus 6A Is a Risk Factor for Multiple Sclerosis - 2022&lt;/h4>
&lt;p>Review Front Immunol . 2022 Feb 10;13:840753. &lt;a href="https://doi.org/10.3389/fimmu.2022.840753.">doi: 10.3389/fimmu.2022.840753.&lt;/a> eCollection 2022.&lt;/p></description></item><item><title>Epstein-Barr Virus increases the risk of many health problems – many studies</title><link>/posts/epstein-barr-virus-increases-the-risk-of-many-health-problems-many-studies.html</link><pubDate>Sat, 19 Feb 2022 00:00:00 +0000</pubDate><guid>/posts/epstein-barr-virus-increases-the-risk-of-many-health-problems-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#video-overview-of-12-epstein-barr---covid-studies-dr-bean-april2023httpswwwyoutubecomwatchvpigk-wh1u2a">Video overview of 12 Epstein-Barr - COVID studies: &lt;a href="https://www.youtube.com/watch?v=Pigk-wh1U2A">Dr. Bean April 2023&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epstein-barr-virus-vitamin-d-and-the-immune-response-connections-with-consequences-for-multiple-sclerosis---dec-2024">Epstein-Barr virus, vitamin D and the immune response: connections with consequences for multiple sclerosis - Dec 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#ebvhelpcom---mentioned-on-reddit---aug-2024httpswwwredditcomrvitamindcomments1evk9rnvitamin_d_levels_seem_normal_still_having_symptoms">EBVHelp.com - mentioned on &lt;a href="https://www.reddit.com/r/VitaminD/comments/1evk9rn/vitamin_d_levels_seem_normal_still_having_symptoms/">Reddit - Aug 2024&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epstein-barr-virus-infection-in-the-development-of-neurological-disorders--2020">Epstein-Barr virus infection in the development of neurological disorders - 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epstein-barr-virus-and-neurological-diseases---jan2022">Epstein-Barr Virus and Neurological Diseases - Jan 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-virus-that-causes-mono-does-a-lot-more-than-that---march2022">The Virus That Causes Mono Does a Lot More Than That - March 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#ebv-caused-137900--208700-cancer-deaths-1-of-total-in2020">EBV caused 137,900 – 208,700 cancer deaths (1% of total) in 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-long-covid-is-now-the-biggest-covid-concern---manystudiespostslong-covid-is-now-the-biggest-covid-concern-many-studies">See also &lt;a href="/posts/long-covid-is-now-the-biggest-covid-concern-many-studies">Long-COVID is now the biggest COVID concern - many studies&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="video-overview-of-12-epstein-barr---covid-studies-dr-bean-april2023httpswwwyoutubecomwatchvpigk-wh1u2a">Video overview of 12 Epstein-Barr - COVID studies: &lt;a href="https://www.youtube.com/watch?v=Pigk-wh1U2A">Dr. Bean April 2023&lt;/a>&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>Stress-Induced Epstein-Barr Virus Reactivation - PMC &lt;a href="https://www.youtube.com/redirect?event=video_description&amp;amp;redir_token=QUFFLUhqbFNKS3RzSmp5YVVvSzJ3dHQ5X0hxUFJpQWMyZ3xBQ3Jtc0tueEhkR1VORy1mYU9kRkJTTnQ5ZUlRQndiMXE3ZE4zZEFCMHJ5WnR5dDZUU0hwSHVDYUVGcXJXaWs2enBFUjF4d2pkWE9KMGR3dmp2YkJWZFBlRnlnM2Z6cW1DRGk4NnhjUWpGMnByUGt1dHhXMl8tWQ&amp;amp;q=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470332/#:~:text=Overview%20of%20EBV%20Reactivation%20and%20the%20Lytic%20Cycle,%2C%20and%20late%20%5B56%5D&amp;amp;v=Pigk-wh1U2A">https://www.ncbi.nlm.nih.gov/pmc/arti&amp;hellip;&lt;/a>.&lt;/p></description></item><item><title>Vitamin D helps both the innate and adaptive immune systems fight COVID-19</title><link>/posts/vitamin-d-helps-both-the-innate-and-adaptive-immune-systems-fight-covid-19.html</link><pubDate>Sat, 29 Jan 2022 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-helps-both-the-innate-and-adaptive-immune-systems-fight-covid-19.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-regulation-of-immune-function-during-covid-19">Vitamin D regulation of immune function during covid-19&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#abstract">Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-viral-respiratory-tract-infections">Vitamin D and viral respiratory tract infections&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pulmonary-immune-defense-mechanisms-and-their-regulation-by-vitamin-d-signaling">Pulmonary immune defense mechanisms and their regulation by vitamin D signaling&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusion">Conclusion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="vitamin-d-regulation-of-immune-function-during-covid-19">Vitamin D regulation of immune function during covid-19&lt;/h3>
&lt;p>Reviews in Endocrine and Metabolic Disorders &lt;a href="https://doi.org/10.1007/s11154-021-09707-4">https://doi.org/10.1007/s11154-021-09707-4&lt;/a>&lt;/p>
&lt;p>Daniel D. Bikle &lt;a href="mailto:Daniel.bikle@ucsf.edu">Daniel.bikle@ucsf.edu&lt;/a> Veterans Affairs Medical Center and University of California San Francisco, 4150 Clement Street (111N), San Francisco, CA 94121, USA&lt;/p>
&lt;h4 id="abstract">Abstract&lt;/h4>
&lt;p>Covid-19 has to date infected a confirmed 275 million people with 5.4 million, now dead, with the count rising every day. Although the virus, SARS-CoV2, causing Covid-19 infects many cells in the body, its infection of the upper and lower respiratory tract (upper airway epithelia and pulmonary alveolar pneumocytes and macrophages) causing what is now called a cytokine storm in the lungs is the major cause of morbidity and mortality. This results from a dysregulation of the innate immune system with an outpouring of proinflammatory cytokines and chemokines leading to abnormal activation of the adaptive immune pathway. Airway epithelia constitutively expresses CYP27B1, the enzyme producing the active vitamin D metabolite, 1,25(OH)2D, and the vitamin D receptor (VDR) for which 1,25(OH)2D is the ligand. Pulmonary alveolar macrophages, on the other hand, are induced to express both CYP27B1 and VDR by various pathogens including viruses and cytokines released from infected epithelia and other immune cells. Although not demonstrated for corona viruses like SARS-CoV2, for other viruses and other respiratory pathogens activation of innate immunity leading to increased local 1,25(OH)2D production has been shown to enhance viral neutralization and clearance while modulating the subsequent pro- inflammatory response. Whether such will be the case for SARS-CoV2 remains to be seen, but is currently being proposed and investigated. This mini review will discuss some of the mechanisms by which vitamin D may help reduce morbidity and mortality in this devastating pandemic.&lt;/p></description></item><item><title>COVID Long-Haul predicted by 4 factors (Epstein-Barr virus, etc)</title><link>/posts/covid-long-haul-predicted-by-4-factors-epstein-barr-virus-etc.html</link><pubDate>Wed, 26 Jan 2022 00:00:00 +0000</pubDate><guid>/posts/covid-long-haul-predicted-by-4-factors-epstein-barr-virus-etc.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#multiple-early-factors-anticipate-post-acute-covid-19-sequelae">Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#study-was-reported-in-the-new-york-times">Study was reported in the New York Times&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#study-was-reported-in-wsj---jan-31-2022">Study was reported in WSJ - Jan 31, 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#another-study-found-5-covid-symptoms-predicted-long-haul---jan-2022">Another study found 5 COVID symptoms predicted Long-Haul - Jan 2022&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="multiple-early-factors-anticipate-post-acute-covid-19-sequelae">Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae&lt;/h4>
&lt;p>Cell January 24, 2022DOI:https://doi.org/10.1016/j.cell.2022.01.014&lt;/p>
&lt;p>&lt;strong>Highlights&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Longitudinal multiomics associate PASC with autoantibodies, viremia and comorbidities&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Reactivation of latent viruses during initial infection may contribute to PASC&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Subclinical autoantibodies negatively correlate with anti-SARS-CoV-2 antibodies&lt;/p></description></item><item><title>Epstein-Barr virus increases risk of Multiple Sclerosis by 32X</title><link>/posts/epstein-barr-virus-increases-risk-of-multiple-sclerosis-by-32x.html</link><pubDate>Sat, 15 Jan 2022 00:00:00 +0000</pubDate><guid>/posts/epstein-barr-virus-increases-risk-of-multiple-sclerosis-by-32x.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#epstein-barr-virus-a-likely-leading-cause-of-multiple-sclerosishttpswwwmdedgecomneurologyarticle250759multiple-sclerosisepstein-barr-virus-likely-leading-cause-multiplechannel393133fecd3dwnl_eve_220115_mdedge-mdedge">&lt;a href="https://www.mdedge.com/neurology/article/250759/multiple-sclerosis/epstein-barr-virus-likely-leading-cause-multiple?channel=39313%3Fecd%3DWNL_eve_220115_mdedge">Epstein-Barr virus a likely leading cause of multiple sclerosis&lt;/a> MDEdge&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#other-viruses-also-increase-the-risk-of-multiple-sclerlosis">Other viruses also increase the risk of Multiple Sclerlosis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#anticipate-future-publications-documenting-that-virually-all-people-with-cfs-or-long-haul-previously-had-ebv">Anticipate future publications documenting that virually all people with CFS or Long-Haul previously had EBV&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="epstein-barr-virus-a-likely-leading-cause-of-multiple-sclerosishttpswwwmdedgecomneurologyarticle250759multiple-sclerosisepstein-barr-virus-likely-leading-cause-multiplechannel393133fecd3dwnl_eve_220115_mdedge-mdedge">&lt;a href="https://www.mdedge.com/neurology/article/250759/multiple-sclerosis/epstein-barr-virus-likely-leading-cause-multiple?channel=39313%3Fecd%3DWNL_eve_220115_mdedge">Epstein-Barr virus a likely leading cause of multiple sclerosis&lt;/a> MDEdge&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&amp;ldquo;EBV is common and infects about 95% of adults. Most individuals are already infected with the virus by age 18 or 20 years, making it difficult to study uninfected populations, said Dr. Ascherio.&amp;rdquo;&lt;/p></description></item><item><title>Epstein Barr Virus and Chronic Fatigue Syndrome</title><link>/posts/epstein-barr-virus-and-chronic-fatigue-syndrome.html</link><pubDate>Sun, 12 Dec 2021 00:00:00 +0000</pubDate><guid>/posts/epstein-barr-virus-and-chronic-fatigue-syndrome.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#early-growth-response-gene-upregulation-in-epsteinbarr-virus-ebv-associated-myalgic-encephalomyelitischronic-fatigue-syndrome-mecfs">Early Growth Response Gene Upregulation in Epstein–Barr Virus (EBV)-Associated Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="early-growth-response-gene-upregulation-in-epsteinbarr-virus-ebv-associated-myalgic-encephalomyelitischronic-fatigue-syndrome-mecfs">Early Growth Response Gene Upregulation in Epstein–Barr Virus (EBV)-Associated Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)&lt;/h4>
&lt;p>Biomolecules 2020, 10(11), 1484; &lt;a href="https://doi.org/10.3390/biom10111484">https://doi.org/10.3390/biom10111484&lt;/a>&lt;/p>
&lt;p>by Jonathan Kerr. Dept of Microbiology, Norfolk &amp;amp; Norwich University Hospital (NNUH), Colney Lane&lt;/p>
&lt;p>Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic multisystem disease exhibiting a variety of symptoms and affecting multiple systems. Psychological stress and virus infection are important. Virus infection may trigger the onset, and psychological stress may reactivate latent viruses, for example, Epstein–Barr virus (EBV). It has recently been reported that EBV induced gene 2 (EBI2) was upregulated in blood in a subset of ME/CFS patients. The purpose of this study was to determine whether the pattern of expression of early growth response (EGR) genes, important in EBV infection and which have also been found to be upregulated in blood of ME/CFS patients, paralleled that of EBI2. EGR gene upregulation was found to be closely associated with that of EBI2 in ME/CFS, providing further evidence in support of ongoing EBV reactivation in a subset of ME/CFS patients. EGR1, EGR2, and EGR3 are part of the cellular immediate early gene response and are important in EBV transcription, reactivation, and B lymphocyte transformation. EGR1 is a regulator of immune function, and is important in vascular homeostasis, psychological stress, connective tissue disease, mitochondrial function, all of which are relevant to ME/CFS. EGR2 and EGR3 are negative regulators of T lymphocytes and are important in systemic autoimmunity.&lt;/p></description></item><item><title>Mutiple Sclerosis half as likely in children spending 30 to 60 minutes per day in the sun</title><link>/posts/mutiple-sclerosis-half-as-likely-in-children-spending-30-to-60-minutes-per-day-in-the-sun.html</link><pubDate>Fri, 10 Dec 2021 00:00:00 +0000</pubDate><guid>/posts/mutiple-sclerosis-half-as-likely-in-children-spending-30-to-60-minutes-per-day-in-the-sun.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#association-between-time-spent-outdoors-and-risk-of-multiple-sclerosis">Association Between Time Spent Outdoors and Risk of Multiple Sclerosis&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="association-between-time-spent-outdoors-and-risk-of-multiple-sclerosis">Association Between Time Spent Outdoors and Risk of Multiple Sclerosis&lt;/h4>
&lt;p>Neurology Dec 2021, 10.1212/WNL.0000000000013045&lt;/p>
&lt;p>Prince Sebastian, View ORCID ProfileNicolas Cherbuin, View ORCID ProfileLisa F Barcellos, Shelly Roalstad, Charles Casper, Janace Hart, Gregory S Aaen, View ORCID ProfileLauren Krupp, View ORCID ProfileLeslie Benson, Mark Gorman, Meghan Candee, Tanuja Chitnis, Manu Goyal, Benjamin Greenberg, Soe Mar, Moses Rodriguez, View ORCID ProfileJennifer Rubin, Teri Schreiner, View ORCID ProfileAmy Waldman, View ORCID ProfileBianca Weinstock-Guttman, Jennifer Graves, View ORCID ProfileEmmanuelle Waubant, View ORCID ProfileRobyn Lucas, US Network of Pediatric Multiple Sclerosis Centers&lt;/p></description></item><item><title>Low Vitamin D etc. more than 3 months after COVID hospitalization</title><link>/posts/low-vitamin-d-etc-more-than-3-months-after-covid-hospitalization.html</link><pubDate>Mon, 15 Nov 2021 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-etc-more-than-3-months-after-covid-hospitalization.html</guid><description>&lt;h4 id="long-term-clinical-and-biochemical-residue-after-covid-19-recovery">Long-term clinical and biochemical residue after COVID-19 recovery&lt;/h4>
&lt;p>Egyptian Liver Journal volume 11, &lt;a href="https://doi.org/10.1186/s43066-021-00144-1">https://doi.org/10.1186/s43066-021-00144-1&lt;/a>&lt;/p>
&lt;p>Mohammed Ali Gameil, Rehab Elsayed Marzouk, Ahmed Hassan Elsebaie &amp;amp; Salah Eldeen Rozaik&lt;/p>
&lt;h4 id="blood-measured-3-to-6-months-after-pcr-positive-test">Blood measured 3 to 6+ months after PCR positive test&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/months.jpg" alt="image" width="500">
&lt;h4 id="healthy-vs-months-after-covid-19-recovery">Healthy vs months after COVID-19 Recovery&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/after-covid-case-control.jpg" alt="image" width="500">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/univariant.jpg" alt="image" width="360">
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;strong>This very interesting study does not show&lt;br>
    1) Levels in persons BEFORE COVID&lt;br>
    2) Levels in people with Long-Haul&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/long-haul-fatigue-etc-common-after-viral-infections-sars12-mers-swine-1918">Long-haul fatigue, etc. common after viral infections (SARS1,2, MERS, Swine, 1918,&amp;hellip;) &lt;/a>&lt;/p></description></item><item><title>Vitamin D was the only supplement that fought COVID-19 (out of 6)</title><link>/posts/vitamin-d-was-the-only-supplement-that-fought-covid-19-out-of-6.html</link><pubDate>Mon, 18 Oct 2021 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-was-the-only-supplement-that-fought-covid-19-out-of-6.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamins-supplements-and-covid-19-a-review-of-currently-available-evidence">Vitamins, supplements and COVID-19: a review of currently available evidence&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-cholecalciferol-calcifediol">Vitamin D (cholecalciferol, calcifediol)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-c-ascorbic-acid">Vitamin C (ascorbic acid)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium">Magnesium&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-b12">Vitamin B12&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#zinc">Zinc&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#alpha-lipoic-acid">Alpha-lipoic acid&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-mineral-and-nutrient-deficiency-in-covid-19">Vitamin, mineral and nutrient deficiency in COVID-19&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusion">Conclusion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="vitamins-supplements-and-covid-19-a-review-of-currently-available-evidence">Vitamins, supplements and COVID-19: a review of currently available evidence&lt;/h3>
&lt;p>Drugs Context. 2021;10:2021-6-2. &lt;a href="https://doi.org/10.7573/dic.2021-6-2">https://doi.org/10.7573/dic.2021-6-2&lt;/a>&lt;/p>
&lt;p>Lauren L Speakman, Sarah M Michienzi, Melissa E Badowski&lt;/p>
&lt;p>Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA&lt;/p></description></item><item><title>Epstein-Barr is yet another virus that deactivates the Vitamin D receptor (COVID later suspected as well)– 2010</title><link>/posts/epstein-barr-is-yet-another-virus-that-deactivates-the-vitamin-d-receptor-covid--ed-as-well-2010.html</link><pubDate>Sun, 17 Oct 2021 00:00:00 +0000</pubDate><guid>/posts/epstein-barr-is-yet-another-virus-that-deactivates-the-vitamin-d-receptor-covid--ed-as-well-2010.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#epstein-barr-virus-encoded-ebna-3-binds-to-vitamin-d-receptor-and-blocks-activation-of-its-target-genes">Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="epstein-barr-virus-encoded-ebna-3-binds-to-vitamin-d-receptor-and-blocks-activation-of-its-target-genes">Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes&lt;/h4>
&lt;p>Cellular and Molecular Life Sciences volume 67, pages4249–4256 (2010) DOI 10.1007/s00018-010-0441-4&lt;/p>
&lt;p>Surya Pavan Yenamandra, Ulf Hellman, Bettina Kempkes, Suhas Deoram Darekar, Sabine Petermann, Tom Sculley, George Klein &amp;amp; Elena Kashuba&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/ebv-actively-deactivates-vitus.pdf">Download the PDF from sci-hub via VitaminDWiki &lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Multiple Sclerosis treated by Vitamin D, recommends investigating high dose Coimbra</title><link>/posts/multiple-sclerosis-treated-by-vitamin-d-recommends-investigating-high-dose-coimbra.html</link><pubDate>Wed, 06 Oct 2021 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-treated-by-vitamin-d-recommends-investigating-high-dose-coimbra.html</guid><description>&lt;p>&lt;strong>Impact of Vitamin D Supplementation on Multiple Sclerosis&lt;/strong>&lt;/p>
&lt;p>Cureus DOI: 10.7759/cureus.18487&lt;/p>
&lt;p>Fenil Gandhi 1 , Sharan Jhaveri 2 , Chaithanya Avanthika 3 4 , Abhishek Singh 5 , Nidhi Jain 6 &lt;a href="mailto:doctornidhijain@gmail.com">doctornidhijain@gmail.com&lt;/a> , Azouba Gulraiz 7 , Pratiksha Shah 8 , Fareeha Nasir 9&lt;/p>
&lt;ol>
&lt;li>Internal Medicine, Shree Krishna Hospital, Anand, IND 2. Internal Medicine, Nathiba Hargovandas Lakhmichand Municipal Medical College, Ahmedabad, IND 3. Medicine and Surgery, Karnataka Institute of Medical Sciences, Hubli, IND 4. Pediatrics, Karnataka Institute of Medical Sciences, Hubli, IND 5. Internal Medicine, Mount Sinai Morningside, New York City, USA 6. Internal Medicine, Sir Ganga Ram Hospital, New Delhi, IND 7. Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA 8. Vascular Surgery, Shree Krishna Hospital, Anand, IND 9. Internal Medicine, Harlem Hospital Center, New York City, USA&lt;/li>
&lt;/ol>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#abstract">Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction-and-background">Introduction And Background&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#review">Review&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-as-an-immunomodulator">Vitamin D as an immunomodulator&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#diagnostic-and-treatment-protocols-currently-in-use-for-multiple-sclerosis-ms">Diagnostic and treatment protocols currently in use for multiple sclerosis (MS)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#instrument-based-diagnostics-span53-56span">Instrument-based diagnostics &lt;span>[53-56]&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#treatment-of-multiple-sclerosis">Treatment of multiple sclerosis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusions">Conclusions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/vit-d-ms.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Virus cause some cancers</title><link>/posts/virus-cause-some-cancers.html</link><pubDate>Sat, 28 Aug 2021 00:00:00 +0000</pubDate><guid>/posts/virus-cause-some-cancers.html</guid><description>&lt;p>&lt;strong>Many virus that cause cancers have been disovered since the 1950&amp;rsquo;s&lt;br>
One such discovery got a Nobel prize in 2020&lt;br>
Many more virus ==&amp;gt; Cancer combinations are suspected&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#viruses-and-cancer--2021">Viruses and Cancer - 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#md-andersen-cancercenter">MD Andersen Cancer Center&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#onocvirus">Onocvirus&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamindwiki">VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#virus-from-hamberger-appears-to-cause-colon-cancer---update-aug-2021">Virus from hamberger appears to cause colon cancer - update Aug 2021&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="viruses-and-cancer--2021">Viruses and Cancer - 2021&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.cancerquest.org/cancer-biology/viruses-and-cancer?gclid=Cj0KCQjwvaeJBhCvARIsABgTDM4NbJiUYs3-vvm5mILuHmKXAZ80sRNH2iqTk8D-YLiVQ61L3j5XsKQaAiK7EALw_wcB">Cancer Quest&lt;/a>&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="https://www.cancerquest.org/cancer-biology/viruses-and-cancer?gclid=Cj0KCQjwvaeJBhCvARIsABgTDM4NbJiUYs3-vvm5mILuHmKXAZ80sRNH2iqTk8D-YLiVQ61L3j5XsKQaAiK7EALw_wcB#1">Epstein-Barr Virus (EBV) - Burkitt&amp;rsquo;s Lymphoma&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://www.cancerquest.org/cancer-biology/viruses-and-cancer?gclid=Cj0KCQjwvaeJBhCvARIsABgTDM4NbJiUYs3-vvm5mILuHmKXAZ80sRNH2iqTk8D-YLiVQ61L3j5XsKQaAiK7EALw_wcB#2">Hepatitis B Virus (HBV) - Liver Cancer&lt;/a>&lt;/p></description></item><item><title>Epstein-Barr Virus probably causes Long-COVID, CFS, and MS - many studies</title><link>/posts/epstein-barr-virus-probably-causes-long-covid-cfs-and-ms-many-studies.html</link><pubDate>Thu, 26 Aug 2021 00:00:00 +0000</pubDate><guid>/posts/epstein-barr-virus-probably-causes-long-covid-cfs-and-ms-many-studies.html</guid><description>&lt;p>&lt;strong>Fact&lt;/strong> Epstein-Barr Virus was &lt;a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus#History">first discovered in 1961&lt;/a>&lt;/p>
&lt;p>&lt;strong>Fact&lt;/strong> &lt;a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus#:~:text=%20about%2090%25%20of%20adults%20have%20evidence%20of%20previous%20infection.">~90% of adults have evidence of previous EBV infection&lt;/a>&lt;/p>
&lt;p>&lt;strong>Fact&lt;/strong> Symptoms come and go with Long-Haul, Multiple Sclerosis, amd CFS&lt;/p>
&lt;p>&lt;strong>Fact&lt;/strong> &lt;a href="/posts/virus-cause-some-cancers">Virus cause some cancers&lt;/a>&lt;/p>
&lt;p>&lt;strong>EBV Implicated with&lt;/strong> &lt;a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus#Role_in_disease">Burkitt&amp;rsquo;s lymphoma, Hodgkin&amp;rsquo;s lymphoma, stomach cancer, MS&lt;/a> &lt;a href="https://www.nih.gov/news-events/nih-research-matters/epstein-barr-virus-autoimmune-diseases">Some Auto-Immune diseases&lt;/a> and CFS - see below&lt;/p>
&lt;p>&lt;strong>Fact&lt;/strong> Multiple Sclerosis is extinguished by high-dose vitamin D&lt;/p>
&lt;p>&lt;strong>Possibility&lt;/strong> High-dose Vitamin D might also fight CFS, Long-Haul&lt;/p>
&lt;p>    &lt;strong>&lt;a href="/tags/resveratrol.html">Resveratrol&lt;/a> may also be needed&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#investigation-of-long-covid-prevalence-and-its-relationship-to-epstein-barr-virus-reactivation---june-2021">Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation - June 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#ebv-may-cause-chronic-fatigue-syndrome---2020">EBV may cause Chronic Fatigue Syndrome - 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#ebv-has-a-protein-which-is-similar-to-that-used-to-make-myelin---feb-2024">EBV has a protein which is similar to that used to make myelin - Feb 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epstein-barr-virusand-vitamin-d---3790-studies-in-aug-2023">&amp;ldquo;Epstein Barr Virus&amp;quot;and &amp;ldquo;Vitamin D&amp;rdquo; - 3,790 studies in Aug 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epstein-barr-virus-and-covid---16700-studies-in-aug-2023">&amp;ldquo;Epstein Barr Virus&amp;rdquo; and COVID - 16,700 studies in Aug 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epstein-barr-virus-long-covid-4700-studies-as-of-march-2025">&amp;ldquo;Epstein Barr Virus&amp;rdquo; &amp;ldquo;long covid&amp;rdquo; 4,700 studies as of March 2025&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-haul-ebv-on-the-web">Long-Haul EBV on the web&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#many-ways-to-increase-receptor-activation-and-get-more-vitamin-d-to-cells">Many ways to increase Receptor activation and get more vitamin D to cells&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="investigation-of-long-covid-prevalence-and-its-relationship-to-epstein-barr-virus-reactivation---june-2021">Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation - June 2021&lt;/h4>
&lt;p>Pathogens 2021, 10(6), 763; &lt;a href="https://doi.org/10.3390/pathogens10060763">https://doi.org/10.3390/pathogens10060763&lt;/a>&lt;/p></description></item><item><title>A virus that most adults have (Cytomegalovirus) decreases the amount of Vitamin D which gets to the cells</title><link>/posts/a-virus-that-most-adults-have-cytomegalovirus-decreases-the-amount-of-vitamin-d--ts-to-the-cells.html</link><pubDate>Tue, 18 May 2021 00:00:00 +0000</pubDate><guid>/posts/a-virus-that-most-adults-have-cytomegalovirus-decreases-the-amount-of-vitamin-d--ts-to-the-cells.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#human-cytomegalovirus-infection-downregulates-vitamin-d-receptor-in-mammalian-cells">Human Cytomegalovirus Infection Downregulates Vitamin-D Receptor in Mammalian Cells&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#abstract">Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#material-and-methods">Material and Methods&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#results">Results&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-metabolites-do-not-inhibit-cmv-replication">Vitamin D metabolites do not inhibit CMV replication&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#14-papers-cited-this-study-as-of-aug-2021">14 papers cited this study as of Aug 2021&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#vitamindwiki">VitaminDWiki&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-receptor">Vitamin D Receptor&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#cmv-on-the-web">CMV on the web&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cmv-and-vitamin-d-on-the-web">CMV and VITAMIN D on the web&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="human-cytomegalovirus-infection-downregulates-vitamin-d-receptor-in-mammalian-cells">Human Cytomegalovirus Infection Downregulates Vitamin-D Receptor in Mammalian Cells&lt;/h3>
&lt;p>J Steroid Biochem Mol Biol. 2017 January ; 165(Pt B ): 356-362. doi:10.1016/j.jsbmb.2016.08.002.&lt;/p></description></item><item><title>Some pathogens and health problems restrict Vitamin D from being used – Coimbra high-dose protocol</title><link>/posts/some-pathogens-and-health-problems-restrict-vitamin-d-from-being-used-coimbra-high-dose-protocol.html</link><pubDate>Mon, 26 Apr 2021 00:00:00 +0000</pubDate><guid>/posts/some-pathogens-and-health-problems-restrict-vitamin-d-from-being-used-coimbra-high-dose-protocol.html</guid><description>&lt;p>&lt;strong>Autoimmune Diseases: A Hypothesis Confirmed by a Therapeutic High-Dose Vitamin D Protocol&lt;/strong>&lt;/p>
&lt;p>Front. Immunol. 12:655739. &lt;a href="https://doi.org/10.3389/fimmu.2021.655739">doi: 10.3389/fimmu.2021.655739&lt;/a>&lt;/p>
&lt;p>Dirk Lemke1&amp;rsquo; Rainer Johannes Klement2咐，Felix Schweiger3, Beatrix Schweiger 3 and Jorg Spitz 4&lt;/p>
&lt;p>1 Praxis Dr. Beatrix Schweiger, Bensheim, Germany, 2 Department of Radiotherapy and Radiation Oncology, Leopoldina Hospital Schweinfurt, Schweinfurt, Germany, 3 Praxis Dr. Beatrix Schweiger, Waldkirch, Germany, 4 Akademie fur menschliche Medizin und evolutionare Gesundheit, Schlangenbad, Germany&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/vitamin-d-resistance-as-a-possible-cause-of-autoimmune-diseases---with-high-dose-protocol.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Long-haul COVID-19 - another hint that Vitamin D should help</title><link>/posts/long-haul-covid-19-another-hint-that-vitamin-d-should-help.html</link><pubDate>Fri, 16 Apr 2021 00:00:00 +0000</pubDate><guid>/posts/long-haul-covid-19-another-hint-that-vitamin-d-should-help.html</guid><description>&lt;p>&lt;strong>&lt;a href="https://youtu.be/HstxLZRRNG0">&amp;ldquo;End of 2020 COVID19 Immunology Recap - PLUS - Special Update for Long-Haulers&amp;rdquo; &lt;/a>&lt;/strong>&lt;/p>
&lt;p>Dr. Patterson attributes long-haul COVID19 to the absence of germinal centers and reports a low CD8 T-cell signature:&lt;/p>
&lt;p>See Minute 16 and min 40-49 (&amp;ldquo;when patients were getting better CD8+T-cells were going UP&amp;rdquo;):&lt;/p>
&lt;p>Remember: CD8+T-cells have the &lt;strong>highest amount of the vit D receptor of all immune cells&lt;/strong>&lt;/p>
&lt;p>&lt;strong>CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis - 2012&lt;/strong>&lt;/p></description></item><item><title>Vitamin D Resistance hypothesis confirmed by Coimbra high-dose vitamin D protocol</title><link>/posts/vitamin-d-resistance-hypothesis-confirmed-by-coimbra-high-dose-vitamin-d-protocol.html</link><pubDate>Wed, 07 Apr 2021 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-resistance-hypothesis-confirmed-by-coimbra-high-dose-vitamin-d-protocol.html</guid><description>&lt;p>&lt;strong>Vitamin D resistance as a Possible Cause of Autoimmune Diseases: A Hypothesis Confirmed by a Therapeutic High-Dose Vitamin D Protocol&lt;/strong>&lt;/p>
&lt;p>Frontiers in Immunology – Hypothesis and Theory &lt;a href="https://doi.org/10.3389/fimmu.2021.655739">doi: 10.3389/fimmu.2021.655739&lt;/a>&lt;/p>
&lt;p>Dirk Lemke1&amp;rsquo; Rainer Johannes Klement2 &lt;a href="mailto:rainer_klement@gmx.de">rainer_klement@gmx.de&lt;/a>，Felix Schweiger3, Beatrix Schweiger3 and Jorg Spitz4&lt;/p>
&lt;p>1 Praxis Dr. Beatrix Schweiger, Bensheim, Germany, 2 Department of Radiotherapy and Radiation Oncology, Leopoldina Hospital Schweinfurt, Schweinfurt, Germany, 3 Praxis Dr. Beatrix Schweiger, Waldkirch, Germany, 4Akademie fur menschliche Medizin und evolutionare Gesundheit, Schlangenbad, Germany&lt;/p></description></item><item><title>Infectious Mononucleosis (virus) and Vitamin D - many studies</title><link>/posts/infectious-mononucleosis-virus-and-vitamin-d-many-studies.html</link><pubDate>Sun, 04 Apr 2021 00:00:00 +0000</pubDate><guid>/posts/infectious-mononucleosis-virus-and-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#treatment-of-infectious-mononucleosis-with-high-dose-vitamin-d-in-three-cases---march-2021">Treatment of Infectious Mononucleosis with High Dose Vitamin D in Three Cases - March 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-between-acute-infectious-mononucleosis-and-vitamin-d-deficiency---sept-2016">Association Between Acute Infectious Mononucleosis and Vitamin D Deficiency - Sept 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="treatment-of-infectious-mononucleosis-with-high-dose-vitamin-d-in-three-cases---march-2021">Treatment of Infectious Mononucleosis with High Dose Vitamin D in Three Cases - March 2021&lt;/h4>
&lt;p>Ann Nutr Disord &amp;amp; Ther - Volume 8 Issue 1 - 2021 ISSN : 2381-8891&lt;/p>
&lt;p>&lt;a href="https://doi.org/10.26420/annnutrdisordther.2021.1068">https://doi.org/10.26420/annnutrdisordther.2021.1068&lt;/a>&lt;/p>
&lt;p>Schwalfenberg GK Department of Family Medicine, Assistant Clinical Professor, University of Alberta, Edmonton, Canada&lt;/p></description></item><item><title>Long-COVID in VitaminDWiki</title><link>/posts/long-covid-in-vitamindwiki.html</link><pubDate>Sat, 30 Jan 2021 00:00:00 +0000</pubDate><guid>/posts/long-covid-in-vitamindwiki.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#sexual-dysfunction-hair-loss-also-linked-with-long-covid---aug-2022">Sexual dysfunction, hair loss also linked with long COVID - Aug 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#us-gov-finally-has-a-long-covid-plan---aug-2022">US Gov. finally has a long-COVID plan - Aug 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#at-least-90-long-covid-groups-exist-around-the-world-in-34-countries---aug-2022">At least 90 long Covid groups exist around the world in 34 countries. - Aug 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#many-with-long-covid-has-low-cortisol-levels-regulated-by-vitamin-d---aug-2022">Many with long-COVID has low Cortisol levels (regulated by Vitamin D) - Aug 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#about-10-million-americans-have-long-haul---april-2022">About 10 million Americans have long-haul - April 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-haul-group-in-facebook-has-190000-members---march-2022">Long-Haul group in Facebook has 190,000 members - March 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-covid-is-destroying-careers-leaving-economic-distress-in-its-wake---dec-2021">Long covid is destroying careers, leaving economic distress in its wake - Dec 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#costly-supplement-cocktail-for-long-haul---2021">Costly supplement cocktail for Long-Haul - 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#covid-is-probably-not-the-only-health-problem-that-results-in-long-haul-1-billion-research--nov-2021">COVID is probably not the only health problem that results in Long Haul ($1 Billion research) Nov 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-haul-covid-likely-caused-by-epstein-barr-virus">Long-Haul COVID likely caused by Epstein-Barr virus&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#survey-of-5000-long-haulers--march-2021">Survey of 5,000 long-haulers- March 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-haul-probably-decreased-if-increase-vitamin-d-getting-to-cells---on-the-web">Long Haul probably decreased if increase Vitamin D getting to cells - on the web&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#more-than-50-long-term-effects-of-covid-19-a-systematic-review-andmeta-analysis---jan-2021">More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis - Jan 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-haul-similar-for-vaccinated-and-unvaccinated---oct-2021">Long-haul similar for vaccinated and unvaccinated - Oct 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-haul--reduced-by-vaccination-studies-range-from-0-to-40---april-2022">Long-Haul reduced by vaccination: studies range from 0% to 40% - April 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#those-who-get-covid-19-after-being-vaccinated-breakthru-are-12-as-likely-to-get-long-haul---sept-2021">Those who get COVID-19 after being vaccinated (breakthru) are 1/2 as likely to get long-haul - Sept 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#13-of-uk-long-haul-has-lasted-more-than-1-year---july-2021">1/3 of UK Long Haul has lasted more than 1 year - July 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-haul-does-not-persist-in-children---jan-9-2022">Long-Haul does not persist in children - Jan 9, 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-haul-support-groups">Long-Haul support groups&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-haul-on-theweb">Long haul on the web&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="sexual-dysfunction-hair-loss-also-linked-with-long-covid---aug-2022">Sexual dysfunction, hair loss also linked with long COVID - Aug 2022&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.mdedge.com/dermatology/article/257023/long-covid/sexual-dysfunction-hair-loss-linked-long-covid?ecd=WNL_eve_220815_mdedge">MDEdge&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Long-haul fatigue, etc. common after viral infections (SARS1,2, MERS, Swine, 1918,...)</title><link>/posts/long-haul-fatigue-etc-common-after-viral-infections-sars12-mers-swine-1918.html</link><pubDate>Sat, 29 Aug 2020 00:00:00 +0000</pubDate><guid>/posts/long-haul-fatigue-etc-common-after-viral-infections-sars12-mers-swine-1918.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#summary">Summary&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-might-help-viral-infections-in-many-ways">Vitamin D might help viral infections in many ways&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#80-percent-of-covid-19-survivors-have-long-haul-symptoms--meta-analysis-jan-30-2021">80 percent of COVID-19 survivors have long-haul symptoms – meta-analysis Jan 30, 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#probably-less-long-haul-covid-19-when-immune-system-was-regenerated-by-vitamin-d-etc--dec-2020">Probably less long-haul COVID-19 when immune system was regenerated by Vitamin D, etc. – Dec 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#several-alternative-covid-19-treatments-greatly-reduce-long-haul-symptoms---feb-2021">Several alternative COVID-19 treatments greatly reduce long-haul symptoms - Feb 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#snips-from-reports-of-long-haul-covid--longcovid--post-covid-syndrome">Snips from reports of Long-haul Covid = longcovid = post-Covid syndrome&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="summary">Summary&lt;/h3>
&lt;ul>
&lt;li>
&lt;p>Some people have long-term health problems after any viral infection&lt;/p></description></item><item><title>Vitamin D Receptor - activation and deactivation- self-hacked</title><link>/posts/vitamin-d-receptor-activation-and-deactivation-self-hacked.html</link><pubDate>Sun, 14 Jul 2019 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-receptor-activation-and-deactivation-self-hacked.html</guid><description>&lt;p>&lt;strong>First 3 sections clipped from &lt;a href="https://selfhacked.com/blog/natural-ways-to-increase-calcitrol-and-vitamin-d-receptor-gene-expression/">Vitamin D Receptor Gene: Activation, Calcitriol, Benefits&lt;/a>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#natural-ways-to-increase-calcitrol-and-vdr">Natural Ways to Increase Calcitrol and VDR&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-inhibits-the-vitamin-d-receptor-vdr-or-calcitriol">What Inhibits The Vitamin D Receptor (VDR) or Calcitriol&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pathogens-that-inhibit-the-vitamin-d-receptor">Pathogens That Inhibit The Vitamin D Receptor&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="natural-ways-to-increase-calcitrol-and-vdr">Natural Ways to Increase Calcitrol and VDR&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;strong>&lt;a href="https://selfhacked.com/blog/top-14-proven-health-benefits-exercise-references-mechanisms/">Exercise&lt;/a>&lt;/strong> &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/10954775">38&lt;/a> – increases calcitriol, but not aerobic exercise &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/12395212">39&lt;/a>.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;strong>&lt;a href="https://selfhacked.com/blog/importance-real-vitamin-retinol/">RXR&lt;/a>&lt;/strong> (and retinol) is needed to produce proteins with the VDR. 1,25D3 binds to the VDR, which then combines with RXR to activate gene expression. (Not all VDR dependent genes need RXR.)&lt;/p></description></item><item><title>Recent brain problems appears to be associated with neurofilament light chains (would aide Vitamin D MS. Alz studies)</title><link>/posts/recent-brain-problems-appears-to-be-associated-with-neurofilament-light-chains-w--ms-alz-studies.html</link><pubDate>Sat, 13 Jul 2019 00:00:00 +0000</pubDate><guid>/posts/recent-brain-problems-appears-to-be-associated-with-neurofilament-light-chains-w--ms-alz-studies.html</guid><description>&lt;h4 id="vitamin-d-supplementation-as-add-on-therapy-in-multiple-sclerosisbalance-between-benefit-and-risk-a-commentary-on-vitamin-d-supplementation-in-central-nervous-system-demyelinating-diseaseenough-is-enough">Vitamin D Supplementation as Add-on Therapy in Multiple Sclerosis—Balance between Benefit and Risk?: A Commentary on Vitamin D Supplementation in Central Nervous System Demyelinating Disease—Enough Is Enough&lt;/h4>
&lt;p>Int. J. Mol. Sci. 2019, 20,1513; doi:10.3390/ijms20061513&lt;/p>
&lt;p>Hans-Klaus Goischke, Hochwaldstrasse 2, D-97769 Bad Brückenau, Germany; &lt;a href="mailto:hkem.goischke@t-online.de">hkem.goischke@t-online.de&lt;/a>&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>&lt;strong>It is great when we can get quick feedback on how well Vitamin D dosing is treating any disease&lt;/strong>&lt;/p>
&lt;h3 id="see-also">See also&lt;/h3>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="https://www.quanterix.com/products-technology/assays/nf-light?gclid=CjwKCAjwgqbpBRAREiwAF046JQWlFwPkgJveMvi5AGwHW9YkjICDAzfzwxgMmuTmnrwiK-IxvCaszBoCQHsQAvD_BwE">Quanterix sells a sNFL test&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://n.neurology.org/content/92/15_Supplement/S56.006">Neurofilament Light Chains as a Marker of Concurrent and Future Active Disease in Relapsing Multiple Sclerosis: An Analysis of Baseline Data From the Phase 3 Ozanimod Clinical Trials (S56.006) April 2019&lt;/a>&lt;/p></description></item><item><title>The interplay between vitamin D and viral infections</title><link>/posts/the-interplay-between-vitamin-d-and-viral-infections.html</link><pubDate>Sun, 17 Feb 2019 00:00:00 +0000</pubDate><guid>/posts/the-interplay-between-vitamin-d-and-viral-infections.html</guid><description>&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/viral-2.jpg" alt="image" width="900">
&lt;p>&lt;strong>FIGURE 2 Vitamin D and induction of antimicrobial peptides against viral infection&lt;/strong> . Vitamin D-induced antimicrobial peptides (LL37 and HBDs) via VDR and RXR dimerization act against viral infections through (1) binding to FPRL1 and CCR6 for recruiting immune cells to site of infection; (2) activation of innate immunity by transactivation of the EGFR; (3) clearance of viral infection through mitochondrial membrane depolarization and release of cytochrome c; (4) down-regulation of cell entry, replication, and viral release; (5) protection of viral RNAs from degradation and induced immunity response throughTLRs activation; (6) and direct effects on virions. Abbreviation: Epidermal growth factor receptor (EGFR), formyl peptide receptor-like 1 (FPRL1), human ß-defensins (HBDs), retinoic X receptor (RXR), toll-like receptor (TLR), and vitamin D receptor (VDR)&lt;/p></description></item><item><title>Treating herpes reduced incidence of senile dementia by 10 X (HSV1 reduces VDR by 8X) – 2018</title><link>/posts/treating-herpes-reduced-incidence-of-senile-dementia-by-10-x-hsv1-reduces-vdr-by-8x-2018.html</link><pubDate>Thu, 17 Jan 2019 00:00:00 +0000</pubDate><guid>/posts/treating-herpes-reduced-incidence-of-senile-dementia-by-10-x-hsv1-reduces-vdr-by-8x-2018.html</guid><description>&lt;h4 id="herpes-viruses-and-senile-dementia-first-population-evidence-for-a-causal-link">Herpes Viruses and Senile Dementia: First Population Evidence for a Causal Link.&lt;/h4>
&lt;p>J Alzheimers Dis. 2018;64(2):363-366. &lt;a href="https://doi.org/10.3233/JAD-180266.">doi: 10.3233/JAD-180266.&lt;/a>&lt;/p>
&lt;p>Itzhaki RF1,2, Lathe R3.&lt;/p>
&lt;p>1 Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.&lt;/p>
&lt;p>2 Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester, UK.&lt;/p>
&lt;p>3 Division of Infection and Pathway Medicine, University of Edinburgh, Little France, Edinburgh, UK.&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;strong>&lt;span style="color:#00F;">Hypothesis:&lt;/span>&lt;/strong>&lt;/p>
&lt;!-- ~tc~ start ~/tc~ -->
&lt;p>**Herpes Virus =&amp;gt; deactivates the Vitamin D Receptor =&amp;gt; Less Vitamin D to Tissue =&amp;gt; Disease&lt;br>
Candidate solutions include&lt;/p></description></item><item><title>Vitamin D and neurological diseases such as stroke, Vascular Dementia, PD, MS</title><link>/posts/vitamin-d-and-neurological-diseases-such-as-stroke-vascular-dementia-pd-ms.html</link><pubDate>Thu, 06 Dec 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-neurological-diseases-such-as-stroke-vascular-dementia-pd-ms.html</guid><description>&lt;p>&lt;strong>Vitamin D in Neurological Diseases: A Rationale for a Pathogenic Impact&lt;/strong>&lt;/p>
&lt;p>International Journal of Molecular Sciences, 2018, 19, 2245; doi:10.3390/ijms19082245&lt;/p>
&lt;p>Rita Moretti &lt;a href="mailto:moretti@units.it">moretti@units.it&lt;/a>, Maria Elisa Morelli © and Paola Caruso&lt;/p>
&lt;p>Neurology Clinic, Department of Medical, Surgical and Health Sciences, University of Trieste, Strada di Fiume, 447, 34149 Trieste, Italy; &lt;a href="mailto:mariaelisa.morelli@gmail.com">mariaelisa.morelli@gmail.com&lt;/a> (M.E.M.); &lt;a href="mailto:caruso.paola1983@libero.it">caruso.paola1983@libero.it&lt;/a> (P.C.)&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/vdr-neurological-diseases.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiency-and-multiple-sclerosis-role-in-the-susceptibility-activity-and-treatment-of-the-disease">Vitamin D Deficiency and Multiple Sclerosis: Role in the Susceptibility, Activity, and Treatment of the Disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiencies-and-ischemic-stroke">Vitamin D Deficiencies and Ischemic Stroke&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiency-and-neurodegenerative-diseases">Vitamin D Deficiency and Neurodegenerative Diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusions">Conclusions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;p>It is widely known that vitamin D receptors have been found in neurons and glial cells, and their highest expression is in the hippocampus, hypothalamus, thalamus and subcortical grey nuclei, and substantia nigra. Vitamin D helps the regulation of neurotrophin, neural differentiation, and maturation, through the control operation of growing factors synthesis (i.e., neural growth factor &lt;span>[NGF]&lt;/span> and glial cell line-derived growth factor (GDNF), the trafficking of the septohippocampal pathway, and the control of the synthesis process of different neuromodulators (such as acetylcholine &lt;span>[Ach]&lt;/span>, dopamine &lt;span>[DA]&lt;/span>, and gamma-aminobutyric &lt;span>[GABA]&lt;/span>). Based on these assumptions, we have written this review to summarize the potential role of vitamin D in neurological pathologies. This work could be titanic and the results might have been very fuzzy and even incoherent had we not conjectured to taper our first intentions and devoted our interests towards three mainstreams, demyelinating pathologies, vascular syndromes, and neurodegeneration. As a result of the lack of useful therapeutic options, apart from the disease-modifying strategies, the role of different risk factors should be investigated in neurology, as their correction may lead to the improvement of the cerebral conditions. We have explored the relationships between the gene-environmental influence and long-term vitamin D deficiency, as a risk factor for the development of different types of neurological disorders, along with the role and the rationale of therapeutic trials with vitamin D implementation.&lt;/p></description></item><item><title>Hypothesis - Dysfunction of Autonomic Nervous System is associated with low vitamin D</title><link>/posts/hypothesis-dysfunction-of-autonomic-nervous-system-is-associated-with-low-vitamin-d.html</link><pubDate>Fri, 16 Feb 2018 00:00:00 +0000</pubDate><guid>/posts/hypothesis-dysfunction-of-autonomic-nervous-system-is-associated-with-low-vitamin-d.html</guid><description>&lt;h4 id="is-vitamin-d-deficiency-implicated-in-autonomic-dysfunction">Is Vitamin D Deficiency Implicated in Autonomic Dysfunction?&lt;/h4>
&lt;p>J Pediatr Neurosci. 2017 Apr-Jun;12(2):119-123. &lt;a href="https://doi.org/10.4103/jpn.JPN_1_17.">doi: 10.4103/jpn.JPN_1_17.&lt;/a>&lt;/p>
&lt;p>Wadhwania R, University of Texas Health Science Center at Houston, Houston, Texas, USA.&lt;/p>
&lt;p>&lt;strong>Dysautonomia&lt;/strong> , dysfunction of the autonomic nervous system, presents with heterogeneous clinical features from an imbalanced regulation of the sympathetic and parasympathetic nervous systems. Low Vitamin D levels can explain the heterogeneous clinical features of&lt;/p>
&lt;ul>
&lt;li>
&lt;p>migraine headaches,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>cardiac and&lt;/p>
&lt;/li>
&lt;li>
&lt;p>gastrointestinal dysfunction, and&lt;/p>
&lt;/li>
&lt;li>
&lt;p>oxidative stress&lt;/p></description></item><item><title>Multiple Sclerosis - low vitamin D, low sun, smoking are the largest modifiable factors</title><link>/posts/multiple-sclerosis-low-vitamin-d-low-sun-smoking-are-the-largest-modifiable-factors.html</link><pubDate>Sat, 09 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-low-vitamin-d-low-sun-smoking-are-the-largest-modifiable-factors.html</guid><description>&lt;h4 id="factors-associated-with-onset-relapses-or-progression-in-multiple-sclerosis-a-systematic-review">Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review&lt;/h4>
&lt;p>NeuroToxicology, April 2016, doi:10.1016/j.neuro.2016.03.020 &lt;strong>78 pages&lt;/strong>&lt;/p>
&lt;p>Kyla A. McKaya, Shayesteh Jahanfarb, Tom Duggana, Stacey Tkachuka, Helen Tremletta &lt;a href="mailto:helen.tremlett@ubc.ca">helen.tremlett@ubc.ca&lt;/a>&lt;/p>
&lt;p>Multiple sclerosis (MS) is a chronic disease of the central nervous system with an unidentified etiology. We systematically reviewed the literature on the possible risk factors associated with MS disease onset, relapses and progression from 1960-2012 by accessing six databases and including relevant&lt;/p></description></item><item><title>Hypothesis: Leishmania parasitic infection can be reduced by Vitamin D</title><link>/posts/hypothesis-leishmania-parasitic-infection-can-be-reduced-by-vitamin-d.html</link><pubDate>Sat, 13 Feb 2016 00:00:00 +0000</pubDate><guid>/posts/hypothesis-leishmania-parasitic-infection-can-be-reduced-by-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-role-of-vitamin-d-in-the-control-of-leishmania-infection">The role of vitamin D in the control of Leishmania infection.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-the-tropical-disease-leishmaniasis--new-findings-on-the-immune-defence-of-the-parasitehttpswwwpeideennewsroompress-releasesyear201923-vitamin-d-and-leishmaniasis-new-findings-immune-defencehtml---nov-2019">&lt;a href="https://www.pei.de/EN/newsroom/press-releases/year/2019/23-vitamin-d-and-leishmaniasis-new-findings-immune-defence.html">Vitamin D and the Tropical Disease Leishmaniasis – New Findings on the Immune Defence of the Parasite&lt;/a> - Nov 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-role-of-vitamin-d-in-the-control-of-leishmania-infection">The role of vitamin D in the control of Leishmania infection.&lt;/h4>
&lt;p>Can J Physiol Pharmacol. 2015 May;93(5):369-76. &lt;a href="https://doi.org/10.1139/cjpp-2014-0372">doi: 10.1139/cjpp-2014-0372&lt;/a>&lt;/p>
&lt;p>Ramos-Martínez E1, Gutierrez-Kobeh L, Villaseñor-Cardoso MI.&lt;/p>
&lt;p>1Unidad de Investigación en Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, Dr. Balmis 148, Colonia Doctores, Cuauhtemoc, México D.F. 06720, México.&lt;/p></description></item><item><title>Multiple Sclerosis risk factors – Vitamin D, parasites, and EBV – 2015</title><link>/posts/multiple-sclerosis-risk-factors-vitamin-d-parasites-and-ebv-2015.html</link><pubDate>Tue, 05 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-factors-vitamin-d-parasites-and-ebv-2015.html</guid><description>&lt;h4 id="multiple-sclerosis-and-environmental-factors-the-role-of-vitamin-d-parasites-and-epstein-barr-virus-infection">Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection.&lt;/h4>
&lt;p>Acta Neurol Scand. 2015;132(199):46-55. &lt;a href="https://doi.org/10.1111/ane.12431.">doi: 10.1111/ane.12431.&lt;/a>&lt;/p>
&lt;p>Correale J1, Gaitán MI1.&lt;/p>
&lt;p>1Department of Neurology, Institute for Neurological Research Dr. Raúl Carrea, FLENI, Buenos Aires, Argentina.&lt;/p>
&lt;p>Pathogenic mechanisms underlying multiple sclerosis development have yet to be clearly identified, but considerable evidence indicates that autoimmunity plays an important role in the etiology of the disease. It is generally accepted that autoimmune diseases like MS arise from complex interactions between genetic susceptibility and environmental factors. Although environmental factors unequivocally influencing MS development have yet to be established, accumulating evidence singles out several candidates, including sunlight-UV exposure or vitamin D deficiency, viral infections, hygiene, and cigarette smoking. Vitamin D deficiency has been associated with different autoimmune diseases. Several investigations indicate 125 (OH)2 vitamin D plays a critical role in shaping T-cell response and inducing T cells with immunosuppressive properties. Likewise, helminth infections represent another potential environmental factor exerting immunomodulatory properties. Both epidemiological and experimental data provide evidence to support autoimmune down-regulation secondary to parasite infections in patients with MS, through regulatory T- and B-cell action, with effects extending beyond simple response to an infectious agent. Finally, different epidemiological studies have demonstrated that Epstein-Barr virus infection confers added risk of developing MS. Proposed mechanisms responsible for this association include activation and expansion of self-reactive T and B cells, lower threshold for self-tolerance breakdown, and enhanced autoreactive B-cell survival, all to be discussed in this review. Understanding environmental factors influencing propensity to MS will lead to new and more effective approaches to prevent and treat the disease.&lt;/p></description></item><item><title>Off topic: Cannabis and disease studies at GreenMedInfo</title><link>/posts/off-topic-cannabis-and-disease-studies-at-greenmedinfo.html</link><pubDate>Mon, 28 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/off-topic-cannabis-and-disease-studies-at-greenmedinfo.html</guid><description>&lt;h4 id="raw-cannabis-juice-helps-young-woman-ditch-40-medicationshttptvgreenmedinfocomraw-cannabis-juice-helps-young-woman-ditch-40-medications">&lt;a href="http://tv.greenmedinfo.com/raw-cannabis-juice-helps-young-woman-ditch-40-medications/">Raw Cannabis Juice Helps Young Woman Ditch 40 Medications&lt;/a>&lt;/h4>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;p>&lt;strong>Note – There is a BIG difference between cannabis products&lt;/strong>&lt;/p>
&lt;p>Most research - such as in the table below does not distinguish between THC and CBD&lt;/p>
&lt;p>In a nutshell :It appears that&lt;/p>
&lt;p>&lt;strong>| | | |
| &amp;mdash; | &amp;mdash; | &amp;mdash; |
| | THC | CBD |
| Benefit | Get high | Pain relief |
| Typical cannabis | 50% | 50% |
| High-grade cannabis | 90% | 10% |
| Pain relief cannabis | 5% | 95% |
| Legal in US states | &amp;lt;10% | 100% |&lt;/strong>&lt;/p></description></item><item><title>Same dose of vitamin D for everyone is virtually impossible</title><link>/posts/same-dose-of-vitamin-d-for-everyone-is-virtually-impossible.html</link><pubDate>Fri, 04 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/same-dose-of-vitamin-d-for-everyone-is-virtually-impossible.html</guid><description>&lt;p>&lt;strong>Optimal Vitamin D Supplementation Doses that Minimize the Risk for Both Low and High Serum 25- Hydroxyvitamin D Concentrations in the General Population&lt;/strong>&lt;/p>
&lt;p>Nutrients 2015, 7(12), 10189-10208; doi:10.3390/nu7125527&lt;/p>
&lt;p>Paul J. Veugelers *, Truong-Minh Pham and John Paul Ekwaru&lt;/p>
&lt;p>Received: 18 August 2015; Accepted: 27 November 2015; Published: 4 December 2015&lt;/p>
&lt;p>School of Public Health, University of Alberta, 350 University Terrace, Edmonton, AB T6G 2T4, Canada; &lt;a href="mailto:ptrminh@gmail.com">ptrminh@gmail.com&lt;/a> (T.-M.P.); &lt;a href="mailto:ekwaru@ualberta.ca">ekwaru@ualberta.ca&lt;/a> (J.P.E.)&lt;/p>
&lt;ul>
&lt;li>Correspondence: &lt;a href="mailto:paul.veugelers@ualberta.ca">paul.veugelers@ualberta.ca&lt;/a>; Tel.: 1-780-492-9095&lt;/li>
&lt;/ul>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>This study agrees with many others:&lt;/p></description></item><item><title>Vitamin D Receptor</title><link>/posts/vitamin-d-receptor.html</link><pubDate>Tue, 04 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-receptor.html</guid><description>&lt;ol>
&lt;li>
&lt;p>It appears that 1/3 of everyone with a vitamin D-related disease has a poor VDR&lt;/p>
&lt;/li>
&lt;li>
&lt;p>A poor VDR cannot be detected by any standard Vitamin D test (nor Calcitriol nor Calcidiol)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>A poor Parathyroid VDR can be detected when high Calcitriol levels fail to decrease PTH levels&lt;/p>
&lt;/li>
&lt;/ol>
&lt;blockquote>
&lt;p>Decreasing PTH shows Vitamin D is getting to Parathyroid - but says nothing about VDRs elsewhere&lt;/p>
&lt;/blockquote>
&lt;ol>
&lt;li>
&lt;p>Many cancers and viruses have learned to protect themselves by deactivating the local VDR&lt;/p></description></item><item><title>Hypothesis – Multiple Sclerosis risk increases with low UV, viral infections, and antibiotics in childhood</title><link>/posts/hypothesis-multiple-sclerosis-risk-increases-with-low-uv-viral-infections-and-an-cs-in-childhood.html</link><pubDate>Sat, 07 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/hypothesis-multiple-sclerosis-risk-increases-with-low-uv-viral-infections-and-an-cs-in-childhood.html</guid><description>&lt;h3 id="environmental-factors-in-multiple-sclerosis">Environmental factors in multiple sclerosis.&lt;/h3>
&lt;p>Presse Med. 2015 Mar 2. pii: S0755-4982(15)00064-0. &lt;a href="https://doi.org/10.1016/j.lpm.2015.01.001.">doi: 10.1016/j.lpm.2015.01.001.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Pantazou V1, Schluep M1, Du Pasquier R2.&lt;/p>
&lt;p>1CHUV, University Hospital of Lausanne, Department of Clinical Neurosciences, Service of Neurology, 1011 Lausanne, Switzerland.&lt;/p>
&lt;p>2CHUV, University Hospital of Lausanne, Department of Clinical Neurosciences, Service of Neurology, 1011 Lausanne, Switzerland; CHUV, University Hospital of Lausanne, Centre of Research in Clinical Neurosciences, Laboratory of Neuroimmunology, 1011 Lausanne, Switzerland. Electronic address: &lt;a href="mailto:renaud.du-pasquier@chuv.ch">renaud.du-pasquier@chuv.ch&lt;/a>.&lt;/p></description></item><item><title>Sore throat and low vitamin D was associated with monnucleosis – small study</title><link>/posts/sore-throat-and-low-vitamin-d-was-associated-with-monnucleosis-small-study.html</link><pubDate>Wed, 04 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/sore-throat-and-low-vitamin-d-was-associated-with-monnucleosis-small-study.html</guid><description>&lt;h4 id="vitamin-d-levels-and-monospot-tests-in-military-personnel-with-acute-pharyngitis-a-retrospective-chart-review">Vitamin D levels and monospot tests in military personnel with acute pharyngitis: a retrospective chart review.&lt;/h4>
&lt;p>PLoS One. 2014 Jul 10;9(7):e101180. &lt;a href="https://doi.org/10.1371/journal.pone.0101180.">doi: 10.1371/journal.pone.0101180.&lt;/a> eCollection 2014.&lt;/p>
&lt;p>Maloney SR1, Almarines D2, Goolkasian P3.&lt;/p>
&lt;p>Some recent studies have proposed an important role for vitamin D in reducing the risk of infection by assisting in the suppression of viruses and by controlling the inflammatory response. A low vitamin D state may have a detrimental effect on the immune system&amp;rsquo;s ability to produce activated CD8+ T cells, and it may increase the inflammatory reaction to Epstein Barr virus. The aim of this chart review was to see if serum 25 OH vitamin D3 levels in service members with acute pharyngitis were lower in those who had positive rather than negative monospot tests. A retrospective chart review was conducted on the medical records of service members who presented to sick call at Camp Lejeune, NC with acute pharyngitis from October 8, 2010 until June 30, 2011. Serum 25 OH vitamin D3 levels were compared between those with positive and negative monospot test results. Of the 25 records that were reviewed, there were 9 (36%) service members with positive results, and they were found to have lower vitamin D levels (Median = 20.80 ng/ml, Interquartile range = 10.15) than those with negative test results (Median = 30.35 ng/ml, Interquartile range = 17.05), Mann-Whitney U = 41, p = .039. Only 1 of the 9 with positive test results had a normal serum 25 OH vitamin D3 level (30 ng/ml or greater) compared with 9 of the 16 with negative test results. Optimal vitamin D stores may play a significant role in reducing the risk of developing acute mononucleosis but larger, prospective studies will be needed to verify these findings.&lt;/p></description></item><item><title>Inflammation, infection, active vitamin D, and Olmesartan</title><link>/posts/inflammation-infection-active-vitamin-d-and-olmesartan.html</link><pubDate>Fri, 26 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/inflammation-infection-active-vitamin-d-and-olmesartan.html</guid><description>&lt;p>Author asked that their paper be removed from VitaminDWiki&lt;/p>
&lt;!-- ~tc~
__Inflammation and vitamin D: the infection connection__
Inflammation Research, October 2014, Volume 63, Issue 10, pp 803-819,
Meg Mangin info@chronicillnessrecovery.org, Rebecca Sinha, Kelly Fincher
Chronic Illness Recovery, Fort Worth, Texas, USA

__Figure 1 Metabolism__
{img fileId=2700}

__Figure 2__
{img attId="4410" width ="400"}

__Figure 3 Hypothesis __
{img attId="4411"}
__~~#00F: {ATTACH(inline="1" id="4409" icon="1")}Download the PDF from VitaminDWiki.{ATTACH}~~__

Introduction
Inflammation is believed to be a contributing factor to many chronic diseases. The influence of vitamin D deficiency on inflammation is being explored but studies have not demonstrated a causative effect.
Methods
Low serum 25(OH)D is also found in healthy persons exposed to adequate sunlight. Despite increased vitamin D supplementation inflammatory diseases are increasing. The current method of determining vitamin D status may be at fault. The level of 25(OH)D does not always reflect the level of 1,25(OH)2D. Assessment of both metabolites often reveals elevated 1,25(OH)2D, indicating abnormal vitamin D endocrine function.
Findings
This article reviews vitamin D's influence on the immune system, examines the myths regarding vitamin D photosynthesis, discusses ways to accurately assess vitamin D status, describes the risks of supplementation, explains the effect of persistent infection on vitamin D metabolism and presents a novel immunotherapy which provides evidence of an infection connection to inflammation.
Conclusion
Some authorities now believe that low 25(OH)D is a consequence of chronic inflammation rather than the cause. Research points to a bacterial etiology pathogenesis for an inflammatory disease process which results in high 1,25(OH)2D and low 25(OH)D. Immunotherapy, directed at eradicating persistent intracellular pathogens, corrects dysregulated vitamin D metabolism and resolves inflammatory symptoms.
{maketoc}
!!!!Introduction
Inflammation is involved in many chronic diseases and concern has been raised about the influence of vitamin D deficiency on inflammatory processes. When studies found an association between inflammatory diseases and low serum 25-hydroxyvitamin D (25(OH)D), further research found evidence of low vitamin D in a large segment of the general population. This led some authorities to declare a world-wide epidemic of vitamin D deficiency and to recommend vitamin D supplementation. Experts are debating the definition of vitamin D deficiency and the appropriate vitamin D doses, while further research is being done to determine if vitamin D supplementation has the intended effect.
According to some current definitions of vitamin D deficiency, even healthy persons, exposed to adequate sunlight, are unable to acquire enough vitamin D without supplementation. Often reiterated causes of vitamin D deficiency can be disputed in the light of more current research. In the absence of definitive studies, authorities are questioning the wisdom of supplementing the general population with vitamin D. The definition of Vitamin D deficiency needs re-evaluation in view of the fact that low 25(OH)D is found in both healthy and sick individuals. Concerns about vitamin D deficiency merit a closer look at the current method of determining vitamin D status because the level of 25(OH)D does not always reflect the level of 1,25-dihydroxyvitamin-D (1,25(OH)2D). Analysis of this active metabolite may reveal elevated 1,25(OH)2D) in the presence of low 25(OH)D and lead to a diagnosis of abnormal vitamin D endocrine system function.
An infectious pathogenesis posits that intracellular bacteria disrupt the vitamin D regulated immune system, resulting in persistent infection and chronic inflammation.
In the clinical setting, a novel immunotherapy is demonstrating the ability to resolve vitamin D metabolism dysfunction, restore immune function, and thus, eliminate infection and reduce inflammation. This review ponders the question, ‘‘Is low 25(OH)D a cause of, or a consequence of inflammation?” The answer is found in the evidence that adds persistent intracellular infection to the equation.
!!!!Vitamin D metabolism
The sequential metabolic processes that convert biologically inactive, parental vitamin D into active metabolites begin when vitamin D3 is photosynthesized in the skin or when vitamin D2 or D3 is ingested. Vitamin D is transported to the liver where it is hydroxylated by an enzyme (CYP2R1, also known as cytochrome P450 2R1) to produce 25(OH)D [1]. 25(OH)D is then transported to the kidneys where it is hydroxylated by another enzyme (CYP27B1, formerly 1a-hydroxylase) to produce 1,25(OH)2D. 1,25(OH)2D (also known as calcitriol), the active metabolite, is the most potent steroid hormone in the human body [2]. Feedback mechanisms regulate production of 1,25(OH)2D in the kidneys via serum levels of parathyroid hormone (PTH), fibroblast-like growth factor- 23 (FGF23) calcium, and phosphate [3]. 1,25(OH)2D is also produced in many other tissues (e.g., skin, macrophages, colon, pancreas, blood vessels, etc.) by enzymatic actions [4]. The vitamin D binding protein (VDBP) transports 1,25(OH)2D to the vitamin D receptor (VDR) in the cell nucleus [5]. The VDR is a member of the nuclear receptor family of ligand-regulated transcription factors. 1,25(OH)2D binds to the VDR and mediates the transcription of DNA, triggered by signaling proteins, like nuclear factor kappa-B (NFk-B) [6] (Fig. 1).
The influence of 1,25(OH)2D on the immune system is one of its most important roles. 1,25(OH)2D regulates the immune system via the VDR which is present in most immune cell types, particularly in antigen-presenting cells (APCs) such as monocytes, macrophages and dendritic cells [7]. 1,25(OH)2D activates the VDR to express antimicrobial peptides (AMPs) such as cathelicidin and beta defensins which attack pathogens [8, 9]. In general, the innate immune system is enhanced and the adaptive immune system is inhibited by 1,25(OH)2D [10, 11]. Thus, an effective immune response is heavily dependent on the vitamin D endocrine system which performs a balancing act of inflammation versus anti-inflammation.
!!!!Vitamin D deficiency
Concerns about vitamin D deficiency arose when studies showed patients with autoimmune diseases have lower levels of serum 25(OH)D and study subjects given vitamin D had lower rates of autoimmune diseases and fewer markers of inflammation [12, 13]. However, authorities have not agreed on the significance of low 25(OH)D and without a consistent normal range for serum 25(OH)D, the definitions of vitamin D insufficiency and deficiency from the Vitamin D Council, the Endocrine Society and the Institute of Medicine vary significantly.
__The Vitamin D Council definition [14]:__
Deficient: 0-40 ng/ml
Sufficient: 40-80 ng/ml
High normal: 80-100 ng/ml
__The Endocrine Society definition [15]:__
Deficiency &lt; 20 ng/ml
Insufficiency = 20-29 ng/ml
__The Institute of Medicine definition [16]:__
Risk/deficiency &lt;12 ng/ml
Risk/insufficiency = 12-20 ng/ml
Sufficient = 20 ng/ml
In 2006, the Merck Manual listed 25-40 ng/ml as the normal 25(OH)D range [17]. Recently, this range has skyrocketed to 30-74 ng/ml [18]. Quest Diagnostics now lists the upper limit of normal 25(OH)D as 100 ng/ml [19]. Laboratory reference ranges for serum 25(OH)D levels have long been based upon average values from populations of healthy individuals but many people are now supplementing with vitamin D. In the US, the leading authority regarding medical research is the prestigious Institute of Medicine (IOM). The 2010 IOM report on vitamin D emphasized that the current measurements, or cut-off points, of sufficiency and deficiency of 25(OH) D in use by laboratories have not been set using rigorous scientific studies. It suggests that since no central authority has determined which cut-off points to use, reports of deficiency and lab ranges may be skewed and numbers overestimated [16]. Therefore, it would be prudent to use the IOM vitamin D deficiency guideline in the clinical setting, for clinical studies and when evaluating research results.
!!!!Purported reasons for vitamin D deficiency
Is low 25(OH)D among the general population an accurate assessment of vitamin D deficiency? Many reasons are cited for the current ‘epidemic’ of vitamin D ‘deficiency’ but closer examination reveals these beliefs are based on outdated or limited studies and can be challenged with more recent research.
Melanin pigmentation is only one factor that determines the amount of vitamin D3 which is photosynthesized [20, 21]. Bogh et al. [22] measured the baseline serum 25(OH)D and total cholesterol levels of 182 fair-skinned and dark-skinned subjects; and studied the effect of UV radiation on their serum 25(OH)D levels. They found the amount of serum 25(OH)D produced was determined by the amount of cholesterol in the skin, not on skin pigmentation. Matsuoka et al. [23] investigated the effect of racial pigmentation on vitamin D3 formation, simulating the process with a fixed dose of UVB radiation and concluded that while racial pigmentation has a photoprotective effect, it does not prevent the generation of normal levels of active vitamin D metabolites. Persons with dark skin also compensate for low 25(OH)D by rapidly converting it to the active 1,25(OH)2D metabolite, thus allowing them to maintain adequate vitamin D status [24]. Skin pigmentation does not appear to negatively affect vitamin D status [25].
Clothing is a barrier to vitamin D photosynthesis but this is an issue only for people who cover themselves from head to toe [26]. It takes relatively little sunlight exposure to acquire adequate stores of vitamin D and few people wear enough clothes to prevent that from happening. Ten to 15 min of sunlight or daylight exposure to a small area of skin (e.g., the forearm or face, etc.) twice a week, without sunscreen, supplies all the vitamin D necessary for health [27]. The belief that sunscreen lotion blocks vitamin D production is based on a 1987 study done by Matsuoka et al. [28] that was funded by the ultraviolet foundation, which is supported by the tanning bed industry. Contradictory information was provided by Diehl and Chiu [29] which concluded that although sunscreens are effective, many may not actually be blocking UV-B because they are improperly or inadequately applied [30]. Thus, sunscreen use may not actually diminish vitamin D synthesis in real world use. However, prolonged unprotected sun exposure should be avoided to reduce the risk of developing skin cancer.
Although pollution can block some ultraviolet radiation, even in urban areas of high pollution 50 % of UV rays reach the ground [31]. A significant amount of UV radiation exposure can be obtained in dense metropolitan areas; tall buildings provide shade but shade gives up to 50 % of UV rays. Indoor workers receive 10-20 % of outdoor workers’ yearly UV exposure [31]; and for many, this may be adequate, especially if sunlight exposure is higher when they are not working. UV radiation is reflected or scattered to varying extents by different surfaces. The scattering and absorption of light by clouds may not significantly reduce natural light exposure because over 90 % of UV rays may penetrate clouds [31]. Environmental factors are rarely an impediment to photosynthesis of adequate vitamin D.
As the skin ages, there is a decline in the cutaneous levels of 7-dehydrocholesterol, resulting in a marked reduction of the skin’s capacity to produce vitamin D3 [32].
However, despite the up to fourfold reduction in vitamin D3 production in a 70-year-old compared to a 20-year-old, the skin has such a high capacity to make vitamin D3 that elders exposed to sunlight will produce an adequate amount of vitamin D3 to satisfy their vitamin D requirement [33, 34].
A 1988 study by Webb et al. [35] is often cited to support the conviction that latitude dramatically influences the amount of solar radiation available to synthesize vitamin D3. However, other researchers who conducted more recent studies refute this hypothesis. Kimlin et al. [36] report, ‘‘It may no longer be correct to assume that vitamin D levels in populations follow latitude gradients’’. And Lubin [37] states, ‘‘Geophysical surveys have shown that UV-B penetration over 24 h, during the summer months at Canadian north latitudes when there are many hours of sunlight, equals or exceeds UV-B penetration at the equator.’’ Ross et al. [16] report that ample opportunities exist to form vitamin D (and store it in the liver and fat for later use) from exposure to sunlight during the spring, summer, and fall months even in the far north latitudes.
Acceptance of these vitamin D myths regarding photosynthesis prevents consideration of the alternate hypothesis—low serum 25(OH)D, despite adequate photosynthesis of vitamin D3, is a result of an inflammatory process.
!!!!Low vitamin D is found in healthy subjects
Many studies of healthy subjects have found levels of 25(OH)D that, by some vitamin D definitions, are declared deficient (hypovitaminosis-D) [38, 39]. Vitamin D levels that are considered deficient have even been found in persons who are exposed to abundant sunlight [40]. Binkley et al. [41] showed a mean 25(OH)D level of 31.6 ng/ml among healthy young adult Hawaiian surfers. It is clear that low levels of 25(OH)D are found in both healthy persons and those with autoimmune or chronic inflammatory diseases. Opposing reasoning can be used to explain this contradiction. One explanation reasons that healthy persons with low 25(OH)D will become sick and sick people will develop lower 25(OH)D levels (Fig. 2); however, studies do not support this hypothesis. The correct explanation may be that, in the absence of disease, low 25(OH)D is normal.
!!!!Low vitamin D in the presence of diseases
Since low 25(OH)D is found in both healthy persons and those with autoimmune or chronic inflammatory diseases, assessing vitamin D status with the measurement of an additional clinical marker may be helpful. It is asserted that D status with measurement of 1,25(OH)2D may be helpful low levels of 25(OH)D accurately reflect vitamin D status; however, measurement of 1,25(OH)2D often demonstrates a positive correlation of elevated 1,25(OH)2D to inflammatory diseases (Fig. 2). This is illustrated by Blaney et al.

Fig. 2 Interpretation of vitamin D deficiency via calcitriol measurement. Since low 25(OH)D is found in both healthy persons and those with autoimmune or chronic inflammatory diseases, assessing vitamin D status with measurement of 1,25(OH)2D may be helpful

in a study of 100 patients with autoimmune and chronic disease which found that 85 % of subjects had levels of 1,25(OH)2D higher than 46.2 pg/ml without hypercalcemia. Although this serum level may be considered normal by some, lab ranges for 1,25(OH)2D may have been skewed high by the presence of patients with unrecognized persistent intracellular infection and thus, dysregulated vitamin D metabolism. The Danish 1,25(OH)2D population data (from a large and reliable study) found the mean value for 1,25(OH)2D in a normal population was 29 pg/ml with a standard deviation of 9.5
. More frequent measurement of both D-metabolites in the clinical and research settings, may shed light on the true meaning of low 25(OH)D.
Rickets is often cited as proof of the need for vitamin D supplementation. However, a review of the metabolic processes involved provides some prospective. Adequate vitamin D is essential to prevent rickets, but adequate calcium is equally important; if either calcium or vitamin D is deficient, bone health suffers. Hypophosphatemia is the common denominator of all rickets; low calcium intake leads to hyperparathyroidism, which leads to high phosphorus excretion and, thus, phosphorus deficiency [44]. Rickets is rare in the developed world; however, children in developing countries, who usually photosynthesize enough vitamin D from sunlight, develop rickets if poverty prevents them from eating enough calcium-rich food [45, 46]. Studies have found that rickets occurs in sunny countries due to poor calcium intake and is cured with increased calcium ingestion [47, 48].
Osteoporosis is another disease which is closely linked with vitamin D. Adequate vitamin D is an important factor in maintaining bone health to avoid osteoporosis but a study by Reid et al. [49] published in The Lancet found little evidence supporting the use of vitamin D supplements by seniors hoping to improve bone density and ward off potential fractures. 1,25(OH)2D maintains calcium homeostasis between blood, cells and bones by stimulating calcium absorption from the intestines, reabsorption in the kidneys, and resorption in bones [50]. 1,25(OH)2D up- regulates the VDR in the small intestine, which then transcribes genes that shuttle calcium and phosphorus through the intestinal epithelium. However, mucosal response and calcium/phosphorus absorption are dependent on a competent VDR and elevated 1,25(OH)2D reduces VDR competence [51]. Thus, calcium and phosphorus absorption may be inhibited if VDR function is impaired by elevated 1,25(OH)2D. This is illustrated by Abreu et al. [52] in a study of Crohn’s patients with elevated 1,25(OH)2D and low bone mineral density which concluded that treatment of the underlying inflammation would improve metabolic bone disease. In fact, there is ample evidence that elevated 1,25(OH)2D leads to bone loss. Brot et al. [53] found that elevated levels of 1,25(OH)2D were strongly associated with decreased bone mineral density and content, and increased bone turnover. When levels are above 42 pg/ml 1,25(OH)2D stimulates bone osteoclasts. This leads to osteoporosis, dental fractures and calcium deposition into the soft tissues [54]. Vanderschueren et al. [55] found that a combination of high 1,25(OH)2D and low 25(OH)D is associated with the poorest bone health.
!!!!Vitamin D supplementation
It is reasoned that if low 25(OH)D indicates a current or potential disease state, then increasing 25(OH)D by supplementing with vitamin D should provide some symptom relief and/or protection. So far, there is scant evidence for this hypothesis [56, 57]. According to Ross et al. [16] in the 2010 IOM report, ‘‘Outcomes related to autoimmune disorders, cancer, cardiovascular disease and hypertension, diabetes and metabolic syndrome, falls and physical performance, immune functioning, infections, neuropsychological functioning, and preeclampsia could not be linked reliably with calcium or vitamin D intake and were often conflicting.’’ Despite the recent increase in vitamin D supplementation, chronic diseases have increased and are expected to continue increasing [58, 59].
Consequently, more vitamin D experts are beginning to reconsider vitamin D supplementation among the general population [60]. Recommending higher vitamin D intake to large populations carries the potential risk of overdosing certain individuals [61]. It is difficult to ingest too much vitamin D from food, and natural mechanisms regulate the amount of vitamin D3 photosynthesized from sunlight [62].
However, elevated 25(OH)D and hypervitaminosis-D can occur due to vitamin D supplementation [63]. A study by Noordam et al. [65] cast doubt on the causal nature of previously reported associations between low levels of vitamin D and age-related diseases and mortality. A comprehensive review by Autier et al. [65] concluded that low concentrations of 25(OH)D are most likely an effect of health disorders and not a cause of illness. Commenting on the findings in a press statement, Autier et al. [64] advised against vitamin D supplementation and explained the observed discrepancy between observational and randomized trials:
Decreases in vitamin D levels are a marker of deteriorating health. Ageing and inflammatory processes involved in disease occurrence and clinical course reduce vitamin D concentrations, which would explain why vitamin D deficiency is reported in a wide range of disorders. We postulate that inflammation is the common factor between most nonskeletal health disorders and low 25(OH)D concentrations. Inflammatory processes involved in disease occurrence and clinical course would reduce 25(OH)D, which would explain why low vitamin D status is reported in a wide range of disorders. However, increases in 25(OH)D have no effect on inflammatory processes or on disorders at the origin of these processes.
A 2014 meta-analysis by Bolland et al. [66] on the effects of vitamin D supplementation on skeletal, vascular, or cancer outcomes concludes that vitamin D supplementation with or without calcium does not reduce skeletal or non-skeletal outcomes in unselected community-dwelling individuals by more than 15 %. The authors further state that future trials with similar designs are unlikely to alter these conclusions. Because of emerging concerns about elevated 25(OH)D, the IOM has shifted the paradigm from thinking about ‘more is better’ to a more risk-averse approach [67]. It has also challenged the notion that harm should be viewed in terms of vitamin D toxicity such as hypercalcemia, hypercalciuria, or metastatic calcification and has advanced the concept of ‘harm’ in terms of chronic disease outcomes and mortality [16]. Because adverse effects of vitamin D supplementation may take decades to be realized, clinicians (mindful of the medical ethics precept ‘‘First, do no harm’’) should err on the side of caution; follow the IOM guideline and wait for the results of longterm vitamin D studies.
!!!!Bacterial pathogenesis of low vitamin D hypothesis
If evidence indicates that most people get adequate vitamin D from sunlight exposure but healthy persons are found to be ‘deficient’ by recent standards, what is the explanation for this phenomenon? Vitamin D proponents use a disease deficiency model to explain low levels of 25(OH)D. Their hypothesis states low 25(OH)D causes chronic diseases; however, a pathogenesis has not been elucidated [68]. Low serum 25(OH)D in the presence of disease can also be explained with a dysregulated vitamin D metabolism model [69]. This hypothesis proposes that low vitamin D is the consequence of a chronic inflammatory process caused by persistent infection. The bacterial pathogenesis theorizes that intracellular (cell wall deficient) bacteria invade nucleated cells, use strategies to avoid destruction and cause abnormal vitamin D endocrine function, resulting in low vitamin D. Excess 1,25(OH)2D is produced in an effort to up-regulate the VDR to transcribe AMPs; and 25(OH)D is rapidly metabolized in the process, resulting in a low serum level. The resulting elevated 1,25(OH)2D causes chronic, systemic inflammation and its accompanying symptoms (Fig. 3).
The existence of bacteria which are capable of invading human cells has been known for over a century and are described by many authors [70, 71]. The lack of a cell wall enables them to enter human cells and proliferate because they fail to elicit an appropriate response when the immune system is compromised. In particular, they enter the macrophages—the very immune cells deployed to kill invading pathogens. The inability of most research labs to culture cell wall deficient (CWD) bacteria has been an obstacle to their acceptance, and reliance on Koch’s postulates has made it difficult to correlate CWD bacteria to specific diseases [72]. But some researchers believe Koch’s postulates may have to be redefined in terms of molecular data when dormant and non-culturable bacteria are implicated as causative agents of mysterious diseases [73]. OConnor et al. [74] (in their article entitled Emerging Infectious Determinants of Chronic Diseases) report, ‘‘microbes can now be irrefutably linked to pathology without meeting Koch’s postulates” and “...powerful tools of molecular biology have exposed new causal links by detecting diffi- cult-to-culture and novel agents in chronic illness settings.’’ Domingue [75] commented, ‘‘This might translate into an etiology for chronic inflammatory diseases, when the stressed bacteria increase in numbers and overwhelm the normal biological functions of the host.’’ Nunez [76] was quoted in the University of Michigan Health System newsletter, ‘‘In our study, the presence of bacterial microbes inside the cell is what triggers the immune response.’’ Rolhion and Darfeuille-Michaud [77] observed that the presence of pathogenic invasive bacteria could be the link between an innate immune response to invasive bacteria and the development of inflammation. A number of studies suggest disease associations with CWD bacteria [78-83]. Verway et al. [79] report ‘‘.data suggest that at least a subset of the genetic predisposition to Crohn’s disease results from defects in the detection and/or processing of intracellular pathogens by the innate immune system.’’ O’Connor et al. [74] state, ‘‘The epidemiologic, clinical, and pathologic features of many chronic inflammatory diseases are consistent with a microbial cause. Infectious agents likely determine more cancers, immune-mediated syndromes, neurodevelopmental disorders, and other chronic conditions than currently appreciated.”
CWD bacteria are considered communicable but not contagious; protective immunity depends on an effective cell-mediated immune response [80]. It is now well appreciated that pathologic processes caused by infectious agents may only emerge clinically after an incubation of decades [81]. Among the speculated causes of the increase in chronic infections are overuse of beta-lactam antibiotics [82, 83] and immunosuppression via excess 25(OH)D production [84] or immunosuppressive medications [85]. Many microbiologists now believe at least some, if not all, of the inflammation which drives the chronic disease process is caused by the presence of these stealthy intracellular pathogens [86]. A considerable body of experimental and clinical evidence supports the concept that difficult-to- culture and dormant bacteria are involved in latency of infection and that these persistent bacteria may be pathogenic [73, 87, 88]. McDougal [89] states, ‘‘Evidence now confirms that non-communicable chronic diseases can stem from infectious agents.’’
!!!!Effects of intracellular pathogens on the immune system
Pathogens gain many advantages by parasitizing immune cells and altering nuclear receptor activity. Tissue invasion provides a privileged niche with access to host protein and iron, sequestration from immune response, and a means for persistence [90]. In the arms race of host-microbe coevolution, successful microbial pathogens have evolved innovative strategies to evade host immune responses. For example, ‘crosstalk manipulation’ undermines host defenses and contributes to microbial adaptive fitness [91, 92]. Pathogenic microbes also induce stress responses which protect the cell from lethal factors, express proteases that degrade AMPs, use biofilms as a shield and modulate host cell motility to facilitate establishment of an infection [93, 94]. Genetic foreign and host protein interactions alter gene transcription and translation mechanisms, and many species survive by horizontal gene transfer [95, 96].
It is theorized that bacteria have developed some of these strategies in order to invade host cells and remain undetected within cellular cytoplasm. Many bacterial pathogens form antibiotic-tolerant persister cells which can replicate within macrophages. In this form they can cause subclinical infection and have been associated with chronic diseases [95, 97, 98]. Intracellular bacteria can modulate cytokine production [99]; and in monocytes and macrophages, cytokine activation markedly inhibits 1,25(OH)2D/ VDR gene transcription [100].
Macrophage microbicidal mechanisms are responsible for the control and elimination of pathogens. 1,25(OH)2D production and action in macrophages activates toll-like receptors to increase expression of the AMP cathelicidin which kills infectious invaders [101, 102]. When the immune system is fighting a persistent microbe, inflammatory molecules are continuously released in an effort to kill the pathogen [103]. Immune defenses stimulate Th17 cells and contribute to the development of chronic inflammatory conditions [104,	105]. An ineffective immunological response causes low-grade inflammation and hagocyte-inflicted tissue damage plays an important role in many chronic diseases [106]; autoimmune patients acquire a distinct pathogenic microbiota and multi-morbidity often results [107, 108]. Therefore, it is reasonable to infer that bacteria have evolved strategies which allow them to persist within host cells. The exact mechanisms are unknown and warrant further study.
!!!!The compromised immune system, infection and vitamin D
In an essay on the renin-angiotensin system (RAS) and immune response, Smith [109] postulated that unresolved cellular stress may be caused by infectious agents to avoid adaptive immune responses. The host immune response has developed many mechanisms to neutralize and remove pathogenic bacteria. In turn, pathogenic bacteria have developed mechanisms to alter and evade the host immune response [110, 111]. Regulation of the VDR is a common mechanism used in the host defense against pathogens but certain microbes have been shown to slow innate immune defenses by down-regulating the VDR:
*Mycobacterium tuberculosis down-regulates VDR activity [112].
*Mycobacterium leprae inhibits VDR activity through down-regulation of CYP27B1 in monocytes [113].
*Aspergillus fumigatus secretes a toxin capable of down-regulating the VDR in macrophages [114].
*Epstein-Barr virus lowers VDR activity [115].
*HIV completely shuts down VDR activity [116].
*In VDR knockout mice, a circumstance that closely mimics extreme VDR dysregulation, 1,25(OH)2D levels increase by a factor of ten [117].
Studies also point to immune system depression and elevated 1,25(OH)2D in chronic diseases [118]:
*Sarcoidosis patients are deficient in cathelicidin despite healthy vitamin D3 levels [119].
*1,25(OH)2D is high (>60 pg/ml) in 42 % of Crohn’s patients and the source of the active vitamin D may be the inflamed intestine [52].
*1,25(OH)2D is elevated in the synovial fluid of patients with RA (rheumatoid arthritis) [120].
*Crohn’s disease decreases expression of cathelicidin [121].
High levels of 1,25(OH)2D may result when down- regulation of the VDR by bacterial ligands prevents the receptor from expressing enzymes necessary to keep 1,25(OH)2D in a normal range [42]. Elevated 1,25(OH)2D further reduces VDR competence, suppresses macrophage function, and blocks the nuclear factor kappa-B pathway; thus inhibiting immune system function [116, 122, 123]. Reducing the ability of the VDR to express elements of innate immune function allows intracellular bacteria to persist in the cytoplasm of nucleated cells and may account for the increased susceptibility to non-bacterial co-infections that are commonly found in patients with chronic illnesses [124, 125]. Theoretically, immune system suppression allows parasitic microbes to persist and proliferate in host phagocytes, successfully compete for nutritional resources, and displace commensal organisms from their niche [126]. Elevated 1,25(OH)2D appears to be evidence of a disabled immune system’s attempt to activate the VDR to combat infection.
!!!!Autoimmune disease
Numerous examples can be found in which pathogens express antigens that cross-react with host antigens or induce local inflammatory responses that can lead to autoimmune responses through a very complex set of circumstances [127]. The prevailing theory regarding the etiology of autoimmune disease states that an overactive immune system produces auto-antibodies against self, but infection as an environmental factor in autoimmunity has long been recognized. An alternate hypothesis posits a bacterial etiology in which a persistent intracellular infection causes a cytokine release that induces signals to T cells and B cells, and the antibodies they produce (to the intracellular invader) include some that attack human proteins, as well as target the pathogens [128, 129]. Christen et al. [130] explored this hypothesis, ‘‘In theory, a structural similarity or identity between the host and an invading pathogen might cause the immune system of the host to react not only to the pathogen but also to self-components.’’ Infections can act as environmental triggers inducing or promoting autoimmune disease in genetically predisposed individuals [131]; researchers have shown how antinuclear antibodies (ANA) are created in response to infectious agents [132, 133].
Vitamin D appears to have a positive effect on autoimmune disease due to immune system suppression [122, 134, 135] and immune suppression is considered therapeutically beneficial for autoimmune diseases [136, 137]. However, vitamin D proponents have failed to recognize that positive effects are due to the immunosuppressive effect of elevated 25(OH)D or to understand that immunosuppression is contraindicated because of the probable presence of intracellular infection. When the immune system is suppressed clinical disease markers and symptoms are reduced but immunosuppression does not address an underlying cause of persistent bacteria, thus relapse is common [138]. Verway et al. [79] wonder, ‘‘Is a specific pathogen responsible for disease or rather is a dysregulated immune response generated against a complex microbial population? Why would immune-suppressive drugs be efficacious if the primary defect is an immune deficiency?” Much of current research focuses on finding drugs to suppress inflammation but, according to Collins [139], 95 % of these studies have failed It seems clear a better direction is needed. Immunotherapy which restores VDR competence corrects dysregulated vitamin D metabolism and eliminates intracellular bacteria could be the answer (as discussed in the section titled Restoring VDR Competence).
!!!!Dysregulated vitamin D metabolism
In a healthy individual, the complex interplay between innate and adaptive immunity cooperates to mount an appropriate response to infection through regulation of the vitamin D endocrine system [140]. The immune system detects and responds to the presence of intracellular bacteria by producing more 1,25(OH)2D to activate the VDR and express the crucial endogenous AMPs which enable the innate immune system to target intracellular pathogens [141]. Renal production of 1,25(OH)2D is tightly selfregulated, with the end product down-regulating its own further production. In contrast, extra-renal tissues (e.g., uterine decidua and placenta, colon, breast, prostate, spleen, bone, keratinocytes, melanoma and synovial cells, pulmonary monocytes and macrophages, etc.) which produce 1,25(OH)2D are regulated by cytokines (e.g., interferon-gamma), lipopolysaccharide, nitric oxide and intracellular VDBP, which activate the enzyme CYP27B1 to stimulate conversion of 25(OH)D to 1,25(OH)2D [142]. This extra-renal production of 1,25(OH)2D in tissues infected with intracellular bacteria can result in an excess in production of 1,25(OH)2D which may contribute to depletion and low levels of 25(OH)D [143] (Fig. 4).
Because extra-renal production of 1,25(OH)2D is primarily dependent on the availability of 25(OH)D [144], supplementation with vitamin D to increase 25(OH)D may promote the production of 1,25(OH)2D in non-renal tissues that are sites of intracellular infection and result in hypervitaminosis-D

{img attId="4412"}
Fig. 4 Proposed hypothesis for excess 1,25(OH)2D production in bacterially-stimulated extrarenal tissues. Extra-renal tissues, which produce 1,25(OH)2D, are regulated by cytokines, lipopolysaccharide, nitric oxide and intracellular VDBP, which activate the enzyme CYP27B1 to stimulate conversion of 25(OH)D to 1,25(OH)2D, resulting in low 25(OH)D

{img attId="4413"}
Fig. 5 Proposed hypothesis for dysregulated vitamin D metabolism caused by intracellular pathogens. Theoretically, when nucleated cells are parasitized by intracellular bacteria, extra-renal production of 1,25(OH)2D increases, the kidneys lose control of 1,25(OH)2D production, and pro-hormone 25(OH)D decreases due to rapid conversion to 1,25(OH)2D

Sunlight appears to play a part in this process and many patients with autoimmune disease report sun sensitivity. The skin (dermal fibroblasts and keratinocytes possess VDR) has the capacity to synthesize 1,25(OH)2D, and represents an important target tissue for 1,25(OH)2D [145]. If keratinocytes in the skin are infected, natural regulation of photosynthesis may be thwarted and solar energy may overstimulate cellular activity, resulting in an increase in cutaneous production of vitamin D3, 25(OH)D and 1,25(OH)2D following sun exposure.
We hypothesize that when nucleated cells are parasitized by intracellular bacteria, extra-renal production of 1,25(OH)2D increases, the kidneys lose control of 1,25(OH)2D production, and pro-hormone 25(OH)D decreases due to rapid conversion to 1,25(OH)2D. 
The following mechanisms are thought to be responsible (Fig. 5):
*Inflammatory cytokines activate CYP27B1, an enzyme that causes more 25(OH)D to be converted to 1,25(OH)2D [146].
*The microbial-repressed VDR cannot transcribe CYP24A1 (formerly 24-hydroxylase), an enzyme that breaks down excess 1,25(OH)2D [147].
*Excess 1,25(OH)2D binds the PXR (pregnane X receptor), to inhibit conversion of vitamin D3 to 25(OH)D so 25(OH)D is down-regulated [148].
*1,25(OH)2D inhibits the hepatic synthesis of 25(OH)D [149].
Thus, low 25(OH)D may be a consequence of the inflammatory process. More studies are concluding that suboptimal circulating levels of vitamin D appear to be caused by the disease process. Waldronn et al. [150] found serum 25(OH)D was decreased following an acute inflammatory insult (i.e., orthopedic surgery) and concluded that hypovitaminosis-D may be the consequence rather than cause of chronic inflammatory diseases. Ferder et al. [151] state, there may be a relationship between inflammatory processes induced by chronic overstimulation of the renin angiotensin system (RAS) and the worldwide vitamin D deficiency. In fact, the pandemic of vitamin D deficiency could be the other face of increased RAS activity, which could potentially cause a lower activity or lower levels of Vitamin D.’’
!!!!Diagnosis of dysregulated vitamin D metabolism
Assessing dysregulated vitamin D metabolism has the potential to guide clinical practice [152, 153]. Vitamin D status is currently determined by measuring the level of serum 25(OH)D which, presumably, reflects the serum levels of other vitamin D metabolites (e.g., vitamin D3, vitamin D2 and 1,25(OH)2D, etc.). This measurement may not, however, provide enough information to assess vitamin D endocrine function. The clinical utility of measuring 1,25(OH)D is not fully understood, but it is clear that associations are being made between this active metabolite of vitamin D and disease states [154]. 1,25(OH)2D is not being used as a measure associated with vitamin D nutritional status or as an intermediate marker related to health outcomes, or even routinely assessed in vitamin D research. In the context of solving the puzzle of low 25(OH)D, the reasons cited for this lapse fail to consider the possibility of abnormal levels in the presence of chronic inflammation:
*1,25(OH)2D has a short half-life (hours) and fluctuates rapidly.
+However, a high result may be discovered even at trough level.
*1,25(OH)2D levels are regulated by PTH, calcium, phosphate.
+This is not true if extra-renal production is prevalent [143].
*1,25(OH)2D does not decrease until 25(OH)D is very low.
+A low 25(OH)D may be a sign that 1,25(OH)2D is abnormally high [55].
*1,25(OH)2D is only over-produced in hypercalcemic disease states such as sarcoidosis.
+Studies show this is not true [42].
*1,25(OH)2D may be elevated as a result of up- regulation of the CYP27B1 enzyme.
+This begs the question, Why is this enzyme elevated [146]?
Measuring both 25(OH)D and 1,25(OH)2D (and PTH, calcium, phosphate when indicated) as clinical markers in
Table 1 D-metabolites tests
Serum 25(OH)D [157]
CPT code: 82306 [157]
Lowest mortality reported at 20 ng/ml [158] Immunosuppression reported when higher than 30 ng/ml [122] Serum 1,25(OH)2D [157]
CPT code: 82652 [157]
ICD-9 code:
275.40 Disorder of calcium metabolism, unspecified [157] Maximum normal = 45 pg/ml [17]
chronic disease is more likely to provide a true picture of vitamin D status, than measuring 25(OH)D alone [155, 156] (Table 1). Measuring 1,25(OH)2D should be considered in patients with low 25(OH)D, abnormal laboratory results (especially inflammatory markers), a diagnosis of autoimmune disease or other chronic inflammatory illness, or signs of chronic systemic inflammation. For example, elevated 1,25(OH)2D may serve as a marker of Crohn’s disease [52]. The 1,25(OH)2D test is a delicate assay which is only done in specialized laboratories. False low results have been observed due to apparent sample mishandling; freezing for transport is advised to prevent sample degradation due to agitation. A high result is always accurate.
!!!!Restoration of VDR competence
The ability to mount an appropriate immune system response to intracellular infection is highly dependent on a competent VDR [159]. When it appears that 1,25(OH)2D is unable to up-regulate the VDR due to microbial activity, VDR competence may be restored with another VDR ligand which acts as an agonist; an agonist increases the signal transduction activity of a cell when bound to a receptor on that cell. Over 3000 synthetic VDR ligands have been identified, but most of these 1,25(OH)2D analogues have no clinical use because of their undue disruption to calcium regulation [160]. A number of nonvitamin D VDR ligands have also been identified: curcu- min, omega-6 fatty acids (e.g., arachidonic acid, linoleic acid), and lithocolic acid (LCA) but are not being used for this purpose [161, 162].
Angiotensin receptor blockers (ARBs) have been shown, via in silico molecular modeling, to modulate VDR activation [163]. The most promising ARB, __olmesartan__ medoxomil (brand name Benicar®) was estimated to have a Ki value in the low nanomolar range, similar to the Ki values of the natural VDR ligands [163].

{img attId="4414"}
Fig. 6 Proposed hypothesis for restoring renal control of 1,25(OH)2D with __olmesartan__. __olmesartan__ is believed to decrease elevated 1,25(OH)2D by several mechanisms

__Olmesartan__ has been noted to cause a significant reduction in elevated 1,25(OH)2D within weeks of initiation, which provides
further evidence of its ability to up-regulate the VDR [164]. __olmesartan__ is believed to decrease elevated 1,25(OH)2D by several VDR-mediated effects (Fig. 6). The up-regulated VDR:
*transcribes CYP24A1 and CYP3A4 (enzymes which reduce 1,25(OH)2D production) [147].
*represses CYP27B1 (the enzyme that hydroxylates 25(OH)D to 1,25(OH)2D) so less 1,25(OH)2D is produced [146].
Consequently, renal control of 1,25(OH)2D production is restored and extra-renal production of 1,25(OH)2D is reduced. A decrease in elevated 1,25(OH)2D means less systemic inflammation, as these studies of __olmesartan__ indicate:
*Improvement of glycemic control and insulin resistance was only observed in the __olmesartan__ group and these effects of __olmesartan__ might be mediated by an antiinflammatory action [165].
*__Olmesartan__ treatment significantly reduced serum levels of inflammatory markers; h-CRP, h-TNFa, IL-6, MCP-1 after 6 weeks of therapy [166].
*Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity [167].
*Blocking angiotensin II receptor increases bone mass [168, 169].
__Olmesartan__ acts in a manner similar to 1,25(OH)2D to reduce inflammation and, by inference, improve immune system function. VDR and RAS receptors are distributed in almost the same tissues. The endogenous VDR ligand 1,25(OH)2D down-regulates the RAS by repressing renin gene expression to reduce inflammation via the nuclear factor-kappa B pathway [170]. __olmesartan__ has a similar effect in that it reduces angiotensin II (a peptide that is implicated in the inflammatory process) [171]. Inappropriate stimulation of the RAS has been associated with the pathogenesis of hypertension, heart attack and stroke [151]. Ferder et al. [151] state, ‘‘Changes in RAS activity and activation of the VDR seem to be inversely related, making it possible to speculate that both systems could have a feedback relationship. The combination of RAS blockade and VDR stimulation appears to be more effective than each one used individually.” Blocking angiotensin II and stimulating the VDR is what __olmesartan__ appears to accomplish and this function is consistent with a theory of VDR incompetence (Fig. 7).
In patients with autoimmune disorders and inflammatory symptoms, __olmesartan__ is noted to provoke an increase in inflammatory symptoms indicative of a Jarisch-Herxheimer reaction (JHR). JHR is a cascade of reactions including inflammation, cytokine release, and endotoxin release as part of the immune response to the disintegration of infected cells [172]. This immunopathology suggests transcription of AMPs by an activated VDR, points to the presence of occult infection and provides additional evidence that __olmesartan__ is a VDR agonist [167, 173, 174]. Theoretically, __olmesartan__ restores VDR competence and, thus, phagocytosis leads to bacterial death; consequently, inflammation is temporarily increased by cytokine reaction to microbial endotoxins and cellular debris from dead host cells and bacteria [175].
Hajishengallis and Lambris [92] conclude that a blockade of hijacked receptors of the innate immune system may offer promising options to control infection and associated immunopathology. Although this use of __olmesartan__ is off- label, its safety profile is well established [176]. The multiple, documented beneficial effects of __olmesartan__, including the ability to reduce cardiovascular and kidney disease, prevent migraines, and reduce oxidative stress, also suggest it could play a key role in the resolution of chronic systemic inflammation [177, 178].
!!!!Clinical use of __olmesartan__
__Olmesartan__ is being used as a novel VDR ligand in the clinical setting [179]. Immunotherapy with __olmesartan__ may also include pulsed administration of select MIC (minimum inhibitory concentration) oral antibiotics to weaken and help eradicate the intracellular pathogens. With each antibiotic dose, inflammatory symptoms (JHR) wax and wane, providing further evidence of persistent infection [180]. Changes in laboratory findings (e.g., BUN, creatinine, CRP, blood counts, liver enzymes) often point to areas of occult inflammation. A correlating treatment strategy is the avoidance of excessive sunlight exposure, foods high in vitamin D and vitamin D supplements to maintain serum 25(OH)D at a level (20-30 ng/ml) that is not likely to suppress the immune system and inhibit bacterial elimination [122, 135, 137].
Accumulating case reports now support the observation that a number of complex, chronic conditions can be improved by restoring VDR function using this type of immunotherapy [179, 181, 182]. It is becoming increasingly clear that microbes slow down immune reactivity by dysregulating the VDR, ultimately to increase their chance of survival. Immune modulatory therapies that enhance VDR expression and activity should, therefore, be considered in the clinical setting [183].
!!!!Discussion
Vitamin D is essential for many important biological processes and most people get an adequate supply from exposure to sunlight (Table 2). Long-term studies are needed to determine if low 25(OH)D in healthy individuals leads to disease. Evidence that vitamin D supplementation cures or prevents chronic disease is inconsistent. Despite increased supplementation chronic inflammatory diseases are on the rise. Attention to the alternate hypothesis—low 25(OH)D is a consequence of the chronic disease process, provoked by persistent intracellular infection—may be crucial to reversing this trend and needs further research.

!!!!Table 2 Key points
*Vitamin D is a steroid hormone which regulates immune system function
*Photosynthesis of vitamin D3 provides adequate vitamin D stores for most individuals
*Low levels of 25(OH)D are seen in healthy individuals, as well as those with chronic inflammatory conditions
*Studies are inconsistent regarding the health benefits of increasing vitamin D stores; vitamin D supplementation may have negative effects
*25(OH)D may not always reflect the level of 1,25(OH)D; accurate assessment of vitamin D status depends on measuring both metabolites
*Intracellular, cell wall deficient bacteria may cause dysregulated vitamin D metabolism and impaired immune system function
*A novel, non-vitamin D VDR ligand (an angiotensin receptor blocker) appears to 
+reactivate the immune system, 
+restore VDR competence, 
+correct dysregulated vitamin D metabolism and 
+reduce inflammatory symptoms
The prevailing dogma that the level of serum 25(OH)D provides an accurate assessment of vitamin D status needs closer examination. Circulating levels of 25(OH)D may not be an accurate reflection of vitamin D status. In those with an autoimmune disease or chronic inflammatory symptoms, 1,25(OH)2D may be elevated. This can lead to osteoporosis and cause inhibition of innate immunity, which is contraindicated in the presence of infection. The resulting immunosuppression may promote persistentinfection which has been implicated in chronic inflammatory diseases.
Human cells live in harmony with many types of microbes but some microbes may become pathogenic under commonly experienced conditions. The innate immune system is designed to kill pathogens via 1,25(OH)2D- mediated VDR transcription of anti-microbial peptides but microbes may use strategies which down-regulate the VDR in order to live and reproduce within nucleated host cells. Studies using more advanced cell culture and molecular techniques are confirming the presence of previously undetected intracellular bacteria. Defense mechanisms that intracellular bacteria use to persist and proliferate need to be investigated. Pathogen-induced VDR dysfunction which causes the release of pro-inflammatory cytokines appears to be at the root of chronic disease and low 25(OH)D. Improving VDR activation may be the key to reducing inflammatory diseases. Treatments that up-regulate the VDR to restore normal immune function, reduce inflammation and eradicate persistent bacterial infections require further research. An immunotherapy which has demonstrated efficacy in reversing vitamin D metabolism dysfunction and reducing inflammatory symptoms is currently being used by clinicians and warrants formal study.
In summary, elevated 1,25(OH)2D, often accompanied by reduced 25(OH)D, is a clinical sign of dysregulated vitamin D metabolism and evidence that the immune system is competing with parasitic microbes for VDR dominance. Failure of the immune system to mount an effective anti-microbial response results in persistent intracellular infection. This induces relentless inflammation (immunopathology) which causes tissue damage and disease symptoms.

Acknowledgments The authors wish to gratefully acknowledge the reviewers who commented on the original manuscript and provided helpful, expert advice. We thank the editor of Inflammation Research, Dr. Mauro Teixeira, for his kind consideration of our work. Special thanks to Tapen Sinha for sharing with us his expertise regarding manuscript formatting and submission. We thank Tom Mangin, Belinda Fenter, Terry Fenter, Debbie Yeager and John Yeager for their support. And we acknowledge with gratitude the generous donors to Chronic Illness Recovery who have enabled us to continue our research.

Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
!!!!References
#Cheng T, Chimeh C, Lu Z, et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Bio Biophs. 2007;460(2):213-7.
#Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88(2):582-6.
#Holick M, Schnoes H, Deluca H, Suda T, Cousins R. Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochem. 1971; 10(14):2799-804.
#Adams J, Hewison M. Extrarenal expression of the 25-hydrox- yvitamin D-1-hydroxylase. Arch Biochem Biophys. 2012; 523(1):95-102.
#Haddad J, Vitamin D. Binding protein (Gc-globulin): multiple tasks. J Steroid Biochem Mol Biol. 1996;53(1-6):579-82.
#Sutton A, MacDonald P. Vitamin D: more than a ‘‘bone-a-fide’’ hormone. Mol Endocrinol. 2003;17(5):777-91.
#White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun. 2008;76(9):3837-43.
#Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009;30(3):131-41.
#Wang T, Nestel F, Bourdeau V, et al. Cutting edge: 1,25-di- hydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173(5):2909-12.
#Hayes C, Nashold F, Spach K, Pedersen L. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand). 2003;49(2):277-300.
#Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol. 2004;34(4):1068-76.
#Maxmen A. Nutrition advice: the vitamin D-lemma. Nature. 2011;475(7354):23-5.
#Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167(16):1730-7.
#For health professionals: position statement on supplementation, blood levels and sun exposure Vitamin D Council. Vitamin D Council. Jan 12, 2010. Available at http://www.vitamindcouncil. org/further-topics/for-health-professionals-position-statement-on- supplementation-blood-levels-and-sun-exposure/. Accessed 28 Apr 2013.
#Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab. 2012;97(4):1153-8.
#Ross AC, Taylor CL, Yaktine AL, Del Valle HB. Dietary reference intakes for calcium and vitamin D. Washington: National Academy of Sciences; 2010. 0-309-16394-3.
#Beers M. Vitamin D Deficiency and Dependency. Merck (Document). Oct 15, 2006. Available at http://web.archive.org/ web/20061015162329/www.merck.com/mrkshared/mmanual/ section1/chapter3/3d.jsp. Accessed 21 Apr 2013.
#Topiwala S. 25-hydroxy vitamin D test. MedlinePlus. Oct 7,
#Available at http://www.nlm.nih.gov/medlineplus/ency/ article/003569.htm. Accessed 21 Apr 2013.
#Vitamin D, 25-Hydroxy, LC/MS/MS. Quest diagnostics. 2013. Available at http://www.questdiagnostics.com/home/physicians/ testing-services/by-test-name/vitamind.html. Accessed 28 Apr 2013.
#Snellman G, Melhus H, Gedeborg R, et al. Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. PLoS One. 2009;4(11):e7747.
#Bogh MK, Schmedes AV, Philipsen PA, Thieden E, Wulf HC. Vitamin D production depends on ultraviolet-B dose but not on dose rate: a randomized controlled trial. Exp Dermatol. 2011; 20(1):14-8.
#Bogh MK, Schmedes AV, Philipsen PA, Theiden E, Wulf HC. Vitamin D production after UVB exposure depends on baseline vitamin D and total cholesterol but not on skin pigmentation. J Invest Dermatol. 2010;130(2):546-53.
#Matsuoka LY, Worstman J, Haddad JG, Kolm P, Hollis BW. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol. 1991;127(4):536-8.
#Matsuoka LY, Wortsman J, Chen TC, Holick MF. Compensation for the interracial variance in the cutaneous synthesis of vitamin D. J Lab Clin Med. 1995;126(5):452-7.
#Villa M, Kelsey J, Chen J, Marcus R. Skin Pigmentation does not affect vitamin D status in community-dwelling Mexican- American women. J Bone Miner Res. 1994;9(Suppl 1):S418.
#Matsuoka LY, Wortsman J, Dannenberg MJ, Holis BW, Lu Z, Holick MF. Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab. 1992;75(4):1099-103.
#Dietary supplement fact sheet: vitamin D. National Institutes of Health. Jan 24, 2011. Available at http://ods.od.nih.gov/ factsheets/VitaminD-HealthProfessional/?print=1. Accessed 10 Mar 2013.
#Matsuoka LY, Ide L, MacLaughlin JA, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab. 1987;64(6):1165-8.
#Diehl JW, Chiu MW. Effects of ambient sunlight and photoprotection on vitamin D status. Dermatol Ther. 2010;23(1): 48-60.
#Youl PH, Janda M, Kimlin M. Vitamin D and sun protection: the impact of mixed public health messages in Australia. Int J Cancer. 2009;124(8):1963-70.
#Global Solar UV Index: A Practical Guide. Geneva, Switzerland: World Health Organization; 2002. ISBN 9241590076.
#MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76(4): 1536-8.
#Chuck A, Todd J, Diffey B. Subliminal ultraviolet-B irradiation for the prevention of vitamin D deficiency in the elderly: a feasibility study. Photodermatol Photoimmunol Photomed. 2001;17(4):168-71.
#Chel VG, Ooms ME, Popp-Snijders C, et al. Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res. 1998;13(8):1238-42.
#Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. Clin Endocrinol Metab. 1988;67(2): 373-8.
#Kimlin MG, Olds WJ, Moore MR. Location and vitamin D synthesis: is the hypothesis validated by geophysical data? J Photochem Photobiol B. 2007;86(3):234-9.
#Lubin D, Jensen EH, Gies HP. Global surface ultraviolet radiation climatology from TOMS and ERBE data. J Geo Res. 1998;103(D20):26061-91.
#Schoenmakers I, Goldberg GR, Prentice A. Abundant sunshine and vitamin D deficiency. Br J Nutr. 2008;99(6):1171-3.
#Al-Othman A, Al-Musharaf S, Al-Daghri NM, et al. Tea and coffee consumption in relation to vitamin D and calcium levels in Saudi adolescents. Nutr J. 2012;11:56.
#Willis KS, Smith DT, Broughton KS, Larson-Meyer DE. Vitamin D status and biomarkers of inflammation in runners. Open Access J Sports Med. 2012;2012(3):35-42.
#Binkley N, Novotny R, Krueger D, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab. 2007;92(6):2130-5.
#Blaney GP, Albert PJ, Proal AD. Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Ann NY Acad Sci. 2009;1173:384-90.
#Brot C, Jorgensen NR, Sorensen OH. The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr. 1999;53(12):920-6.
#Tiosano D, Hochberg Z. Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab. 2009;27(4): 392-401.
#Rickets. MedlinePlus. Aug 1, 2012. Available at http://www. nlm.nih.gov/medlineplus/ency/article/000344.htm. Accessed 6 May 2013.
#Lerch C, Meissner T. Interventions for the prevention of nutritional rickets in term born children. Cochrane Database Syst Rev. 2007;4:CD006164.
#Pettifor JM, Ross P, Wang J, Moodley G, Couper-Smith J. Rickets in children of rural origin in South Africa: is low dietary calcium a factor? J Pediatr. 1978;92(2):320-4.
#Pettifor JM. Nutritional rickets: deficiency of vitamin D, calcium, or both? Am J Clin Nutr. 2004;80(6 Suppl):1725S-9S.
#Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet. 2013;383:146-55.
#Boden SD, Kaplan FS. Calcium homeostasis. Orthop Clin North Am. 1990;21(1):31-42.
#Sun J. Vitamin D and mucosal immune function. Curr Opin Gastroenterol. 2010;26(6):591-5.
#Abreu MT, Kantorovich V, Vasiliauskas EA, et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25- dihydroxyvitamin D and low bone mineral density. Gut. 2004;53(8):1129-36.
#Brot C, J0rgensen N, Madsen OR, Jensen LB, S0rensen OH. Relationships between bone mineral density, serum vitamin D metabolites and calcium:phosphorus intake in healthy peri- menopausal women. J Intern Med. 1999;245(5):509-16.
#Ishizuka S, Kurihara N, Miura D, et al. Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25- dihydroxyvitamin D3 from pagetic bone marrow cells. J Steroid Biochem Mol Biol. 2004;89-90(1-5):331-4.
#Vanderschueren D, Pye SR, O’Neill TW, et al. Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS). J Clin Endocrinol Metab. 2013;98(3):995-1005.
#Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the US. Preventive Services Task Force. Ann Intern Med. 2011;155(12): 827-38.
#Whayne TF Jr. Vitamin D: popular cardiovascular supplement but benefit must be evaluated. Int J Angiol. 2011;20(2):63-72.
#Shelby J. Needs great, evidence lacking for people with multiple chronic conditions. Scribd. Apr 2013. Accessed 7 May 2013.
#Mattke S, Klautzer L, Mengistu T, Hu J, Wu H. Health and wellbeing in the home: a global analysis of needs, expectations, and priorities for home health care technology. Rand Corporation. 2010. http://www.rand.org/pubs/occasional_papers/OP323.html. Accessed 7 May 2013.
#Tseng L. Controversies in vitamin D supplementation. eScholar- ship. 2003. http://www.escholarship.org/uc/item/4m84d4fn# page-1. Accessed 7 May 2013.
#Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2011;(7):CD007470.
#Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr. 1995;61(3 Sup- pl):638S-45S.
#Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69(5):842-56.
#Noordam R, de Craen AJ, Pedram P, et al. Levels of 25-hy- droxyvitamin D in familial longevity: the Leiden Longevity Study. CMAJ. 2012;184(18):E963-8.
#Autier P, Boniol M, Pizot C, Mullie P. Vitamin D: chasing a myth? Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2013.
#Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014;4(2):307-20.
#Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-8.
#Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87:1080S-6S.
#Albert PJ, Proal AD, Marshall TG. Vitamin D the alternative hypothesis. Autoimmun Rev. 2009;8(8):639-44.
#Madoff S, editor. The Bacterial L-forms. 1st ed. USA: Marcel Dekker Inc; 1986.
#Allan EJ, Hoischen C, Gumpert J. Bacterial L-forms. Adv Appl Microbiol. 2009;68:1-39.
#Boya P. Lysosomal function and dysfunction: mechanism and disease. Antioxid Redox Signal. 2010;17(5):766-74.
#Domingue GJ, Woody HB. Bacterial persistence and expression of disease. Clin Microbiol Rev. 1997;10(2):320-44.
#O’Connor SM, Taylor CE, Hughes JM. Emerging infectious determinants of chronic diseases. Emerg Infect Dis. 2006;12(7): 1051-7.
#Domingue GJ. Demystifying pleomorphic forms in persistence and expression of disease: are they bacteria, and is peptidogly- can the solution? Discov Med. 2010;10(52):234-46.
#Rueter A. Microbes start immune response by sneaking inside cells. University of Michigan Health System. Apr 16, 2007. http://www2.med.umich.edu/prmc/media/newsroom/details.cfm? ID=577. Accessed 8 May 2013.
#Rolhion N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis. 2007;13(10):1277-83.
#Onwuamaegbu ME, Belcher RA, Soare C. Cell wall-deficient bacteria as a cause of infections: a review of the clinical significance. J Int Med Res. 2005;33(1):1-20.
#Verway M, Behr MA, White JH. VitaminD NOD2, autophay and Crohn’s disease. Expert Rev Clin Immunol. 2010;6(4): 505-8.
#Pirofski L, Casadevall A. Q and A what is a pathogen? A question that begs the point. BMC Biol. 2012;12:6.
#Hof H. Opportunistic intracellular bacteria and immunity. Antibiotic treatment of infections with intracellular bacteria. USA: Springer; 2002.
#Fuller E, Elmer C, Nattress F, Horne G, Cook P, Fawcett T. Beta-lactam resistance in Staphylococcus aureus cells that do not require a cell wall for integrity. Antimicrob Agents Che- mother. 2005;49(12):5075-80.
#Wroblewska J, Janicka G, Gospodarek E, Szymankiewicz M. L-forms of Staphylococcus epidermidis induced by penicillin. Pol J Microbiol. 2006;55(3):243-4.
#Garssen J, Vandebriel RJ, De Gruijl FR, et al. UVB exposure- induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology. 1999;97(3):506-14.
#Riminton DS, Hartung HP, Reddel SW. Managing the risks of immunosuppression. Curr Opin Neurol. 2011;24(3):217-23.
#Wall S, Kunze ZM, Saboor S, et al. Identification of spheroplast- like agents isolated from tissues of patients with Crohn’s disease and control tissues by polymerase chain reaction. J Clin Microbiol. 1993;31(5):1241-5.
#Negi M, Takemura T, Guzman J, et al. Localization of propi- onibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Mod Pathol. 2012;25(9):1284-97.
#Astrauskiene D, Bernotiene E. New insights into bacterial persistence in reactive arthritis. Clin Exp Rheumatol. 2007;25(3): 470-9.
#McDougal JS. Emerging infectious diseases. Centers for Disease Control and Prevention. Mar 2006. http://wwwnc.cdc.gov/eid/ article/12/3/05-1409_article.htm#suggestedcitation. Accessed 8 May 2013.
#Kozarov E. Bacterial invasion of vascular cell types: vascular infectology and atherogenesis. Future Cardiol. 2012;8(1): 123-38.
#Khan N, Gowthaman U, Pahari S, Agrewala JN. Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vici! PLoS Pathog. 2012;8(6):e1002676.
#Hajishengallis G, Lambris JD. Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol. 2011;11(33):187-200.
#Dorr T, Vulic M, Lewis K. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 2010;8(2):e1000317.
#Fuks JM, Arrighi RB, Weidner JM, et al. GABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondii. PLoS Pathog. 2012;8(12): e1003051.
#Smillie CS, Smith MB, Friedman J, Cordero OX, David LA, Alm EJ. Ecology drives a global network of gene exchange connecting the human microbiome. Nature. 2011;480(7376): 241-4.
#Riley DR, Sieber KB, Robinson KM, et al. Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLOS Comput Biol. 2013;9(6):e1003107.
#Helaine S, Cheverton AM, Watson KG, Faure LM, Matthews SA, Holden DW. Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science. 2014;343(6167):204-208. Available at http://www.sciencemag. org. Accessed 21 Jan 2014.
#Eishi Y. Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes. Biomed Res Int. 2013;2013:935289.
#Wang KX, Chen L. Helicobacter pylori L-form and patients with chronic gastritis. World J Gastroenterol. 2004;10(9): 1306-9.
#Chen Y, Liu W, Sun T, et al. 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting MicroRNA-155-SOCS1 in macrophages. J Immunol. 2013; 190(7):3687-95.
#Nauciel C. Immune defenses against intracellular bacterial infection. In: Paradise LJ, Friedman H, Bendinelli M, editors. Opportunistic intracellular bacteria and immunity. New York: Kluwer Academic; 2002.
#Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770-3.
#Alexander C, Rietschel ET. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res. 2001;7(3):167-202.
#McGeachy MJ, McSorley SJ. Microbial-induced Th17: superhero or supervillain? J Immunol. 2012;189(7):3285-91.
#Oswald-Richter KA, Beachboard DC, Seeley EH, et al. Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL. J Clin Immunol. 2012;32(5):1129-40.
#Labro M. Interference of antibacterial agents with phagocyte functions: immunomodulation or ‘‘immuno-fairy tales’’? Clin Microbiol Rev. 2000;13(4):615-50.
#Giongo A, Gano KA, Crabb DB, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011; 5(1):82—91.
#Anderson G, Horvath J. The growing burden of chronic disease in America. Public Health Rep. 2004;119(3):263-70.
#Smith G. Angiotensin and systems thinking: wrapping your mind around the big picture. Ochsner J Spring. 2013;13(1): 11-25.
#Woolard MD, Frelinger JA. Outsmarting the host: bacteria modulating the immune response. Immunol Res. 2008;41(3): 188-202.
#Dermine JF, Desjardins M. Survival of intracellular pathogens within macrophages. Protoplasma. 1999;210(1-2):11-24.
#Xu Y, Xie J, Li Y, et al. Using a cDNA microarray to study cellular gene expression altered by Mycobacterium tuberculosis. Chin Med J (Engl). 2003;116(7):1070-3.
#Liu PT, Wheelwright M, Teles R, et al. MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat Med. 2012;18(2):267-73.
#Coughlan CA, Chotirmall SH, Renwick J, et al. The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis. Am J Respir Crit Care Med. 2012; 186(10):999-1007.
#Yenamandra SP, Lundin A, Arulampalam V, et al. Expression profile of nuclear receptors upon Epstein—Barr virus induced B cell transformation. Exp Oncol. 2009;31(2):92-6.
#Haug CJ, Aukrust P, Haug E, M0rkrid L, Muller F, Fr0land SS. Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab. 1998;83(11):3832-8.
#Yoshizawa T, Handa Y, Uematsu Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997;16(4):391-6.
#Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down- regulates monocyte TLR expression and triggers. Eur J Immunol. 2006;36(2):361-70.
#Barna BP, Culver DA, Kanchwala A, et al. Alveolar macrophage cathelicidin deficiency in severe sarcoidosis. J Innate Immun. 2012;4(5-6):569-78.
#Mawer EB, Hayes ME, Still PE, et al. Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis. J Bone Miner Res. 1991;6(7):733-9.
#Wang TT, Dabbas B, Laperriere EG, et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15- defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem. 2010;285(4):2227-31.
#Lemire J. 1,25-Dihydroxyvitamin D3—a hormone with immunomodulatory properties. Z Rheumatol. 2000;59(Suppl 1): 24-7.
#Deb DK, Chen Y, Zhang Z, et al. 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway. 296(5): F1212-8.
#Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr. 1989;114(1):555-60.
#Wu S, Sun J. Vitamin D receptor, and macroautophagy in inflammation and infection. Discov Med. 2011;11(59):325-35.
#Domingue G, Turner B, Schlegel JU. Cell-wall deficient bacterial variants in kidney tissue. Detection by immunofluorescence. Urology. 1974;3(3):288-92.
#Pleister A, Eckels DD. Cryptic infection and autoimmunity. Autoimmun Rev. 2003;2(3):126-32.
#Chan TD, Wood K, Hermes JR, et al. Elimination of germinal- center-derived self-reactive B cells is governed by the location and concentration of self-antigen. Immunity. 2012;37(5): 893-904.
#Blander JM, Torchinsky MB, Campisi L. Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells. Immunol Res. 2012;54(1-3):50-68.
#Christen U, Hintermann E, Holdener M, von Herrath MG. Viral triggers for autoimmunity: is the ‘glass of molecular mimicry’ half full or half empty? J Autoimmun. 2010;34(1):38-44.
#Proal AD, Albert PJ, Marshall TG. Autoimmune disease and the human metagenome. In: Nelson KE, editor. Metagenomics of the human body. 1st ed. USA: Springer; 2011.
#Berlin T, Zandman-Goddard G, Blank M, et al. Autoantibodies in nonautoimmune individuals during infections. Ann NY Acad Sci. 2007;1108:584-93.
#Molina V, Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity. 2005;38(3): 235-45.
#Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr. 2003;23:117-45.
#Zhang Y, Leung DY, Richers BN, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012;188(5): 2127-35.
#Bohm M, Luger TA, Schneider M, Schwarz T, Kuhn A. New insight into immunosuppression and treatment of autoimmune diseases. Clin Exp Rheumatol. 2006;24(1 Suppl 40):S67-71.
#Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007;66(9):1137-42.
#Kim HM, Chung MJ, Chung JB. Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment. Pancreas. 2010;39(5):555-60.
#Collins FS. Reengineering translational science: the time is right. Sci Transl Med. 2011;3(90):9017.
#Norman A. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88(2):491S-9S.
#Rasmussen SB, Reinert LS, Paludan SR. Innate recognition of intracellular pathogens: detection and activation of the first line of defense. APMIS. 2009;117(5-6):323-37.
#Dusso AS, Kamimura S, Gallieni M, et al. gamma-Interferon- induced resistance to 1,25-(OH)2D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab. 1997;82(7): 2222-32.
#Edfeldt K, Liu PT, Chun R, et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci USA. 2010; 107(52):22593-8.
#Lambert PW, Stern PH, Avioli RC, et al. Evidence for extrarenal production of 1 alpha,25-dihydroxyvitamin D in man. J Clin Invest. 1982;69(3):722-5.
#Reichrath J. Vitamin D and the skin: an ancient friend, revisited. Exp Dermatol. 2007;16(7):618-25.
#Bikle DD. Vitamin D and immune function: understanding common pathways. Curr Osteoporos Rep. 2009;7(2):58-63.
#Jones G, Prosser DE, Kaufman M. 25-Hydroxyvitamin D-24- hydroxylase (CYP24A1): Its important role in the degradation of vitamin D. Arch Biochem Biophys. 2012;523(1):9-18.
#Xu Y, Hashizume T, Shuhart MC, et al. Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin
#D(3): implications for drug-induced osteomalacia. Mol Pharmacol. 2006;69(1):56-65.
#Bell NH, Shaw S, Turner RT. Evidence that 1,25-dihydroxyvi- tamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest. 1984;74(4):1540-4.
#Waldron JL, Ashby HL, Cornes MP, et al. Vitamin D: a negative acute phase reactant. J Clin Pathol. 2013 (Epub ahead of print).
#Ferder M, Inserra F, Manucha W, Ferder L. The world pandemic of Vitamin D deficit could possibly be explained by cellular inflammatory response activity induced by the renin angiotensin system. Am J Physiol Cell Physiol. 2013 (Epub ahead of print).
#Akbaraly TN, Hamer M, Ferrie JE, et al. Chronic inflammation as a determinant of future aging phenotypes. CMAJ. 2013 (Epub ahead of print).
#Phillips CM, Perry IJ. Does inflammation determine metabolic health status in obese and nonobese adults? J Clin Endocrinol Metab. 2013;98(10):E1610-9.
#Strathmann FG, Laha TJ, Hoofnagle AN. Quantification of 1a,25 dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. Clin Chem. 2011;57(9):1279-85.
#Hollis B. Detection of vitamin D and its major metabolites. In: Feldman D, Pike JW, Glorieux F, editors. vitamin D. San Diego: Elsevier Academic; 2005.
#Perez T. Bacteria induced vitamin D receptor dysfunction in autoimmune disease; theoretical and practical implication for interpretation of serum vitamin D metabolite levels. Paper presented at: 6th International Congress on Autoimmunity, 2006; Porto, Portugal.
#Vitamin D Assay Testing. Medicare Limited Coverage Tests— Covered Diagnosis Codes. Nov 14, 2011. Available at http:// www.sonoraquest.com/uploads/docs/Vitamin_D_Assay_ Testing.pdf?AspxAutoDetectCookieSupport=1. Accessed 31 Jan 2014.
#Durup DJHCJSPHALB. A reverse J-shaped association of allcause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab. 2012;97(8): 2644-52.
#Liu PT, Schenk M, Walker VP, et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One. 2009;4(6):e5810.
#Carlberg C, Molnar F. Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands. Curr Top Med Chem. 2006;6(12):1243-53.
#Haussler M, Haussler C, Bartik L, et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev. 2008;66(10 Suppl 2):98-112.
#Ishizawa M, Matsunawa M, Adachi R, et al. Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia. J Lipid Res. 2008;49(4): 763-72.
#Marshall TG, Lee RE, Marshall FE. Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b. Theor Biol Med Model. 2006;3:1.
#Waterhouse JC, Marshall TG, Fenter B, Mangin M, Blaney G. High levels of active 1,25-dihydroxyvitamin D despite low levels of the 25-hydroxyvitamin D precursor-implications of dysregulated vitamin D for diagnosis and treatment of chronic disease. In: Stolzt VD, editor. Vitamin D: New Research. New York: Nova Science Publishers; 2006.
#Arao T, Okada Y, Mori H, Nishida K, Tanaka Y. Antihypertensive and metabolic effects of high-dose __olmesartan__ and telmisartan in type 2 diabetes patients with hypertension. Endocr J. 2013; (Epub ahead of print).
#Fliser D, Buchholz K, Haller H. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation. 2004;110(9): 1103-7.
#Platten M, Youssef S, Hur EM, et al. Blocking angiotensinconverting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci USA. 2009;106(35):14948-53.
#Izu Y, Mizoguchi F, Kawamata A, et al. Angiotensin II type 2 receptor blockade increases bone mass. J Biol Chem. 2009;284(8):4857-64.
#Shimuru H, Nakagami H, Osako MK, et al. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J. 2008;22(7):2465-75.
#Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Di- hydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110(2):229-38.
#Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003;35(6):881-900.
#Herxheimer K, Martin H. So-called Herxheimer reaction. Arch Derm Syphilol. 1926;13(1):115-7.
#Sonawane A, Santos JC, Mishra BB, et al. Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages. Cell Microbiol. 2011;13(10):1601-17.
#Nickel D, Busch M, Mayer D, Hagemann B, Knoll V, Stenger S. Hypoxia triggers the expression of human beta defensin 2 and antimicrobial activity against Mycobacterium tuberculosis in human macrophages. J Immunol. 2012;188(8):4001-7.
#Hurley JC. Antibiotic-induced release of endotoxin. A therapeutic paradox. Drug Saf. Mar 1995;12(3):183-95.
#Schwocho LR, Masonson HN. Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects. J Clin Pharmacol. 2001;41(5):515-27.
#Ferrario C. Effect of angiotensin receptor blockade on endothelial function: focus on __olmesartan__ medoxomil. Vasc Health Risk Manag. 2009;5(1):301-14.
#Takizawa S, Dan T, Uesugi T, et al. A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damage. J Cereb Blood Flow Metab. 2009;29(10): 1665-72.
#Proal AD, Albert PJ, Marshall TG, Blaney GP, Lindseth LA. Immunostimulation in the treatment for chronic fatigue syn- drome/myalgic encephalomyelitis. Immunol Res. 2013;56: 398-412.
#Hof H. Antibiotic treatment of infections with intracellular bacteria. In: Paradise LJ, Friedman H, Bendinelli M, editors. Opportunistic intracellular bacteria and immunity. New York: Kluwer Academic; 2002.
#Waterhouse JC, Perez TH, Albert PJ. Reversing bacteria- induced vitamin D receptor dysfunction is key to autoimmune disease. Ann NY Acad Sci. 2009;1173:757-65.
#Mangin M. Monitoring recovery from autoimmune disease with an interactive, internet-based clinical trial based on a molecular model of chronic disease. Paper presented at: 6th International Congress on Autoimmunity, 2008; Porto, Portugal.
#Kongsbak M, Levring TB, Geisler C, von Essen MR. The vitamin D receptor and T cell function. Front Immunol. 2013; 4:148.</description></item><item><title>T1DM, toll-like receptors and vitamin D in rats</title><link>/posts/t1dm-toll-like-receptors-and-vitamin-d-in-rats.html</link><pubDate>Wed, 21 May 2014 00:00:00 +0000</pubDate><guid>/posts/t1dm-toll-like-receptors-and-vitamin-d-in-rats.html</guid><description>&lt;h3 id="the-role-of-toll-like-receptors-and-vitamin-d-in-diabetes-mellitus-type-1---a-review">The role of toll-like receptors and vitamin D in diabetes mellitus type 1 - a review.&lt;/h3>
&lt;p>Scandinavian Journal of Immunology ; Received Date : 24-Mar-2014 Revised Date : 28-Apr-2014 Accepted Date : 04-May-2014&lt;/p>
&lt;p>Daria M. Adamczak1,3 &lt;a href="mailto:daria.m.adamczak@gmail.com">daria.m.adamczak@gmail.com&lt;/a>, Jan K. Nowak2, Magdalena Frydrychowicz3*, Mariusz Kaczmarek3*, Jan Sikora3&lt;/p>
&lt;p>1 Poznan University of Medical Sciences, Clinical Hospital No. 1, Poznan, Poland&lt;/p>
&lt;p>2 Poznan University of Medical Sciences, Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan, Poland&lt;/p></description></item><item><title>Vitamin D Conference papers and poster abstracts – London</title><link>/posts/vitamin-d-conference-papers-and-poster-abstracts-london.html</link><pubDate>Thu, 24 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-conference-papers-and-poster-abstracts-london.html</guid><description>&lt;p>&lt;strong>&lt;span style="color:#F00;">188 abstracts&lt;/span>&lt;/strong>&lt;/p>
&lt;p>Browser (cntrl F usually) can FIND words, phrases, authors, etc.&lt;/p>
&lt;p>Note: due to extraction and formatting problems all &lt;span>[ became ( &lt;del>hs&lt;/del> &lt;del>hs&lt;/del> and all ]&lt;/span> became )&lt;/p>
&lt;p>Conference is described at: &lt;a href="/posts/vitamin-d-conference-in-england-april-23-25-2014">Vitamin D conference in England - April 23-25 2014&lt;/a>&lt;/p>
&lt;p>These absracts of presentations and posters were published in the &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/25054551?dopt=Abstract">Journal Nutrients&lt;/a> July 2014&lt;/p>
&lt;p>    Note: Clicking on Hide Health Problems above will make it easier to read the Table of Contents&lt;/p></description></item><item><title>MS and vitamin D consensus from Brazil - 40-100 ng, not monotherapy</title><link>/posts/ms-and-vitamin-d-consensus-from-brazil-40-100-ng-not-monotherapy.html</link><pubDate>Wed, 12 Mar 2014 00:00:00 +0000</pubDate><guid>/posts/ms-and-vitamin-d-consensus-from-brazil-40-100-ng-not-monotherapy.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#dr-cicero-galli-coimbra-brazil-is-not-mentioned-as-an-author-contributor-nor-as-a-reference">Dr. Cicero Galli Coimbra (Brazil) is not mentioned as an author, contributor, nor as a reference&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#supplementation-and-therapeutic-use-of-vitamin-d-in-patients-with-multiple-sclerosis">Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis:&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-ms-and-eae">VITAMIN D, MS, AND EAE&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#randomized-and-controlled-clinical-trials-with-vitamin-d-in-the-treatment-of-ms">RANDOMIZED AND CONTROLLED CLINICAL TRIALS WITH VITAMIN D IN THE TREATMENT OF MS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-other-issues">VITAMIN D AND OTHER ISSUES&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#safety-profile">SAFETY PROFILE&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d--side-effects">VITAMIN D – SIDE EFFECTS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#final-considerations">FINAL CONSIDERATIONS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#acknowledgements">ACKNOWLEDGEMENTS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">REFERENCES&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="dr-cicero-galli-coimbra-brazil-is-not-mentioned-as-an-author-contributor-nor-as-a-reference">Dr. Cicero Galli Coimbra (Brazil) is not mentioned as an author, contributor, nor as a reference&lt;/h3>
&lt;p>&lt;strong>Suspect it is because Dr. Coimbra:&lt;/strong>&lt;/p></description></item><item><title>Prevention with vitamin D in Multiple Sclerosis is logical – editorial</title><link>/posts/prevention-with-vitamin-d-in-multiple-sclerosis-is-logical-editorial.html</link><pubDate>Thu, 04 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/prevention-with-vitamin-d-in-multiple-sclerosis-is-logical-editorial.html</guid><description>&lt;h4 id="vitamin-d-and-multiple-sclerosis-timing-of-sampling-treatment-and-prevention">Vitamin D and multiple sclerosis: timing of sampling, treatment and prevention.&lt;/h4>
&lt;p>Biomark Med. 2013 Apr;7(2):193-5. &lt;a href="https://doi.org/10.2217/bmm.13.10.">doi: 10.2217/bmm.13.10.&lt;/a> PMID: 23547812&lt;/p>
&lt;p>Sundström P, Salzer J.&lt;/p>
&lt;p>Department of Pharmacology &amp;amp; Clinical Neuroscience, Section of Neurology, Umeå University, 901 87 Umeå, Sweden. &lt;a href="mailto:peter.sundstrom@neuro.umu.se">peter.sundstrom@neuro.umu.se&lt;/a>.&lt;/p>
&lt;p>With today&amp;rsquo;s knowledge, it is the authors&amp;rsquo; view that enough scientific data exist to suggest that multiple sclerosis patients should be informed about the association between vitamin D levels and multiple sclerosis inflammatory disease activity&lt;/p></description></item><item><title>Sjögren’s syndrome (2nd most common rheumatic disease) and vitamin D - many studies</title><link>/posts/sjogrens-syndrome-2nd-most-common-rheumatic-disease-and-vitamin-d-many-studies.html</link><pubDate>Thu, 04 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/sjogrens-syndrome-2nd-most-common-rheumatic-disease-and-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-sjögrens-disease-revealing-the-connectionsa-systematic-review-and-meta-analysis---jan-2023">Vitamin D and Sjögren’s Disease: Revealing the Connections—A Systematic Review and Meta-Analysis - Jan 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#dry-eye-more-severe-with-lower-vitamin-d-in-sjögren-syndrome---dec-2019">Dry eye more severe with lower vitamin D in Sjögren Syndrome - Dec 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-sjögren-syndrome---review-april-2017">Vitamin D and Sjögren syndrome - Review April 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#novel-aspects-of-sjögrens-syndrome-in-2012">Novel aspects of Sjögren’s syndrome in 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#sections-on-vitamin-d-clipped-from-the-pdf">Sections on vitamin D clipped from the PDF&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#novel-aspects-of-ss-the-role-of-infections-and-vitamin-d-infections-and-ss">Novel aspects of SS: the role of infections and vitamin D Infections and SS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#low-levels-of-vitamin-d-are-associated-with-neuropathy-and-lymphoma-among-patients-with-ss">Low levels of vitamin D are associated with neuropathy and lymphoma among patients with SS&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#low-levels-of-vitamin-d-are-associated-with-neuropathy-and-lymphoma-among-patients-with-sjögrens-syndrome">Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren&amp;rsquo;s syndrome.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#clips-from-wikipedia-april-2013">Clips from Wikipedia April 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mega-doses-of-vitamin-d-reduces-sjögrens-fatigue-for-one-person">Mega Doses Of Vitamin D reduces Sjögren’s fatigue for one person&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h2 id="vitamin-d-and-sjögrens-disease-revealing-the-connectionsa-systematic-review-and-meta-analysis---jan-2023">Vitamin D and Sjögren’s Disease: Revealing the Connections—A Systematic Review and Meta-Analysis - Jan 2023&lt;/h2>
&lt;p>Nutrients 2023, 15(3), 497; &lt;a href="https://doi.org/10.3390/nu15030497">https://doi.org/10.3390/nu15030497&lt;/a>&lt;/p></description></item><item><title>Vitamin D increasingly associated with inflammation such as RA, TB, Lupus, and cancer</title><link>/posts/vitamin-d-increasingly-associated-with-inflammation-such-as-ra-tb-lupus-and-cancer.html</link><pubDate>Mon, 25 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-increasingly-associated-with-inflammation-such-as-ra-tb-lupus-and-cancer.html</guid><description>&lt;h3 id="there-are-two-articles-on-this-page">There are two articles on this page&lt;/h3>
&lt;hr>
&lt;h3 id="an-update-vitamin-d-deficiency-and-risk-for-rheumatic-diseases">An Update: Vitamin D Deficiency and Risk for Rheumatic Diseases&lt;/h3>
&lt;p>Paul Gatenby, Robyn Lucas, Ashwin Swaminathan&lt;/p>
&lt;p>Curr Opin Rheumatol. 2013;25(2):184-191.&lt;/p>
&lt;h4 id="diseases-include">Diseases include&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>Lupus&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Rheumatoid Arthritis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Juvenile Idiopathic Arthritis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Systemic Vasculitis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Psoriatic Arthritis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Scleroderma&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Behcet&amp;rsquo;s Disease&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Spondyloarthropathies&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Connective Tissue Disease&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>&lt;strong>PDF is attached at the bottom of this page&lt;/strong>&lt;/p>
&lt;hr>
&lt;h3 id="further-emergent-evidence-for-the-vitamin-d-endocrine-system-involvement-in-autoimmune-rheumatic-disease-risk-and-prognosis">Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis&lt;/h3>
&lt;p>&lt;strong>Annals of Rheumatic Diseases EDITORIAL&lt;/strong> , April 2013 Vol 72 No 4&lt;/p></description></item><item><title>Vitamin D can inhibit enveloped virus (e.g. Corona, Herpes, Bird Flu, Epstein, Hepatitis, RSV, etc.)</title><link>/posts/vitamin-d-can-inhibit-enveloped-virus-eg-corona-herpes-bird-flu-epstein-hepatitis-rsv-etc.html</link><pubDate>Tue, 12 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-can-inhibit-enveloped-virus-eg-corona-herpes-bird-flu-epstein-hepatitis-rsv-etc.html</guid><description>&lt;!-- ~tc~ start ~/tc~ -->
&lt;p>&lt;strong>&lt;a href="http://en.wikipedia.org/wiki/Viral_envelope%20">Examples of enveloped virus&lt;/a>   &lt;a href="/tags/coronavirus.html">Coronavirus&lt;/a>, &lt;a href="/posts/herpes-virus-and-vitamin-d-many-studies">Herpes simplex&lt;/a> (cold sore), &lt;a href="/posts/shingles-and-vitamin-d">Shingles&lt;/a>, &lt;a href="/posts/epstein-barr-virus-increases-the-risk-of-many-health-problems-many-studies">Epstein-Barr&lt;/a>, Hepatitis A &amp;amp; &lt;a href="/posts/hepatitis-b-virus-and-vitamin-d-many-studies">B&lt;/a> &amp;amp; &lt;a href="/posts/vitamin-d-prevents-hepatitis-c-and-helps-treat-it-many-studies">C&lt;/a>, &lt;a href="https://en.wikipedia.org/wiki/Human_metapneumovirus">HMPV&lt;/a>, &lt;a href="/posts/stop-zika-birth-defects-with-vitamin-d">Zika&lt;/a>, &lt;a href="/posts/overview-hiv-and-vitamin-d">HIV&lt;/a>, &lt;a href="/posts/dengue-fever-decimated-by-vitamin-d-many-studies">Dengue&lt;/a>, Yellow fever, &lt;a href="/posts/measles-and-low-vitamin-d-vitamin-a">Measles&lt;/a>, Mumps, smallpox, &lt;a href="/posts/monkeypox-and-vitamin-d-several-studies">Monkeypox&lt;/a>, &lt;a href="/posts/vitamin-d-may-protect-against-ebola">Ebola&lt;/a>, rabies, &lt;a href="/posts/overview-influenza-and-vitamin-d">influenza&lt;/a>, West Nile, &lt;a href="/posts/valley-fever-may-be-prevented-and-treated-with-vitamin-d">Valley Fever&lt;/a>, &lt;a href="/posts/croup-due-to-viruses-has-surged-with-omicron">Croup&lt;/a>, Lasa Fever, &lt;a href="https://www.perplexity.ai/search/hight-vitamin-d-fight-hemorrha-Yd9azku2SpO4zUQHlyFgRA">Hemorrhagic Fever&lt;/a>, &lt;a href="/posts/bird-flu-possible-pandemic-vitamin-d-can-prevent-it-many-studies">H5N1 bird flu&lt;/a>&lt;/strong>&lt;/p>
&lt;!-- ~tc~ end ~/tc~ -->
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/webp/enveloped.webp" alt="image" width="500">
&lt;hr>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-the-anti-viral-state---march-2011">Vitamin D and the anti-viral state - March 2011&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#does-vitamin-d-fight-most-enveloped-virus---asked-perplexity-ai---aug-2024">Does Vitamin D fight most enveloped virus? - Asked Perplexity AI - Aug 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-and-the-anti-viral-state---march-2011">Vitamin D and the anti-viral state - March 2011&lt;/h4>
&lt;p>J Clin Virol. 2011 March; 50(3): 194–200.&lt;/p></description></item><item><title>Vitamin D: Is It the Best Thing Under the Sun - Medscape</title><link>/posts/vitamin-d-is-it-the-best-thing-under-the-sun-medscape.html</link><pubDate>Fri, 08 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-it-the-best-thing-under-the-sun-medscape.html</guid><description>&lt;p>Robert Finn; Deborah Flapan; Darbe Rotach&lt;/p>
&lt;h3 id="the-following-is-the-first-of-25-images">The following is the first of 25 images&lt;/h3>
&lt;img src="/attachments/d3.mock.jpg" alt="image"> 
&lt;p>The number of research studies on vitamin D has soared in recent years.&lt;/p>
&lt;p>Citations of studies involving vitamin D increased from 1142 in the year 2000 to 3877 in 2012.&lt;/p>
&lt;p>In comparison, citations for research on vitamin A and vitamin C have remained more or less level.&lt;/p>
&lt;p>You have to register with &lt;a href="http://www.medscape.com/features/slideshow/vitamin-d#20">Medscape&lt;/a> to see the other images, with text&lt;/p></description></item><item><title>Hypothesis of Autoimmunity which includes Epstein-Barr Virus and Vitamin D Deficiency – 2012</title><link>/posts/hypothesis-of-autoimmunity-which-includes-epstein-barr-virus-and-vitamin-d-deficiency-2012.html</link><pubDate>Sun, 25 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/hypothesis-of-autoimmunity-which-includes-epstein-barr-virus-and-vitamin-d-deficiency-2012.html</guid><description>&lt;h4 id="cd8-t-cell-deficiency-epstein-barr-virus-infection-vitamin-d-deficiency-and-steps-to-autoimmunity-a-unifying-hypothesis">CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis&lt;/h4>
&lt;p>Autoimmune Diseases, Volume 2012 (2012), Article ID 189096, 16 pages, Review Article&lt;/p>
&lt;p>Michael P. Pender 1,2&lt;/p>
&lt;p>1 School of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia&lt;/p>
&lt;p>2 Department of Neurology, Royal Brisbane and Women&amp;rsquo;s Hospital, Brisbane, QLD 4029, Australia&lt;/p>
&lt;p>Received 18 August 2011; Revised 3 October 2011; Accepted 16 October 2011&lt;/p>
&lt;p>Academic Editor: Corrado Betterle&lt;/p></description></item><item><title>Epigenetics, vitamin D, and Multiple Sclerosis</title><link>/posts/epigenetics-vitamin-d-and-multiple-sclerosis.html</link><pubDate>Wed, 21 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/epigenetics-vitamin-d-and-multiple-sclerosis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#epigenetic-changes-in-patients-with-multiple-sclerosis---nov-2012">Epigenetic changes in patients with multiple sclerosis - Nov 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epigenetics---is-it-real-new-york-times-review-of-plos-genetics-article---july-2016">Epigenetics - is it real: New York Times review of PLOS Genetics article - July 2016&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="epigenetic-changes-in-patients-with-multiple-sclerosis---nov-2012">Epigenetic changes in patients with multiple sclerosis - Nov 2012&lt;/h2>
&lt;p>Nat Rev Neurol. 2012 Nov 20. &lt;a href="https://doi.org/10.1038/nrneurol.2012.226.">doi: 10.1038/nrneurol.2012.226.&lt;/a>&lt;/p>
&lt;p>Koch MW, Metz LM, Kovalchuk O.&lt;/p>
&lt;p>Department of Clinical Neurosciences, University of Calgary, Foothills Hospital, 1403-29th Street N. W., Calgary, AB T2N 2T9, Canada.&lt;/p>
&lt;p>Epigenetic changes influence gene expression without altering the DNA sequence. DNA methylation, histone modification and microRNA-associated post-transcriptional gene silencing are three key epigenetic mechanisms. Multiple sclerosis (MS) is a disease of the CNS with both inflammatory and neurodegenerative features. Although studies on epigenetic changes in MS only began in the past decade, a growing body of literature suggests that epigenetic changes may be involved in the development of MS, possibly by mediating the effects of environmental risk factors, such as&lt;/p></description></item><item><title>Is the Iranian Revolution to Blame for the Increasing Incidence of Multiple Sclerosis in Iran</title><link>/posts/is-the-iranian-revolution-to-blame-for-the-increasing-incidence-of-multiple-sclerosis-in-iran.html</link><pubDate>Mon, 15 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/is-the-iranian-revolution-to-blame-for-the-increasing-incidence-of-multiple-sclerosis-in-iran.html</guid><description>&lt;p>There are two items on this page&lt;/p>
&lt;hr>
&lt;h3 id="multiple-sclerosis-and-the-iranian-revolution">MULTIPLE SCLEROSIS AND THE IRANIAN REVOLUTION&lt;/h3>
&lt;p>J Neurol Neurosurg Psychiatry 2013;84:e2 doi:10.1136/jnnp-2013-306573.185&lt;/p>
&lt;p>Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23–24 October 2013&lt;/p>
&lt;p>Julia Pakpoor⇓,&lt;/p>
&lt;p>Sreeram Ramagopalan&lt;/p>
&lt;p>University of Oxford; Barts and the London School of Medicine and Dentistry&lt;/p>
&lt;p>Multiple Sclerosis (MS) is a complex neurological disorder most likely caused by gene–environment interactions. There is a latitudinal gradient of MS prevalence and vitamin D deficiency has been strongly implicated in MS aetiology. Iran is a country of high levels of sunshine which has previously been considered a low–risk MS region. However, Iran has recently observed an &lt;strong>&lt;span style="color:#F00;">8.3–fold rise in the incidence of MS between 1989–2006&lt;/span>.&lt;/strong> 1 Previous studies have indicated a genetic predisposition to MS in the Iranian population but genetic changes are unlikely to account for the substantial rise in MS over the last few decades. Thus, we aimed to develop a novel hypothesis to explain the identification of Iran as a high–risk MS region. We believe that the influence of decreased sunshine exposure and vitamin D levels on MS risk needs to be strongly considered in the context of Iran&amp;rsquo;s history. In 1979 the Iranian Revolution took place and a country previously under great Western influences became an Islamic republic. It became a government requirement for women to wear loose–fitting clothing and the veil in public; it has previously been shown that veiled women have lower vitamin D levels compared to unveiled women. This significant cultural shift would not only potentially explain the observed increase in MS but notably, it would account for the increasing female preponderance of MS in Iran. Given that the average age of MS onset is 30 years old and that MS incidence in Iran just over 30 years following the revolution is the highest so far recorded, an association with the Iranian revolution and reduced subsequent vitamin D levels in particularly pregnant women is likely. Lifestyle changes such as urbanization and use of sunscreen may to some extent have contributed to increased vitamin D deficiency, but these are unlikely to contribute to the particularly high increase in MS observed in Iran as these changes occurred across the developed world and there is no evidence to suggest that they were particularly great in Iran. &lt;strong>A similar high incidence of MS has been observed among Iranian immigrants in countries at high latitude such as Sweden&lt;/strong> where Iranian immigrants have a reported greater prevalence of MS compared to the general population, &lt;strong>despite wearing a veil not being a requirement.&lt;/strong> Instead it is well–known that UVB exposure is lower in countries at high latitude and thus, a similar effect of increased MS incidence due to vitamin D deficiency may be observed among those in Iran wearing the veil and those resident in countries at high latitude, even if they are not wearing the veil. Therefore, vitamin D repletion is a critical public health issue for Iranians both within and outside Iran, and could help prevent an emerging MS epidemic in this population. More generally, this region is highly interesting for MS research and highlights that regions of exception to the latitudinal gradient of MS prevalence are an under–appreciated and very useful resource in evaluating MS aetiology.&lt;/p></description></item><item><title>Infectious mononucleosis and lack of UV linearly linked to MS in England</title><link>/posts/infectious-mononucleosis-and-lack-of-uv-linearly-linked-to-ms-in-england.html</link><pubDate>Thu, 08 Dec 2011 00:00:00 +0000</pubDate><guid>/posts/infectious-mononucleosis-and-lack-of-uv-linearly-linked-to-ms-in-england.html</guid><description>&lt;h4 id="relationship-of-uv-exposure-to-prevalence-of-multiple-sclerosis-in-england">Relationship of UV exposure to prevalence of multiple sclerosis in England&lt;/h4>
&lt;p>Neurology. 2011 April 19; 76(16): 1410–1414. &lt;a href="https://doi.org/10.1212/WNL.0b013e318216715e">doi: 10.1212/WNL.0b013e318216715e&lt;/a>&lt;/p>
&lt;p>S.V. Ramagopalan, DPhil, A.E. Handel, BMBCh, G. Giovannoni, MD, S. Rutherford Siegel, PhD, G.C. Ebers, MD, FMedSci, &lt;a href="mailto:george.ebers@clneuro.ox.ac.uk">george.ebers@clneuro.ox.ac.uk&lt;/a> and G. Chaplin, MS &lt;a href="mailto:guc5@psu.edu">guc5@psu.edu&lt;/a>&lt;/p>
&lt;p>From the Wellcome Trust Centre for Human Genetics (S.V.R., A.E.H., G.C.E.) and Department of Clinical Neurology (S.V.R., A.E.H., G.C.E.), University of Oxford, Oxford; Blizard Institute of Cell and Molecular Science (S.V.R., G.G.), Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, UK; and Department of Anthropology (S.R.S., G.C.), The Pennsylvania State University, Philadelphia.&lt;/p></description></item><item><title>Primates Nutrient Requirements – 2003</title><link>/posts/primates-nutrient-requirements-2003.html</link><pubDate>Tue, 27 Sep 2011 00:00:00 +0000</pubDate><guid>/posts/primates-nutrient-requirements-2003.html</guid><description>&lt;h3 id="nutrient-requirements-of-nonhuman-primates-second-revised-edition">Nutrient Requirements of Nonhuman Primates: Second Revised Edition&lt;/h3>
&lt;p>&lt;strong>Committee on Animal Nutrition, Ad Hoc Committee on Nonhuman Primate Nutrition, National Research Council&lt;/strong>&lt;/p>
&lt;p>ISBN: 0-309-51524-6, 308 pages, 8.5 x 11, (2003)&lt;/p>
&lt;p>&lt;strong>Includes Vitamin D, Vitamin K, Sulfur, Iodine, Magnesium, and many others&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Note IU are typically given per&lt;/strong> &lt;span style="color:#00F;">kg of FEED&lt;/span> &lt;strong>not WEIGHT&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/primates-nutrional-requirements.pdf">Download the PDF from VitaminDWiki.&lt;/a>&lt;/strong>&lt;/p>
&lt;h3 id="vitamin-d">Vitamin D&lt;/h3>
&lt;p>For the primate species that have been studied, vitamin D is not an essential component of the diet as long as they have adequate exposure to sunlight (Holick, 1994). But it appears to be essential in the tissues of most primates for maintenance of calcium and phosphorus homeostasis and for normal bone mineralization (Holick, 1996). In the absence of solar exposure, these primates must be exposed to sources of artificial light of appropriate wavelengths or must receive sufficient vitamin D in the diet. In this review we will try to put into perspective what is known about vitamin D in humans and to compare this information with what is known about its role in nonhuman primates and other vertebrates.!&lt;/p></description></item><item><title>Multiple Sclerosis etc. strongly associated with Epstein-Barr virus (and vitamin D)</title><link>/posts/multiple-sclerosis-etc-strongly-associated-with-epstein-barr-virus-and-vitamin-d.html</link><pubDate>Thu, 25 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-etc-strongly-associated-with-epstein-barr-virus-and-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-epstein-barr-virus-and-endogenous-retroviruses-in-multiple-sclerosis---facts-and-hypotheses---march-2021">Vitamin D, Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis - facts and hypotheses - March 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#evidence-for-the-role-of-a-virus-in-ms-httpswwwnationalmssocietyorgwhat-is-mswhat-causes-msviruses-national-ms-org-2021">&lt;a href="https://www.nationalmssociety.org/What-is-MS/What-Causes-MS/Viruses">Evidence for the role of a virus in MS &lt;/a> National MS Org 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epsteinbarr-virus-in-multiple-sclerosis-theory-and-emerging-immunotherapies---march-2020">Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies - March 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-role-of-epstein-barr-virus-in-multiple-sclerosis">The role of Epstein-Barr virus in multiple sclerosis:&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#exploring-the-effect-of-vitamin-d3-supplementation-on-the-anti-ebv-antibody-response-in-relapsing-remitting-multiple-sclerosis---2018">Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis - 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epstein-barr-virus-and-mononucleosis">Epstein-Barr Virus and Mononucleosis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#other-diseases-associated-with-epstein-barr-virus">Other diseases associated with Epstein-Barr Virus&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-epstein-barr-virus-and-endogenous-retroviruses-in-multiple-sclerosis---facts-and-hypotheses---march-2021">Vitamin D, Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis - facts and hypotheses - March 2021&lt;/h4>
&lt;p>J Integr Neurosci. 2021 Mar 30;20(1):233-238. &lt;a href="https://doi.org/10.31083/j.jin.2021.01.392.">doi: 10.31083/j.jin.2021.01.392.&lt;/a>&lt;/p></description></item><item><title>People with no UV for 6 months in the winter need at least 2000 IU of vitamin D</title><link>/posts/people-with-no-uv-for-6-months-in-the-winter-need-at-least-2000-iu-of-vitamin-d.html</link><pubDate>Fri, 06 May 2011 00:00:00 +0000</pubDate><guid>/posts/people-with-no-uv-for-6-months-in-the-winter-need-at-least-2000-iu-of-vitamin-d.html</guid><description>&lt;h3 id="response-to-vitamin-d-supplementation-during-antarctic-winter-is-related-to-bmi">Response to vitamin D supplementation during Antarctic winter is related to BMI,&lt;/h3>
&lt;p>and supplementation can mitigate Epstein-Barr Virus Reactivation.&lt;/p>
&lt;p>J Nutr. 2011 Apr 1;141(4):692-7.&lt;/p>
&lt;p>Zwart SR, Mehta SK, Ploutz-Snyder R, Bourbeau Y, Locke JP, Pierson DL, Smith SM.&lt;/p>
&lt;p>Universities Space Research Association, Houston, TX 77058, USA.&lt;/p>
&lt;p>Maintaining vitamin D status without sunlight exposure is difficult without supplementation. This study was designed to better understand interrelationships between periodic vitamin D supplementation and immune function in Antarctic workers. The effect of 2 oral dosing regimens of vitamin D supplementation on vitamin D status and markers of immune function was evaluated in people in Antarctica with no UV light exposure for 6 mo.&lt;/p></description></item><item><title>Overview MS and vitamin D</title><link>/posts/overview-ms-and-vitamin-d.html</link><pubDate>Tue, 03 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/overview-ms-and-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#ms-and-vitamin-d-overview">MS and Vitamin D Overview&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#health-problems-which-occur-up-to-5-years-before-depression-constipation-utis-and-sexual-dysfunction">Health problems which occur up to 5 years before: Depression, constipation, UTIs, and sexual dysfunction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#genes-ms-and-vitamin-d">Genes, MS, and Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#low-d-leads-to-ms-which-further-lowers-vitamin-d">Low D leads to MS which further lowers vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#as-ms-progresses-msers-tend-to-stop-working">As MS progresses, MSers tend to stop working&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#decreased-ms-relapse-rate-with-better-diet---2015">Decreased MS relapse rate with better diet - 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#increasing-cost-of-ms-drugs---too-big-to-fail">Increasing cost of MS drugs - too big to fail?&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="ms-and-vitamin-d-overview">MS and Vitamin D Overview&lt;/h4>
&lt;!-- ~tc~ start ~/tc~ -->
&lt;p>&lt;strong>&lt;span style="color:#00F;">Clinical interventions have shown that Vitamin D can prevent, treat, and even cure Multiple Sclerosis, at a tiny fraction of the cost of the drugs now used to treat it, and without side effects.&lt;/span>&lt;/strong>&lt;/p></description></item><item><title>Overview Fibromyalgia or Chronic Fatigue and vitamin D</title><link>/posts/overview-fibromyalgia-or-chronic-fatigue-and-vitamin-d.html</link><pubDate>Wed, 09 Jun 2010 00:00:00 +0000</pubDate><guid>/posts/overview-fibromyalgia-or-chronic-fatigue-and-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-is-one-of-10-nutritional-supplements-which-appear-to-treat-fibromyalgia-combo-needed--july-2024">Vitamin D is one of 10 nutritional supplements which appear to treat Fibromyalgia (combo needed?) – July 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#chronic-fatigue-syndrome-and-long-haulcovid-19">Chronic Fatigue Syndrome and Long-haul COVID-19&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cfs-and-virus-as-of-sept-2024-include">CFS and Virus as of Sept 2024 include:&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mecfs-study-feb-2024-deep-phenotyping-identifies-abnormalities-in-mecfshttpswwwmdedgecominternalmedicinearticle267956immunologydeep-phenotyping-identifies-abnormalities-mecfsecdwnl_eve_240222_mdedge-md-edge--deep-phenotyping-of-post-infectious-myalgic-encephalomyelitischronic-fatigue-syndrome-httpsdoiorg101038s41467-024-45107-3httpsdoiorg101038s41467-024-45107-3-free-pdf">ME/CFS study Feb 2024** &lt;a href="https://www.mdedge.com/internalmedicine/article/267956/immunology/deep-phenotyping-identifies-abnormalities-me/cfs?ecd=WNL_EVE_240222_mdedge">‘Deep Phenotyping’ Identifies Abnormalities in ME/CFS&lt;/a> MD Edge **** Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome **&lt;a href="https://doi.org/10.1038/s41467-024-45107-3">https://doi.org/10.1038/s41467-024-45107-3&lt;/a> FREE PDF&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#17-of-american-women-now-have-mecfs---2022-cdc-dec-2023httpswwwcdcgovnchsproductsdatabriefsdb488htm-2021-2022">1.7% of American women now have ME/CFS - 2022 &lt;a href="https://www.cdc.gov/nchs/products/databriefs/db488.htm">CDC Dec 2023&lt;/a> (2021-2022)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#fibromyalgia-treated-with-50000-iu-vitamin-d-weekly-and-rehab-therapy-for-6-months--june2022-can-the-combination-of-rehabilitation-and-vitamin-d-supplementation-improve-fibromyalgia-symptoms-at-all-ages--j-funct-morphol-kinesiol-2022-jun-207251-doi-103390jfmk7020051httpsdoiorg103390jfmk7020051">Fibromyalgia treated with 50,000 IU Vitamin D weekly and rehab therapy for 6 months – June 2022** Can the Combination of Rehabilitation and Vitamin D Supplementation Improve Fibromyalgia Symptoms at All Ages? **J Funct Morphol Kinesiol. 2022 Jun 20;7(2):51. &lt;a href="https://doi.org/10.3390/jfmk7020051.">doi: 10.3390/jfmk7020051.&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#11-of-12-studies-found-vitamin-d-helped-fibromyalgia---review-march2022-efficacy-of-vitamin-d-supplementation-in-the-improvement-of-clinical-status-in-patients-diagnosed-with-fibromyalgia-syndrome-a-systematic-review-curr-rheumatol-rev-2022-mar-7-doi-1021741573397118666220307122152httpsdoiorg1021741573397118666220307122152-behind-95-paywall">11 of 12 studies found Vitamin D helped Fibromyalgia - review March 2022** Efficacy of Vitamin D Supplementation in the Improvement of Clinical Status in Patients Diagnosed with Fibromyalgia Syndrome: A Systematic Review **Curr Rheumatol Rev. 2022 Mar 7. &lt;a href="https://doi.org/10.2174/1573397118666220307122152">doi: 10.2174/1573397118666220307122152&lt;/a> behind $95 paywall&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#german-website-and-book--relief-in-1week---2014">German website and book – relief in 1 week - 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#4-vitamin-d-books-with-sections-on-chronic-painfibromyalgia">4 Vitamin D books with sections on Chronic Pain/ Fibromyalgia&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#loading-dose-of-vitamind">Loading Dose of Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#after-loading-the-dose-just-one-tiny-capsule-every-2weeks">After loading the dose, just one tiny capsule every 2 weeks&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#fibromyalgia-worse-if-low-vitamin-d--june2020-association-between-low-vitamin-d-levels-and-the-greater-impact-of-fibromyalgia-j-clin-med-res-2020-jul127436-442-doi-1014740jocmr4136httpsdoiorg1014740jocmr4136">Fibromyalgia worse if low vitamin D – June 2020** Association Between Low Vitamin D Levels and the Greater Impact of Fibromyalgia **J Clin Med Res. 2020 Jul;12(7):436-442. &lt;a href="https://doi.org/10.14740/jocmr4136">doi: 10.14740/jocmr4136&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-pubmed---cfs-fibromyalgia-and-vitamind-search-for-fibromyalgia-or-chronic-fatigue-vitamin-d-httpswwwncbinlmnihgovpubmedtermfibromyalgia20or20chronic20fatigue20vitamin20d-141-items-as-of-april-2024--psychological-outcomes-and-quality-of-life-of-fibromyalgia-patients-with-vitamin-d-supplementation-a-meta-analysis---april-2023-doi-103390jcm12072750httpsdoiorg103390jcm12072750-free-pdf-8-trials-looks-good">See also PubMed - CFS, Fibromyalgia, and Vitamin D.** &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=(fibromyalgia%20OR%20%22Chronic%20Fatigue%22)%20%22vitamin%20d%22">Search for (fibromyalgia OR &amp;ldquo;Chronic Fatigue&amp;rdquo;) &amp;ldquo;vitamin d&amp;rdquo; &lt;/a> 141 items as of April 2024 *** Psychological Outcomes and Quality of Life of Fibromyalgia Patients with Vitamin D Supplementation-A Meta-Analysis - April 2023 &lt;a href="https://doi.org/10.3390/jcm12072750.">doi: 10.3390/jcm12072750.&lt;/a> FREE PDF 8 trials looks good&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web---cfsfibromyalgia">See also web - CFS, Fibromyalgia&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#me-and-cfs-share-85-of-the-altered-genes---jan-2024-chronic-fatigue-syndrome-and-fibromyalgia-a-single-disease-entityhttpswwwmdedgecomneurologyarticle267402neurologychronic-fatigue-syndrome-and-fibromyalgia-single-disease-entityecdwnl_eve_240117_mdedge-md-edge--close-to-2100-proteins-were-identified-of-which-nearly-1800-were-common-to-both-conditions">ME and CFS share 85% of the altered genes - Jan 2024** &lt;a href="https://www.mdedge.com/neurology/article/267402/neurology/chronic-fatigue-syndrome-and-fibromyalgia-single-disease-entity?ecd=WNL_EVE_240117_mdedge">Chronic Fatigue Syndrome and Fibromyalgia: A Single Disease Entity?&lt;/a> MD Edge *** &amp;ldquo;Close to 2,100 proteins were identified, of which nearly 1,800 were common to both conditions.&amp;rdquo;&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#fibromyalgia-description---diagnosis-takes-manyyears">Fibromyalgia description - diagnosis takes many years&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#fibromyalgia-pain-is-worse-than-laborpain---1988">Fibromyalgia pain is worse than labor pain - 1988&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nice-body-chart-by-drcareyhttpdrcareydachmanwordpresscom">Nice body chart by &lt;a href="http://drcareydachman.wordpress.com/">Dr. Carey&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#easyimmunehealthhttpwwweasy-immune-healthcomfibromyalgia-and-vitamin-dhtml2014-fibromyalgia-and-vitamin-d-dont-get-misdiagnosed--fibromyalgia-and-vitamin-d-deficiency-very-often-have-completely-identical-symptoms--large-numbers-of-people-have-been-misdiagnosed-with-fibromyalgia-when-they-simply-have-vitamin-d-deficiency--dont-be-one-of-them">&lt;a href="http://www.easy-immune-health.com/fibromyalgia-and-vitamin-d.html">EasyImmuneHealth&lt;/a> 2014?** Fibromyalgia and Vitamin D Don&amp;rsquo;t Get Misdiagnosed **** Fibromyalgia and Vitamin D Deficiency very often have COMPLETELY IDENTICAL symptoms. **Large numbers of people have been misdiagnosed with Fibromyalgia when they simply have Vitamin D Deficiency- don&amp;rsquo;t be one of them.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#chronic-fatigue-syndrome-associated-with-different-gutbacteria">Chronic Fatigue Syndrome associated with different gut bacteria&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#5-common-causes-of-chronic-fatigue---sept2018-5-common-causes-of-chronic-fatigue-and-tests-that-help-reveal-the-causehttpswwwselfhackedcomblogchronic-fatigue-blood-testsmpweb1367-228-20028-self-hacked-1-anemia-iron-deficiency-vitamin-b12-deficiency-folate-vitamin-b9-deficiency">5 Common Causes of Chronic Fatigue - Sept 2018** &lt;a href="https://www.selfhacked.com/blog/chronic-fatigue-blood-tests/?mpweb=1367-228-20028">5 Common Causes of Chronic Fatigue and Tests That Help Reveal The Cause&lt;/a> Self Hacked **1) Anemia: Iron Deficiency, Vitamin B12 Deficiency, Folate (Vitamin B9) Deficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-fights-fibromyalgia---a-few-pubmedstudies">Magnesium fights Fibromyalgia - a few PubMed studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#a-wiki-dedicated-to-me-chronic-fatiguesyndrome---jan-2024-httpsme-pediaorgwikihttpsme-pediaorgwiki-3300-entries-as-of-jan-2024">A Wiki dedicated to ME/ Chronic Fatigue Syndrome - Jan 2024** &lt;a href="https://me-pedia.org/wiki">https://me-pedia.org/wiki&lt;/a> **3,300 entries as of Jan 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cfs-sufferer-for-25-years-helped-by-improving-his-mitochondria---may2022-toby-rodgershttpstobyrogerssubstackcompchronic-pain-mecfs-post-exertionalsr--he-was-helped-by-sarah-myhills-book-diagnosis-and-treatment-of-chronic-fatigue-syndrome-and-myalgic-encephalitis-2nd-ed-its-mitochondria-not-hypochondria">CFS sufferer for 25 years helped by improving his mitochondria - May 2022** &lt;a href="https://tobyrogers.substack.com/p/chronic-pain-mecfs-post-exertional?s=r">Toby Rodgers&lt;/a> *** He was helped by Sarah Myhill’s book, Diagnosis and Treatment of Chronic Fatigue Syndrome and Myalgic Encephalitis, 2nd ed.: It’s Mitochondria, Not Hypochondria&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="vitamin-d-is-one-of-10-nutritional-supplements-which-appear-to-treat-fibromyalgia-combo-needed--july-2024">Vitamin D is one of 10 nutritional supplements which appear to treat Fibromyalgia (combo needed?) – July 2024&lt;/h4>
&lt;p>**Neuronutritional Approach to Fibromyalgia Management: A Narrative Review&lt;/p></description></item></channel></rss>